id	sid	tid	token	lemma	pos
dpc-6006	1	1	dermatology	dermatology	NOUN
dpc-6006	1	2	:	:	PUNCT
dpc-6006	1	3	practical	practical	ADJ
dpc-6006	1	4	and	and	CCONJ
dpc-6006	1	5	conceptual	conceptual	ADJ
dpc-6006	1	6	original	original	ADJ
dpc-6006	1	7	article	article	NOUN
dpc-6006	1	8	|	|	ADV
dpc-6006	1	9	dermatol	dermatol	ADJ
dpc-6006	1	10	pract	pract	NOUN
dpc-6006	1	11	concept	concept	NOUN
dpc-6006	1	12	.	.	PUNCT
dpc-6006	2	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	2	2	1	1	NUM
dpc-6006	2	3	clinicopathological	clinicopathological	ADJ
dpc-6006	2	4	factors	factor	NOUN
dpc-6006	2	5	predicting	predict	VERB
dpc-6006	2	6	melanoma	melanoma	NOUN
dpc-6006	2	7	recurrence	recurrence	NOUN
dpc-6006	2	8	:	:	PUNCT
dpc-6006	2	9	a	a	DET
dpc-6006	2	10	study	study	NOUN
dpc-6006	2	11	from	from	ADP
dpc-6006	2	12	south	south	PROPN
dpc-6006	2	13	east	east	PROPN
dpc-6006	2	14	ireland	ireland	PROPN
dpc-6006	2	15	aneela	aneela	PROPN
dpc-6006	2	16	razzaq1	razzaq1	PROPN
dpc-6006	2	17	,	,	PUNCT
dpc-6006	2	18	maryam	maryam	PROPN
dpc-6006	2	19	shahad2	shahad2	PROPN
dpc-6006	2	20	,	,	PUNCT
dpc-6006	2	21	anam	anam	PROPN
dpc-6006	2	22	allah	allah	PROPN
dpc-6006	2	23	ditta3	ditta3	PROPN
dpc-6006	2	24	1	1	NUM
dpc-6006	2	25	department	department	NOUN
dpc-6006	2	26	of	of	ADP
dpc-6006	2	27	breast	breast	NOUN
dpc-6006	2	28	,	,	PUNCT
dpc-6006	2	29	endocrine	endocrine	NOUN
dpc-6006	2	30	and	and	CCONJ
dpc-6006	2	31	general	general	ADJ
dpc-6006	2	32	surgery	surgery	NOUN
dpc-6006	2	33	,	,	PUNCT
dpc-6006	2	34	university	university	NOUN
dpc-6006	2	35	hospital	hospital	NOUN
dpc-6006	2	36	waterford	waterford	PROPN
dpc-6006	2	37	,	,	PUNCT
dpc-6006	2	38	ireland	ireland	NOUN
dpc-6006	2	39	2	2	NUM
dpc-6006	2	40	surgical	surgical	ADJ
dpc-6006	2	41	registrar	registrar	NOUN
dpc-6006	2	42	,	,	PUNCT
dpc-6006	2	43	watim	watim	NOUN
dpc-6006	2	44	medical	medical	ADJ
dpc-6006	2	45	and	and	CCONJ
dpc-6006	2	46	general	general	ADJ
dpc-6006	2	47	hospital	hospital	NOUN
dpc-6006	2	48	,	,	PUNCT
dpc-6006	2	49	pakistan	pakistan	PROPN
dpc-6006	2	50	3	3	NUM
dpc-6006	2	51	military	military	ADJ
dpc-6006	2	52	hospital	hospital	NOUN
dpc-6006	2	53	,	,	PUNCT
dpc-6006	2	54	rawalpindi	rawalpindi	PROPN
dpc-6006	2	55	,	,	PUNCT
dpc-6006	2	56	pakistan	pakistan	PROPN
dpc-6006	2	57	key	key	ADJ
dpc-6006	2	58	words	word	NOUN
dpc-6006	2	59	:	:	PUNCT
dpc-6006	3	1	melanoma	melanoma	ADJ
dpc-6006	3	2	,	,	PUNCT
dpc-6006	3	3	clinicopathological	clinicopathological	ADJ
dpc-6006	3	4	predictors	predictor	NOUN
dpc-6006	3	5	,	,	PUNCT
dpc-6006	3	6	recurrence	recurrence	NOUN
dpc-6006	3	7	,	,	PUNCT
dpc-6006	3	8	clark	clark	NOUN
dpc-6006	3	9	level	level	NOUN
dpc-6006	3	10	,	,	PUNCT
dpc-6006	3	11	lymphovascular	lymphovascular	ADJ
dpc-6006	3	12	invasion	invasion	NOUN
dpc-6006	3	13	citation	citation	NOUN
dpc-6006	3	14	:	:	PUNCT
dpc-6006	3	15	razzaq	razzaq	VERB
dpc-6006	3	16	a	a	PRON
dpc-6006	3	17	,	,	PUNCT
dpc-6006	3	18	shahad	shahad	PROPN
dpc-6006	3	19	m	m	PROPN
dpc-6006	3	20	,	,	PUNCT
dpc-6006	3	21	ditta	ditta	PROPN
dpc-6006	3	22	aa	aa	PROPN
dpc-6006	3	23	.	.	PUNCT
dpc-6006	4	1	clinicopathological	clinicopathological	ADJ
dpc-6006	4	2	factors	factor	NOUN
dpc-6006	4	3	predicting	predict	VERB
dpc-6006	4	4	melanoma	melanoma	NOUN
dpc-6006	4	5	recurrence	recurrence	NOUN
dpc-6006	4	6	:	:	PUNCT
dpc-6006	4	7	a	a	DET
dpc-6006	4	8	study	study	NOUN
dpc-6006	4	9	from	from	ADP
dpc-6006	4	10	south	south	PROPN
dpc-6006	4	11	east	east	PROPN
dpc-6006	4	12	ireland	ireland	PROPN
dpc-6006	4	13	.	.	PUNCT
dpc-6006	5	1	dermatol	dermatol	NOUN
dpc-6006	5	2	pract	pract	PROPN
dpc-6006	5	3	concept	concept	NOUN
dpc-6006	5	4	.	.	PUNCT
dpc-6006	6	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	6	2	.	.	PUNCT
dpc-6006	7	1	doi	doi	NOUN
dpc-6006	7	2	:	:	PUNCT
dpc-6006	7	3	https://doi.org/10.5826/dpc.1504a6006	https://doi.org/10.5826/dpc.1504a6006	PROPN
dpc-6006	7	4	accepted	accept	VERB
dpc-6006	7	5	:	:	PUNCT
dpc-6006	7	6	october	october	PROPN
dpc-6006	7	7	6	6	NUM
dpc-6006	7	8	,	,	PUNCT
dpc-6006	7	9	2025	2025	NUM
dpc-6006	7	10	;	;	PUNCT
dpc-6006	7	11	published	publish	VERB
dpc-6006	7	12	:	:	PUNCT
dpc-6006	8	1	october	october	PROPN
dpc-6006	8	2	2025	2025	NUM
dpc-6006	8	3	copyright	copyright	NOUN
dpc-6006	8	4	:	:	PUNCT
dpc-6006	8	5	©	©	PROPN
dpc-6006	8	6	2025	2025	NUM
dpc-6006	8	7	razzaq	razzaq	X
dpc-6006	8	8	et	et	PROPN
dpc-6006	8	9	al	al	PROPN
dpc-6006	8	10	.	.	PUNCT
dpc-6006	9	1	this	this	PRON
dpc-6006	9	2	is	be	AUX
dpc-6006	9	3	an	an	DET
dpc-6006	9	4	open	open	ADJ
dpc-6006	9	5	-	-	PUNCT
dpc-6006	9	6	access	access	NOUN
dpc-6006	9	7	article	article	NOUN
dpc-6006	9	8	distributed	distribute	VERB
dpc-6006	9	9	under	under	ADP
dpc-6006	9	10	the	the	DET
dpc-6006	9	11	terms	term	NOUN
dpc-6006	9	12	of	of	ADP
dpc-6006	9	13	the	the	DET
dpc-6006	9	14	creative	creative	ADJ
dpc-6006	9	15	commons	common	NOUN
dpc-6006	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-6006	9	17	license	license	NOUN
dpc-6006	9	18	(	(	PUNCT
dpc-6006	9	19	by	by	ADP
dpc-6006	9	20	-	-	PUNCT
dpc-6006	9	21	nc-4.0	nc-4.0	NOUN
dpc-6006	9	22	)	)	PUNCT
dpc-6006	9	23	,	,	PUNCT
dpc-6006	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-6006	9	25	,	,	PUNCT
dpc-6006	9	26	which	which	PRON
dpc-6006	9	27	permits	permit	VERB
dpc-6006	9	28	unrestricted	unrestricted	ADJ
dpc-6006	9	29	noncommercial	noncommercial	ADJ
dpc-6006	9	30	use	use	NOUN
dpc-6006	9	31	,	,	PUNCT
dpc-6006	9	32	distribution	distribution	NOUN
dpc-6006	9	33	,	,	PUNCT
dpc-6006	9	34	and	and	CCONJ
dpc-6006	9	35	reproduction	reproduction	NOUN
dpc-6006	9	36	in	in	ADP
dpc-6006	9	37	any	any	DET
dpc-6006	9	38	medium	medium	NOUN
dpc-6006	9	39	,	,	PUNCT
dpc-6006	9	40	provided	provide	VERB
dpc-6006	9	41	the	the	DET
dpc-6006	9	42	original	original	ADJ
dpc-6006	9	43	authors	author	NOUN
dpc-6006	9	44	and	and	CCONJ
dpc-6006	9	45	source	source	NOUN
dpc-6006	9	46	are	be	AUX
dpc-6006	9	47	credited	credit	VERB
dpc-6006	9	48	.	.	PUNCT
dpc-6006	10	1	funding	funding	NOUN
dpc-6006	10	2	:	:	PUNCT
dpc-6006	10	3	none	none	NOUN
dpc-6006	10	4	.	.	PUNCT
dpc-6006	11	1	competing	compete	VERB
dpc-6006	11	2	interests	interest	NOUN
dpc-6006	11	3	:	:	PUNCT
dpc-6006	11	4	none	none	NOUN
dpc-6006	11	5	.	.	PUNCT
dpc-6006	12	1	authorship	authorship	NOUN
dpc-6006	12	2	:	:	PUNCT
dpc-6006	12	3	all	all	DET
dpc-6006	12	4	authors	author	NOUN
dpc-6006	12	5	have	have	AUX
dpc-6006	12	6	contributed	contribute	VERB
dpc-6006	12	7	significantly	significantly	ADV
dpc-6006	12	8	to	to	ADP
dpc-6006	12	9	this	this	DET
dpc-6006	12	10	publication	publication	NOUN
dpc-6006	12	11	.	.	PUNCT
dpc-6006	13	1	corresponding	correspond	VERB
dpc-6006	13	2	author	author	NOUN
dpc-6006	13	3	:	:	PUNCT
dpc-6006	13	4	aneela	aneela	X
dpc-6006	13	5	razzaq	razzaq	PROPN
dpc-6006	13	6	,	,	PUNCT
dpc-6006	13	7	mbbs	mbbs	PROPN
dpc-6006	13	8	,	,	PUNCT
dpc-6006	13	9	mrcs	mrcs	NOUN
dpc-6006	13	10	,	,	PUNCT
dpc-6006	13	11	fcps(i	fcps(i	NOUN
dpc-6006	13	12	/	/	SYM
dpc-6006	13	13	imm	imm	NOUN
dpc-6006	13	14	)	)	PUNCT
dpc-6006	13	15	,	,	PUNCT
dpc-6006	13	16	department	department	NOUN
dpc-6006	13	17	of	of	ADP
dpc-6006	13	18	breast	breast	NOUN
dpc-6006	13	19	,	,	PUNCT
dpc-6006	13	20	endocrine	endocrine	NOUN
dpc-6006	13	21	and	and	CCONJ
dpc-6006	13	22	general	general	ADJ
dpc-6006	13	23	surgery	surgery	NOUN
dpc-6006	13	24	,	,	PUNCT
dpc-6006	13	25	university	university	NOUN
dpc-6006	13	26	hospital	hospital	NOUN
dpc-6006	13	27	waterford	waterford	PROPN
dpc-6006	13	28	,	,	PUNCT
dpc-6006	13	29	dunmore	dunmore	PROPN
dpc-6006	13	30	road	road	PROPN
dpc-6006	13	31	,	,	PUNCT
dpc-6006	13	32	waterford	waterford	PROPN
dpc-6006	13	33	,	,	PUNCT
dpc-6006	13	34	x91	x91	PROPN
dpc-6006	13	35	er8e	er8e	PROPN
dpc-6006	13	36	,	,	PUNCT
dpc-6006	13	37	ireland	ireland	NOUN
dpc-6006	13	38	.	.	PUNCT
dpc-6006	14	1	orchid	orchid	PROPN
dpc-6006	14	2	i	i	PROPN
dpc-6006	14	3	d	d	PROPN
dpc-6006	14	4	:	:	PUNCT
dpc-6006	14	5	0009	0009	NUM
dpc-6006	14	6	-	-	SYM
dpc-6006	14	7	0005	0005	NUM
dpc-6006	14	8	-	-	PUNCT
dpc-6006	14	9	4107	4107	NUM
dpc-6006	14	10	-	-	SYM
dpc-6006	14	11	4801	4801	NUM
dpc-6006	14	12	.	.	PUNCT
dpc-6006	15	1	e	e	X
dpc-6006	15	2	-	-	NOUN
dpc-6006	15	3	mail	mail	NOUN
dpc-6006	15	4	:	:	PUNCT
dpc-6006	16	1	aneelarazzaq34@gmail.com	aneelarazzaq34@gmail.com	X
dpc-6006	16	2	introduction	introduction	NOUN
dpc-6006	16	3	:	:	PUNCT
dpc-6006	16	4	cutaneous	cutaneous	ADJ
dpc-6006	16	5	malignant	malignant	ADJ
dpc-6006	16	6	melanoma	melanoma	NOUN
dpc-6006	16	7	is	be	AUX
dpc-6006	16	8	a	a	DET
dpc-6006	16	9	neoplastic	neoplastic	ADJ
dpc-6006	16	10	transformation	transformation	NOUN
dpc-6006	16	11	of	of	ADP
dpc-6006	16	12	melanocytes	melanocyte	NOUN
dpc-6006	16	13	and	and	CCONJ
dpc-6006	16	14	a	a	DET
dpc-6006	16	15	major	major	ADJ
dpc-6006	16	16	cause	cause	NOUN
dpc-6006	16	17	of	of	ADP
dpc-6006	16	18	skin	skin	NOUN
dpc-6006	16	19	cancer	cancer	NOUN
dpc-6006	16	20	–	–	PUNCT
dpc-6006	16	21	related	relate	VERB
dpc-6006	16	22	mortality	mortality	NOUN
dpc-6006	16	23	.	.	PUNCT
dpc-6006	17	1	ireland	ireland	PROPN
dpc-6006	17	2	,	,	PUNCT
dpc-6006	17	3	with	with	ADP
dpc-6006	17	4	its	its	PRON
dpc-6006	17	5	fair	fair	ADJ
dpc-6006	17	6	-	-	PUNCT
dpc-6006	17	7	skinned	skinned	ADJ
dpc-6006	17	8	population	population	NOUN
dpc-6006	17	9	,	,	PUNCT
dpc-6006	17	10	continues	continue	VERB
dpc-6006	17	11	to	to	PART
dpc-6006	17	12	see	see	VERB
dpc-6006	17	13	rising	rise	VERB
dpc-6006	17	14	incidence	incidence	NOUN
dpc-6006	17	15	rates	rate	NOUN
dpc-6006	17	16	,	,	PUNCT
dpc-6006	17	17	highlighting	highlight	VERB
dpc-6006	17	18	the	the	DET
dpc-6006	17	19	importance	importance	NOUN
dpc-6006	17	20	of	of	ADP
dpc-6006	17	21	identifying	identify	VERB
dpc-6006	17	22	clinicopathological	clinicopathological	ADJ
dpc-6006	17	23	predictors	predictor	NOUN
dpc-6006	17	24	of	of	ADP
dpc-6006	17	25	recurrence	recurrence	NOUN
dpc-6006	17	26	.	.	PUNCT
dpc-6006	18	1	objectives	objective	NOUN
dpc-6006	18	2	:	:	PUNCT
dpc-6006	18	3	to	to	PART
dpc-6006	18	4	assess	assess	VERB
dpc-6006	18	5	the	the	DET
dpc-6006	18	6	relationship	relationship	NOUN
dpc-6006	18	7	between	between	ADP
dpc-6006	18	8	excision	excision	NOUN
dpc-6006	18	9	margins	margin	NOUN
dpc-6006	18	10	and	and	CCONJ
dpc-6006	18	11	melanoma	melanoma	NOUN
dpc-6006	18	12	recurrence	recurrence	NOUN
dpc-6006	18	13	,	,	PUNCT
dpc-6006	18	14	with	with	ADP
dpc-6006	18	15	emphasis	emphasis	NOUN
dpc-6006	18	16	on	on	ADP
dpc-6006	18	17	anatomical	anatomical	ADJ
dpc-6006	18	18	distribution	distribution	NOUN
dpc-6006	18	19	and	and	CCONJ
dpc-6006	18	20	clinicopathological	clinicopathological	ADJ
dpc-6006	18	21	features	feature	NOUN
dpc-6006	18	22	.	.	PUNCT
dpc-6006	19	1	methods	method	NOUN
dpc-6006	19	2	:	:	PUNCT
dpc-6006	19	3	this	this	DET
dpc-6006	19	4	retrospective	retrospective	ADJ
dpc-6006	19	5	observational	observational	ADJ
dpc-6006	19	6	study	study	NOUN
dpc-6006	19	7	analyzed	analyze	VERB
dpc-6006	19	8	565	565	NUM
dpc-6006	19	9	patient	patient	NOUN
dpc-6006	19	10	records	record	NOUN
dpc-6006	19	11	from	from	ADP
dpc-6006	19	12	university	university	NOUN
dpc-6006	19	13	hospital	hospital	PROPN
dpc-6006	19	14	waterford	waterford	PROPN
dpc-6006	19	15	,	,	PUNCT
dpc-6006	19	16	ireland	ireland	PROPN
dpc-6006	19	17	,	,	PUNCT
dpc-6006	19	18	meeting	meet	VERB
dpc-6006	19	19	predefined	predefine	VERB
dpc-6006	19	20	criteria	criterion	NOUN
dpc-6006	19	21	.	.	PUNCT
dpc-6006	20	1	data	datum	NOUN
dpc-6006	20	2	collected	collect	VERB
dpc-6006	20	3	included	include	VERB
dpc-6006	20	4	age	age	NOUN
dpc-6006	20	5	,	,	PUNCT
dpc-6006	20	6	sex	sex	NOUN
dpc-6006	20	7	,	,	PUNCT
dpc-6006	20	8	primary	primary	ADJ
dpc-6006	20	9	tumor	tumor	NOUN
dpc-6006	20	10	site	site	NOUN
dpc-6006	20	11	,	,	PUNCT
dpc-6006	20	12	disease	disease	NOUN
dpc-6006	20	13	stage	stage	NOUN
dpc-6006	20	14	,	,	PUNCT
dpc-6006	20	15	breslow	breslow	ADJ
dpc-6006	20	16	thickness	thickness	NOUN
dpc-6006	20	17	,	,	PUNCT
dpc-6006	20	18	clark	clark	NOUN
dpc-6006	20	19	level	level	NOUN
dpc-6006	20	20	,	,	PUNCT
dpc-6006	20	21	mitotic	mitotic	ADJ
dpc-6006	20	22	figures	figure	NOUN
dpc-6006	20	23	,	,	PUNCT
dpc-6006	20	24	ulceration	ulceration	NOUN
dpc-6006	20	25	,	,	PUNCT
dpc-6006	20	26	lymphovascular	lymphovascular	PROPN
dpc-6006	20	27	invasion	invasion	NOUN
dpc-6006	20	28	,	,	PUNCT
dpc-6006	20	29	sentinel	sentinel	ADJ
dpc-6006	20	30	lymph	lymph	NOUN
dpc-6006	20	31	node	node	NOUN
dpc-6006	20	32	involvement	involvement	NOUN
dpc-6006	20	33	,	,	PUNCT
dpc-6006	20	34	and	and	CCONJ
dpc-6006	20	35	adequacy	adequacy	NOUN
dpc-6006	20	36	of	of	ADP
dpc-6006	20	37	excision	excision	NOUN
dpc-6006	20	38	margins	margin	NOUN
dpc-6006	20	39	.	.	PUNCT
dpc-6006	21	1	statistical	statistical	ADJ
dpc-6006	21	2	analysis	analysis	NOUN
dpc-6006	21	3	was	be	AUX
dpc-6006	21	4	conducted	conduct	VERB
dpc-6006	21	5	using	use	VERB
dpc-6006	21	6	spss	spss	PROPN
dpc-6006	21	7	26.0	26.0	NUM
dpc-6006	21	8	.	.	PUNCT
dpc-6006	22	1	results	result	NOUN
dpc-6006	22	2	:	:	PUNCT
dpc-6006	22	3	significant	significant	ADJ
dpc-6006	22	4	predictors	predictor	NOUN
dpc-6006	22	5	of	of	ADP
dpc-6006	22	6	recurrence	recurrence	NOUN
dpc-6006	22	7	included	include	VERB
dpc-6006	22	8	age	age	NOUN
dpc-6006	22	9	≥65	≥65	NUM
dpc-6006	22	10	years	year	NOUN
dpc-6006	22	11	,	,	PUNCT
dpc-6006	22	12	breslow	breslow	ADJ
dpc-6006	22	13	thickness	thickness	NOUN
dpc-6006	22	14	>	>	X
dpc-6006	22	15	4.0	4.0	NUM
dpc-6006	22	16	mm	mm	NOUN
dpc-6006	22	17	,	,	PUNCT
dpc-6006	22	18	clark	clark	NOUN
dpc-6006	22	19	level	level	NOUN
dpc-6006	22	20	iv	iv	NUM
dpc-6006	22	21	–	–	PUNCT
dpc-6006	22	22	v	v	NOUN
dpc-6006	22	23	,	,	PUNCT
dpc-6006	22	24	ulceration	ulceration	NOUN
dpc-6006	22	25	,	,	PUNCT
dpc-6006	22	26	lymphovascular	lymphovascular	ADJ
dpc-6006	22	27	invasion	invasion	NOUN
dpc-6006	22	28	(	(	PUNCT
dpc-6006	22	29	p<0.001	p<0.001	PROPN
dpc-6006	22	30	)	)	PUNCT
dpc-6006	22	31	,	,	PUNCT
dpc-6006	22	32	and	and	CCONJ
dpc-6006	22	33	positive	positive	ADJ
dpc-6006	22	34	sentinel	sentinel	NOUN
dpc-6006	22	35	lymph	lymph	NOUN
dpc-6006	22	36	node	node	PROPN
dpc-6006	22	37	biopsy	biopsy	NOUN
dpc-6006	22	38	(	(	PUNCT
dpc-6006	22	39	p=0.004	p=0.004	PROPN
dpc-6006	22	40	)	)	PUNCT
dpc-6006	22	41	.	.	PUNCT
dpc-6006	23	1	inadequate	inadequate	ADJ
dpc-6006	23	2	excision	excision	NOUN
dpc-6006	23	3	margins	margin	NOUN
dpc-6006	23	4	were	be	AUX
dpc-6006	23	5	also	also	ADV
dpc-6006	23	6	linked	link	VERB
dpc-6006	23	7	to	to	ADP
dpc-6006	23	8	increased	increase	VERB
dpc-6006	23	9	recurrence	recurrence	NOUN
dpc-6006	23	10	.	.	PUNCT
dpc-6006	24	1	conversely	conversely	ADV
dpc-6006	24	2	,	,	PUNCT
dpc-6006	24	3	early	early	ADJ
dpc-6006	24	4	-	-	PUNCT
dpc-6006	24	5	stage	stage	NOUN
dpc-6006	24	6	disease	disease	NOUN
dpc-6006	24	7	,	,	PUNCT
dpc-6006	24	8	thin	thin	ADJ
dpc-6006	24	9	breslow	breslow	ADJ
dpc-6006	24	10	lesions	lesion	NOUN
dpc-6006	24	11	(	(	PUNCT
dpc-6006	24	12	≤1.0	≤1.0	X
dpc-6006	24	13	mm	mm	NOUN
dpc-6006	24	14	)	)	PUNCT
dpc-6006	24	15	,	,	PUNCT
dpc-6006	24	16	and	and	CCONJ
dpc-6006	24	17	clark	clark	PROPN
dpc-6006	24	18	level	level	PROPN
dpc-6006	24	19	ii	ii	PROPN
dpc-6006	24	20	were	be	AUX
dpc-6006	24	21	associated	associate	VERB
dpc-6006	24	22	with	with	ADP
dpc-6006	24	23	lower	low	ADJ
dpc-6006	24	24	recurrence	recurrence	NOUN
dpc-6006	24	25	risk	risk	NOUN
dpc-6006	24	26	.	.	PUNCT
dpc-6006	25	1	conclusions	conclusion	NOUN
dpc-6006	25	2	:	:	PUNCT
dpc-6006	25	3	this	this	DET
dpc-6006	25	4	study	study	NOUN
dpc-6006	25	5	demonstrates	demonstrate	VERB
dpc-6006	25	6	a	a	DET
dpc-6006	25	7	significant	significant	ADJ
dpc-6006	25	8	association	association	NOUN
dpc-6006	25	9	between	between	ADP
dpc-6006	25	10	narrow	narrow	ADJ
dpc-6006	25	11	excision	excision	NOUN
dpc-6006	25	12	margins	margin	NOUN
dpc-6006	25	13	and	and	CCONJ
dpc-6006	25	14	melanoma	melanoma	NOUN
dpc-6006	25	15	recurrence	recurrence	NOUN
dpc-6006	25	16	,	,	PUNCT
dpc-6006	25	17	particularly	particularly	ADV
dpc-6006	25	18	in	in	ADP
dpc-6006	25	19	anatomically	anatomically	ADV
dpc-6006	25	20	complex	complex	ADJ
dpc-6006	25	21	areas	area	NOUN
dpc-6006	25	22	like	like	ADP
dpc-6006	25	23	the	the	DET
dpc-6006	25	24	head	head	NOUN
dpc-6006	25	25	and	and	CCONJ
dpc-6006	25	26	neck	neck	NOUN
dpc-6006	25	27	.	.	PUNCT
dpc-6006	26	1	the	the	DET
dpc-6006	26	2	findings	finding	NOUN
dpc-6006	26	3	underscore	underscore	VERB
dpc-6006	26	4	the	the	DET
dpc-6006	26	5	importance	importance	NOUN
dpc-6006	26	6	of	of	ADP
dpc-6006	26	7	individualized	individualized	ADJ
dpc-6006	26	8	surgical	surgical	ADJ
dpc-6006	26	9	planning	planning	NOUN
dpc-6006	26	10	to	to	PART
dpc-6006	26	11	ensure	ensure	VERB
dpc-6006	26	12	oncological	oncological	ADJ
dpc-6006	26	13	safety	safety	NOUN
dpc-6006	26	14	while	while	SCONJ
dpc-6006	26	15	preserving	preserve	VERB
dpc-6006	26	16	function	function	NOUN
dpc-6006	26	17	and	and	CCONJ
dpc-6006	26	18	appearance	appearance	NOUN
dpc-6006	26	19	.	.	PUNCT
dpc-6006	27	1	adherence	adherence	NOUN
dpc-6006	27	2	to	to	ADP
dpc-6006	27	3	excision	excision	NOUN
dpc-6006	27	4	margin	margin	NOUN
dpc-6006	27	5	guidelines	guideline	NOUN
dpc-6006	27	6	and	and	CCONJ
dpc-6006	27	7	long	long	ADJ
dpc-6006	27	8	-	-	PUNCT
dpc-6006	27	9	term	term	NOUN
dpc-6006	27	10	follow	follow	NOUN
dpc-6006	27	11	-	-	PUNCT
dpc-6006	27	12	up	up	NOUN
dpc-6006	27	13	are	be	AUX
dpc-6006	27	14	essential	essential	ADJ
dpc-6006	27	15	,	,	PUNCT
dpc-6006	27	16	especially	especially	ADV
dpc-6006	27	17	in	in	ADP
dpc-6006	27	18	patients	patient	NOUN
dpc-6006	27	19	with	with	ADP
dpc-6006	27	20	high	high	ADJ
dpc-6006	27	21	-	-	PUNCT
dpc-6006	27	22	risk	risk	NOUN
dpc-6006	27	23	histological	histological	ADJ
dpc-6006	27	24	features	feature	NOUN
dpc-6006	27	25	.	.	PUNCT
dpc-6006	28	1	abstract	abstract	ADJ
dpc-6006	28	2	2	2	NUM
dpc-6006	28	3	original	original	ADJ
dpc-6006	28	4	article	article	NOUN
dpc-6006	28	5	|	|	ADV
dpc-6006	28	6	dermatol	dermatol	ADJ
dpc-6006	28	7	pract	pract	NOUN
dpc-6006	28	8	concept	concept	NOUN
dpc-6006	28	9	.	.	PUNCT
dpc-6006	29	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	29	2	introduction	introduction	NOUN
dpc-6006	29	3	malignant	malignant	ADJ
dpc-6006	29	4	melanomas	melanoma	NOUN
dpc-6006	29	5	represent	represent	VERB
dpc-6006	29	6	a	a	DET
dpc-6006	29	7	neoplastic	neoplastic	ADJ
dpc-6006	29	8	conversion	conversion	NOUN
dpc-6006	29	9	of	of	ADP
dpc-6006	29	10	the	the	DET
dpc-6006	29	11	neural	neural	ADJ
dpc-6006	29	12	crest	crest	NOUN
dpc-6006	29	13	-	-	PUNCT
dpc-6006	29	14	derived	derive	VERB
dpc-6006	29	15	melanocyte	melanocyte	NOUN
dpc-6006	29	16	[	[	X
dpc-6006	29	17	1	1	NUM
dpc-6006	29	18	]	]	PUNCT
dpc-6006	29	19	.	.	PUNCT
dpc-6006	30	1	the	the	DET
dpc-6006	30	2	year	year	NOUN
dpc-6006	30	3	2018	2018	NUM
dpc-6006	30	4	saw	see	VERB
dpc-6006	30	5	malignant	malignant	ADJ
dpc-6006	30	6	melanoma	melanoma	NOUN
dpc-6006	30	7	afflicting	afflict	VERB
dpc-6006	30	8	approximately	approximately	ADV
dpc-6006	30	9	a	a	DET
dpc-6006	30	10	third	third	NOUN
dpc-6006	30	11	of	of	ADP
dpc-6006	30	12	a	a	DET
dpc-6006	30	13	million	million	NUM
dpc-6006	30	14	people	people	NOUN
dpc-6006	30	15	globally	globally	ADV
dpc-6006	30	16	,	,	PUNCT
dpc-6006	30	17	while	while	SCONJ
dpc-6006	30	18	57,000	57,000	NUM
dpc-6006	30	19	died	die	VERB
dpc-6006	30	20	as	as	ADP
dpc-6006	30	21	consequence	consequence	NOUN
dpc-6006	30	22	of	of	ADP
dpc-6006	30	23	the	the	DET
dpc-6006	30	24	disease	disease	NOUN
dpc-6006	30	25	,	,	PUNCT
dpc-6006	30	26	with	with	ADP
dpc-6006	30	27	both	both	CCONJ
dpc-6006	30	28	these	these	DET
dpc-6006	30	29	numbers	number	NOUN
dpc-6006	30	30	expected	expect	VERB
dpc-6006	30	31	to	to	PART
dpc-6006	30	32	double	double	VERB
dpc-6006	30	33	by	by	ADP
dpc-6006	30	34	2040	2040	NUM
dpc-6006	31	1	[	[	X
dpc-6006	31	2	2	2	NUM
dpc-6006	31	3	]	]	PUNCT
dpc-6006	31	4	.	.	PUNCT
dpc-6006	32	1	the	the	DET
dpc-6006	32	2	disease	disease	NOUN
dpc-6006	32	3	is	be	AUX
dpc-6006	32	4	known	know	VERB
dpc-6006	32	5	to	to	PART
dpc-6006	32	6	be	be	AUX
dpc-6006	32	7	more	more	ADV
dpc-6006	32	8	common	common	ADJ
dpc-6006	32	9	in	in	ADP
dpc-6006	32	10	fair	fair	ADJ
dpc-6006	32	11	-	-	PUNCT
dpc-6006	32	12	skinned	skin	VERB
dpc-6006	32	13	individuals	individual	NOUN
dpc-6006	32	14	,	,	PUNCT
dpc-6006	32	15	and	and	CCONJ
dpc-6006	32	16	ireland	ireland	NOUN
dpc-6006	32	17	is	be	AUX
dpc-6006	32	18	no	no	DET
dpc-6006	32	19	exception	exception	NOUN
dpc-6006	32	20	.	.	PUNCT
dpc-6006	33	1	malignant	malignant	ADJ
dpc-6006	33	2	melanoma	melanoma	NOUN
dpc-6006	33	3	is	be	AUX
dpc-6006	33	4	reported	report	VERB
dpc-6006	33	5	to	to	PART
dpc-6006	33	6	be	be	AUX
dpc-6006	33	7	the	the	DET
dpc-6006	33	8	fifth	fifth	ADJ
dpc-6006	33	9	most	most	ADV
dpc-6006	33	10	frequently	frequently	ADV
dpc-6006	33	11	occurring	occur	VERB
dpc-6006	33	12	invasive	invasive	ADJ
dpc-6006	33	13	malignancy	malignancy	NOUN
dpc-6006	33	14	in	in	ADP
dpc-6006	33	15	the	the	DET
dpc-6006	33	16	country	country	NOUN
dpc-6006	33	17	,	,	PUNCT
dpc-6006	33	18	with	with	ADP
dpc-6006	33	19	a	a	DET
dpc-6006	33	20	steadily	steadily	ADV
dpc-6006	33	21	increasing	increase	VERB
dpc-6006	33	22	incidence	incidence	NOUN
dpc-6006	33	23	[	[	X
dpc-6006	33	24	3	3	NUM
dpc-6006	33	25	]	]	PUNCT
dpc-6006	33	26	.	.	PUNCT
dpc-6006	34	1	this	this	DET
dpc-6006	34	2	surge	surge	NOUN
dpc-6006	34	3	is	be	AUX
dpc-6006	34	4	attributed	attribute	VERB
dpc-6006	34	5	to	to	ADP
dpc-6006	34	6	an	an	DET
dpc-6006	34	7	increased	increase	VERB
dpc-6006	34	8	exposure	exposure	NOUN
dpc-6006	34	9	to	to	ADP
dpc-6006	34	10	ultraviolet	ultraviolet	ADJ
dpc-6006	34	11	radiation	radiation	NOUN
dpc-6006	34	12	whether	whether	SCONJ
dpc-6006	34	13	through	through	ADP
dpc-6006	34	14	the	the	DET
dpc-6006	34	15	sun	sun	NOUN
dpc-6006	34	16	or	or	CCONJ
dpc-6006	34	17	tanning	tan	VERB
dpc-6006	34	18	salon	salon	NOUN
dpc-6006	34	19	exposure	exposure	NOUN
dpc-6006	34	20	[	[	X
dpc-6006	34	21	4	4	NUM
dpc-6006	34	22	]	]	PUNCT
dpc-6006	34	23	.	.	PUNCT
dpc-6006	35	1	however	however	ADV
dpc-6006	35	2	,	,	PUNCT
dpc-6006	35	3	other	other	ADJ
dpc-6006	35	4	factors	factor	NOUN
dpc-6006	35	5	have	have	AUX
dpc-6006	35	6	also	also	ADV
dpc-6006	35	7	been	be	AUX
dpc-6006	35	8	implicated	implicate	VERB
dpc-6006	35	9	and	and	CCONJ
dpc-6006	35	10	include	include	VERB
dpc-6006	35	11	variables	variable	NOUN
dpc-6006	35	12	such	such	ADJ
dpc-6006	35	13	as	as	ADP
dpc-6006	35	14	immunosuppressive	immunosuppressive	ADJ
dpc-6006	35	15	states	state	NOUN
dpc-6006	35	16	(	(	PUNCT
dpc-6006	35	17	drugs	drug	NOUN
dpc-6006	35	18	,	,	PUNCT
dpc-6006	35	19	virus	virus	NOUN
dpc-6006	35	20	,	,	PUNCT
dpc-6006	35	21	genetic	genetic	ADJ
dpc-6006	35	22	conditions	condition	NOUN
dpc-6006	35	23	,	,	PUNCT
dpc-6006	35	24	and	and	CCONJ
dpc-6006	35	25	neoplastic	neoplastic	ADJ
dpc-6006	35	26	disease	disease	NOUN
dpc-6006	35	27	)	)	PUNCT
dpc-6006	35	28	,	,	PUNCT
dpc-6006	35	29	history	history	NOUN
dpc-6006	35	30	of	of	ADP
dpc-6006	35	31	combination	combination	NOUN
dpc-6006	35	32	therapy	therapy	NOUN
dpc-6006	35	33	with	with	ADP
dpc-6006	35	34	psoralen	psoralen	NOUN
dpc-6006	35	35	and	and	CCONJ
dpc-6006	35	36	ultraviolet	ultraviolet	ADJ
dpc-6006	35	37	a	a	DET
dpc-6006	35	38	light	light	NOUN
dpc-6006	35	39	(	(	PUNCT
dpc-6006	35	40	puva	puva	PROPN
dpc-6006	35	41	)	)	PUNCT
dpc-6006	35	42	,	,	PUNCT
dpc-6006	35	43	and	and	CCONJ
dpc-6006	35	44	a	a	DET
dpc-6006	35	45	history	history	NOUN
dpc-6006	35	46	of	of	ADP
dpc-6006	35	47	the	the	DET
dpc-6006	35	48	neoplasm	neoplasm	NOUN
dpc-6006	35	49	in	in	ADP
dpc-6006	35	50	a	a	DET
dpc-6006	35	51	first	first	ADJ
dpc-6006	35	52	-	-	PUNCT
dpc-6006	35	53	degree	degree	NOUN
dpc-6006	35	54	relative	relative	NOUN
dpc-6006	35	55	[	[	X
dpc-6006	35	56	5	5	NUM
dpc-6006	35	57	]	]	PUNCT
dpc-6006	35	58	.	.	PUNCT
dpc-6006	36	1	evaluation	evaluation	NOUN
dpc-6006	36	2	includes	include	VERB
dpc-6006	36	3	not	not	PART
dpc-6006	36	4	only	only	ADV
dpc-6006	36	5	establishing	establish	VERB
dpc-6006	36	6	the	the	DET
dpc-6006	36	7	diagnosis	diagnosis	NOUN
dpc-6006	36	8	but	but	CCONJ
dpc-6006	36	9	also	also	ADV
dpc-6006	36	10	staging	stage	VERB
dpc-6006	36	11	the	the	DET
dpc-6006	36	12	disease	disease	NOUN
dpc-6006	36	13	.	.	PUNCT
dpc-6006	37	1	using	use	VERB
dpc-6006	37	2	a	a	DET
dpc-6006	37	3	combination	combination	NOUN
dpc-6006	37	4	of	of	ADP
dpc-6006	37	5	history/	history/	NUM
dpc-6006	37	6	examination	examination	NOUN
dpc-6006	37	7	,	,	PUNCT
dpc-6006	37	8	biopsies	biopsy	NOUN
dpc-6006	37	9	,	,	PUNCT
dpc-6006	37	10	and	and	CCONJ
dpc-6006	37	11	imaging	imaging	NOUN
dpc-6006	37	12	,	,	PUNCT
dpc-6006	37	13	the	the	DET
dpc-6006	37	14	managing	manage	VERB
dpc-6006	37	15	team	team	NOUN
dpc-6006	37	16	has	have	VERB
dpc-6006	37	17	to	to	PART
dpc-6006	37	18	establish	establish	VERB
dpc-6006	37	19	the	the	DET
dpc-6006	37	20	presence	presence	NOUN
dpc-6006	37	21	of	of	ADP
dpc-6006	37	22	melanoma	melanoma	NOUN
dpc-6006	37	23	and	and	CCONJ
dpc-6006	37	24	its	its	PRON
dpc-6006	37	25	subtype	subtype	NOUN
dpc-6006	37	26	,	,	PUNCT
dpc-6006	37	27	the	the	DET
dpc-6006	37	28	site	site	NOUN
dpc-6006	37	29	of	of	ADP
dpc-6006	37	30	the	the	DET
dpc-6006	37	31	disease	disease	NOUN
dpc-6006	37	32	,	,	PUNCT
dpc-6006	37	33	presence	presence	NOUN
dpc-6006	37	34	of	of	ADP
dpc-6006	37	35	ulceration	ulceration	NOUN
dpc-6006	37	36	,	,	PUNCT
dpc-6006	37	37	the	the	DET
dpc-6006	37	38	degree	degree	NOUN
dpc-6006	37	39	of	of	ADP
dpc-6006	37	40	tumor	tumor	NOUN
dpc-6006	37	41	thickness	thickness	NOUN
dpc-6006	37	42	,	,	PUNCT
dpc-6006	37	43	spread	spread	VERB
dpc-6006	37	44	to	to	ADP
dpc-6006	37	45	regional	regional	ADJ
dpc-6006	37	46	lymph	lymph	NOUN
dpc-6006	37	47	nodes	node	NOUN
dpc-6006	37	48	,	,	PUNCT
dpc-6006	37	49	number	number	NOUN
dpc-6006	37	50	of	of	ADP
dpc-6006	37	51	lymph	lymph	NOUN
dpc-6006	37	52	nodes	node	NOUN
dpc-6006	37	53	involved	involve	VERB
dpc-6006	37	54	,	,	PUNCT
dpc-6006	37	55	and	and	CCONJ
dpc-6006	37	56	the	the	DET
dpc-6006	37	57	presence	presence	NOUN
dpc-6006	37	58	of	of	ADP
dpc-6006	37	59	distant	distant	ADJ
dpc-6006	37	60	metastasis	metastasis	NOUN
dpc-6006	37	61	,	,	PUNCT
dpc-6006	37	62	all	all	PRON
dpc-6006	37	63	of	of	ADP
dpc-6006	37	64	which	which	PRON
dpc-6006	37	65	have	have	VERB
dpc-6006	37	66	a	a	DET
dpc-6006	37	67	direct	direct	ADJ
dpc-6006	37	68	impact	impact	NOUN
dpc-6006	37	69	on	on	ADP
dpc-6006	37	70	prognosis	prognosis	NOUN
dpc-6006	37	71	[	[	X
dpc-6006	37	72	6,7	6,7	NUM
dpc-6006	37	73	]	]	PUNCT
dpc-6006	37	74	.	.	PUNCT
dpc-6006	38	1	the	the	DET
dpc-6006	38	2	five	five	NUM
dpc-6006	38	3	-	-	PUNCT
dpc-6006	38	4	year	year	NOUN
dpc-6006	38	5	survival	survival	NOUN
dpc-6006	38	6	rate	rate	NOUN
dpc-6006	38	7	for	for	ADP
dpc-6006	38	8	stage	stage	NOUN
dpc-6006	38	9	1	1	NUM
dpc-6006	38	10	disease	disease	NOUN
dpc-6006	38	11	is	be	AUX
dpc-6006	38	12	over	over	ADP
dpc-6006	38	13	90	90	NUM
dpc-6006	38	14	%	%	NOUN
dpc-6006	38	15	,	,	PUNCT
dpc-6006	38	16	but	but	CCONJ
dpc-6006	38	17	rapidly	rapidly	ADV
dpc-6006	38	18	drops	drop	VERB
dpc-6006	38	19	to	to	ADP
dpc-6006	38	20	45%–77	45%–77	NUM
dpc-6006	38	21	%	%	NOUN
dpc-6006	38	22	and	and	CCONJ
dpc-6006	38	23	to	to	ADP
dpc-6006	38	24	27%–70	27%–70	NUM
dpc-6006	38	25	%	%	NOUN
dpc-6006	38	26	in	in	ADP
dpc-6006	38	27	those	those	PRON
dpc-6006	38	28	suffering	suffer	VERB
dpc-6006	38	29	from	from	ADP
dpc-6006	38	30	stage	stage	NOUN
dpc-6006	38	31	2	2	NUM
dpc-6006	38	32	and	and	CCONJ
dpc-6006	38	33	3	3	NUM
dpc-6006	38	34	disease	disease	NOUN
dpc-6006	38	35	,	,	PUNCT
dpc-6006	38	36	respectively	respectively	ADV
dpc-6006	38	37	,	,	PUNCT
dpc-6006	38	38	while	while	SCONJ
dpc-6006	38	39	patients	patient	NOUN
dpc-6006	38	40	with	with	ADP
dpc-6006	38	41	stage	stage	NOUN
dpc-6006	38	42	4	4	NUM
dpc-6006	38	43	disease	disease	NOUN
dpc-6006	38	44	have	have	VERB
dpc-6006	38	45	a	a	DET
dpc-6006	38	46	five	five	NUM
dpc-6006	38	47	-	-	PUNCT
dpc-6006	38	48	year	year	NOUN
dpc-6006	38	49	survival	survival	NOUN
dpc-6006	38	50	rate	rate	NOUN
dpc-6006	38	51	of	of	ADP
dpc-6006	38	52	below	below	ADP
dpc-6006	38	53	20	20	NUM
dpc-6006	38	54	%	%	NOUN
dpc-6006	38	55	[	[	X
dpc-6006	38	56	8	8	NUM
dpc-6006	38	57	]	]	PUNCT
dpc-6006	38	58	.	.	PUNCT
dpc-6006	39	1	management	management	NOUN
dpc-6006	39	2	of	of	ADP
dpc-6006	39	3	malignant	malignant	ADJ
dpc-6006	39	4	melanomas	melanomas	NOUN
dpc-6006	39	5	centers	center	NOUN
dpc-6006	39	6	around	around	ADP
dpc-6006	39	7	wide	wide	ADJ
dpc-6006	39	8	local	local	ADJ
dpc-6006	39	9	excision	excision	NOUN
dpc-6006	39	10	,	,	PUNCT
dpc-6006	39	11	with	with	ADP
dpc-6006	39	12	sentinel	sentinel	ADJ
dpc-6006	39	13	lymph	lymph	NOUN
dpc-6006	39	14	node	node	PROPN
dpc-6006	39	15	biopsy	biopsy	NOUN
dpc-6006	39	16	(	(	PUNCT
dpc-6006	39	17	slnb	slnb	NOUN
dpc-6006	39	18	)	)	PUNCT
dpc-6006	39	19	and/or	and/or	CCONJ
dpc-6006	39	20	lymph	lymph	VERB
dpc-6006	39	21	node	node	NOUN
dpc-6006	39	22	dissection	dissection	NOUN
dpc-6006	39	23	when	when	SCONJ
dpc-6006	39	24	the	the	DET
dpc-6006	39	25	disease	disease	NOUN
dpc-6006	39	26	is	be	AUX
dpc-6006	39	27	diagnosed	diagnose	VERB
dpc-6006	39	28	at	at	ADP
dpc-6006	39	29	an	an	DET
dpc-6006	39	30	early	early	ADJ
dpc-6006	39	31	stage	stage	NOUN
dpc-6006	39	32	,	,	PUNCT
dpc-6006	39	33	while	while	SCONJ
dpc-6006	39	34	more	more	ADV
dpc-6006	39	35	advanced	advanced	ADJ
dpc-6006	39	36	disease	disease	NOUN
dpc-6006	39	37	is	be	AUX
dpc-6006	39	38	managed	manage	VERB
dpc-6006	39	39	with	with	ADP
dpc-6006	39	40	a	a	DET
dpc-6006	39	41	combination	combination	NOUN
dpc-6006	39	42	of	of	ADP
dpc-6006	39	43	surgery	surgery	NOUN
dpc-6006	39	44	and	and	CCONJ
dpc-6006	39	45	adjuvant	adjuvant	ADJ
dpc-6006	39	46	treatment	treatment	NOUN
dpc-6006	39	47	or	or	CCONJ
dpc-6006	39	48	even	even	ADV
dpc-6006	39	49	radiotherapy	radiotherapy	VERB
dpc-6006	39	50	[	[	X
dpc-6006	39	51	9,10	9,10	NUM
dpc-6006	39	52	]	]	X
dpc-6006	39	53	.	.	PUNCT
dpc-6006	40	1	an	an	DET
dpc-6006	40	2	essential	essential	ADJ
dpc-6006	40	3	requirement	requirement	NOUN
dpc-6006	40	4	from	from	ADP
dpc-6006	40	5	successful	successful	ADJ
dpc-6006	40	6	surgery	surgery	NOUN
dpc-6006	40	7	is	be	AUX
dpc-6006	40	8	the	the	DET
dpc-6006	40	9	need	need	NOUN
dpc-6006	40	10	for	for	ADP
dpc-6006	40	11	margins	margin	NOUN
dpc-6006	40	12	clear	clear	ADJ
dpc-6006	40	13	of	of	ADP
dpc-6006	40	14	neoplastic	neoplastic	ADJ
dpc-6006	40	15	cells	cell	NOUN
dpc-6006	40	16	on	on	ADP
dpc-6006	40	17	excision	excision	NOUN
dpc-6006	40	18	[	[	X
dpc-6006	40	19	9,10	9,10	NUM
dpc-6006	40	20	]	]	X
dpc-6006	40	21	.	.	PUNCT
dpc-6006	41	1	we	we	PRON
dpc-6006	41	2	conducted	conduct	VERB
dpc-6006	41	3	this	this	DET
dpc-6006	41	4	study	study	NOUN
dpc-6006	41	5	with	with	ADP
dpc-6006	41	6	the	the	DET
dpc-6006	41	7	express	express	ADJ
dpc-6006	41	8	purpose	purpose	NOUN
dpc-6006	41	9	of	of	ADP
dpc-6006	41	10	determining	determine	VERB
dpc-6006	41	11	the	the	DET
dpc-6006	41	12	outcomes	outcome	NOUN
dpc-6006	41	13	of	of	ADP
dpc-6006	41	14	management	management	NOUN
dpc-6006	41	15	for	for	ADP
dpc-6006	41	16	malignant	malignant	ADJ
dpc-6006	41	17	melanoma	melanoma	NOUN
dpc-6006	41	18	in	in	ADP
dpc-6006	41	19	our	our	PRON
dpc-6006	41	20	setup	setup	NOUN
dpc-6006	41	21	,	,	PUNCT
dpc-6006	41	22	recurrence	recurrence	NOUN
dpc-6006	41	23	,	,	PUNCT
dpc-6006	41	24	and	and	CCONJ
dpc-6006	41	25	clinicopathological	clinicopathological	ADJ
dpc-6006	41	26	markers	marker	NOUN
dpc-6006	41	27	associated	associate	VERB
dpc-6006	41	28	with	with	ADP
dpc-6006	41	29	its	its	PRON
dpc-6006	41	30	increased	increased	ADJ
dpc-6006	41	31	risk	risk	NOUN
dpc-6006	41	32	.	.	PUNCT
dpc-6006	42	1	methods	method	NOUN
dpc-6006	42	2	we	we	PRON
dpc-6006	42	3	conducted	conduct	VERB
dpc-6006	42	4	a	a	DET
dpc-6006	42	5	retrospective	retrospective	ADJ
dpc-6006	42	6	study	study	NOUN
dpc-6006	42	7	of	of	ADP
dpc-6006	42	8	patients	patient	NOUN
dpc-6006	42	9	reporting	report	VERB
dpc-6006	42	10	to	to	ADP
dpc-6006	42	11	university	university	PROPN
dpc-6006	42	12	hospital	hospital	PROPN
dpc-6006	42	13	waterford	waterford	PROPN
dpc-6006	42	14	,	,	PUNCT
dpc-6006	42	15	ireland	ireland	PROPN
dpc-6006	42	16	,	,	PUNCT
dpc-6006	42	17	with	with	ADP
dpc-6006	42	18	melanomas	melanomas	PROPN
dpc-6006	42	19	from	from	ADP
dpc-6006	42	20	january	january	PROPN
dpc-6006	42	21	2016	2016	NUM
dpc-6006	42	22	to	to	ADP
dpc-6006	42	23	february	february	PROPN
dpc-6006	42	24	2023	2023	NUM
dpc-6006	42	25	.	.	PUNCT
dpc-6006	43	1	the	the	DET
dpc-6006	43	2	study	study	NOUN
dpc-6006	43	3	sample	sample	NOUN
dpc-6006	43	4	was	be	AUX
dpc-6006	43	5	based	base	VERB
dpc-6006	43	6	on	on	ADP
dpc-6006	43	7	565	565	NUM
dpc-6006	43	8	records	record	NOUN
dpc-6006	43	9	extracted	extract	VERB
dpc-6006	43	10	from	from	ADP
dpc-6006	43	11	the	the	DET
dpc-6006	43	12	hospital	hospital	NOUN
dpc-6006	43	13	’s	’s	PART
dpc-6006	43	14	database	database	NOUN
dpc-6006	43	15	.	.	PUNCT
dpc-6006	44	1	data	datum	NOUN
dpc-6006	44	2	were	be	AUX
dpc-6006	44	3	coded	code	VERB
dpc-6006	44	4	in	in	ADP
dpc-6006	44	5	the	the	DET
dpc-6006	44	6	statistical	statistical	ADJ
dpc-6006	44	7	package	package	NOUN
dpc-6006	44	8	for	for	ADP
dpc-6006	44	9	social	social	ADJ
dpc-6006	44	10	sciences	science	NOUN
dpc-6006	44	11	(	(	PUNCT
dpc-6006	44	12	spss	spss	PROPN
dpc-6006	44	13	)	)	PUNCT
dpc-6006	44	14	version	version	NOUN
dpc-6006	44	15	26	26	NUM
dpc-6006	44	16	(	(	PUNCT
dpc-6006	44	17	armonk	armonk	PROPN
dpc-6006	44	18	,	,	PUNCT
dpc-6006	44	19	ny	ny	PROPN
dpc-6006	44	20	:	:	PROPN
dpc-6006	44	21	ibm	ibm	PROPN
dpc-6006	44	22	corp	corp	PROPN
dpc-6006	44	23	)	)	PUNCT
dpc-6006	44	24	and	and	CCONJ
dpc-6006	44	25	analyzed	analyze	VERB
dpc-6006	44	26	for	for	ADP
dpc-6006	44	27	accuracy	accuracy	NOUN
dpc-6006	44	28	.	.	PUNCT
dpc-6006	45	1	partial	partial	ADJ
dpc-6006	45	2	records	record	NOUN
dpc-6006	45	3	were	be	AUX
dpc-6006	45	4	completed	complete	VERB
dpc-6006	45	5	using	use	VERB
dpc-6006	45	6	the	the	DET
dpc-6006	45	7	hospital	hospital	NOUN
dpc-6006	45	8	medical	medical	ADJ
dpc-6006	45	9	records	record	NOUN
dpc-6006	45	10	database	database	NOUN
dpc-6006	45	11	.	.	PUNCT
dpc-6006	46	1	records	record	NOUN
dpc-6006	46	2	that	that	PRON
dpc-6006	46	3	could	could	AUX
dpc-6006	46	4	not	not	PART
dpc-6006	46	5	be	be	AUX
dpc-6006	46	6	completed	complete	VERB
dpc-6006	46	7	were	be	AUX
dpc-6006	46	8	excluded	exclude	VERB
dpc-6006	46	9	from	from	ADP
dpc-6006	46	10	statistical	statistical	ADJ
dpc-6006	46	11	analysis	analysis	NOUN
dpc-6006	46	12	.	.	PUNCT
dpc-6006	47	1	an	an	DET
dpc-6006	47	2	audit	audit	NOUN
dpc-6006	47	3	team	team	NOUN
dpc-6006	47	4	re	re	VERB
dpc-6006	47	5	-	-	VERB
dpc-6006	47	6	verified	verify	VERB
dpc-6006	47	7	all	all	DET
dpc-6006	47	8	histopathology	histopathology	NOUN
dpc-6006	47	9	reports	report	NOUN
dpc-6006	47	10	for	for	ADP
dpc-6006	47	11	the	the	DET
dpc-6006	47	12	biopsy	biopsy	NOUN
dpc-6006	47	13	of	of	ADP
dpc-6006	47	14	the	the	DET
dpc-6006	47	15	primary	primary	ADJ
dpc-6006	47	16	lesion	lesion	NOUN
dpc-6006	47	17	as	as	ADV
dpc-6006	47	18	well	well	ADV
dpc-6006	47	19	as	as	ADP
dpc-6006	47	20	the	the	DET
dpc-6006	47	21	slnb	slnb	NOUN
dpc-6006	47	22	,	,	PUNCT
dpc-6006	47	23	and	and	CCONJ
dpc-6006	47	24	the	the	DET
dpc-6006	47	25	data	datum	NOUN
dpc-6006	47	26	pertaining	pertain	VERB
dpc-6006	47	27	to	to	ADP
dpc-6006	47	28	total	total	ADJ
dpc-6006	47	29	margins	margin	NOUN
dpc-6006	47	30	with	with	ADP
dpc-6006	47	31	operation	operation	NOUN
dpc-6006	47	32	notes	note	NOUN
dpc-6006	47	33	.	.	PUNCT
dpc-6006	48	1	ethical	ethical	ADJ
dpc-6006	48	2	approval	approval	NOUN
dpc-6006	48	3	was	be	AUX
dpc-6006	48	4	sought	seek	VERB
dpc-6006	48	5	and	and	CCONJ
dpc-6006	48	6	received	receive	VERB
dpc-6006	48	7	.	.	PUNCT
dpc-6006	49	1	data	datum	NOUN
dpc-6006	49	2	were	be	AUX
dpc-6006	49	3	analyzed	analyze	VERB
dpc-6006	49	4	using	use	VERB
dpc-6006	49	5	statistical	statistical	ADJ
dpc-6006	49	6	package	package	NOUN
dpc-6006	49	7	for	for	ADP
dpc-6006	49	8	the	the	DET
dpc-6006	49	9	social	social	ADJ
dpc-6006	49	10	sciences	sciences	PROPN
dpc-6006	49	11	version	version	PROPN
dpc-6006	49	12	26.0	26.0	NUM
dpc-6006	49	13	.	.	PUNCT
dpc-6006	50	1	mean	mean	VERB
dpc-6006	50	2	and	and	CCONJ
dpc-6006	50	3	standard	standard	ADJ
dpc-6006	50	4	deviation	deviation	NOUN
dpc-6006	50	5	(	(	PUNCT
dpc-6006	50	6	sd	sd	NOUN
dpc-6006	50	7	)	)	PUNCT
dpc-6006	50	8	were	be	AUX
dpc-6006	50	9	calculated	calculate	VERB
dpc-6006	50	10	for	for	ADP
dpc-6006	50	11	quantitative	quantitative	ADJ
dpc-6006	50	12	variables	variable	NOUN
dpc-6006	50	13	,	,	PUNCT
dpc-6006	50	14	specifically	specifically	ADV
dpc-6006	50	15	age	age	NOUN
dpc-6006	50	16	,	,	PUNCT
dpc-6006	50	17	breslow	breslow	ADJ
dpc-6006	50	18	thickness	thickness	NOUN
dpc-6006	50	19	,	,	PUNCT
dpc-6006	50	20	and	and	CCONJ
dpc-6006	50	21	number	number	NOUN
dpc-6006	50	22	of	of	ADP
dpc-6006	50	23	mitotic	mitotic	ADJ
dpc-6006	50	24	figures	figure	NOUN
dpc-6006	50	25	per	per	ADP
dpc-6006	50	26	high	high	ADJ
dpc-6006	50	27	-	-	PUNCT
dpc-6006	50	28	power	power	NOUN
dpc-6006	50	29	field	field	NOUN
dpc-6006	50	30	.	.	PUNCT
dpc-6006	51	1	melanoma	melanoma	NOUN
dpc-6006	51	2	in	in	ADP
dpc-6006	51	3	situ	situ	ADJ
dpc-6006	51	4	cases	case	NOUN
dpc-6006	51	5	were	be	AUX
dpc-6006	51	6	under	under	ADV
dpc-6006	51	7	-	-	PUNCT
dpc-6006	51	8	represented	represent	VERB
dpc-6006	51	9	in	in	ADP
dpc-6006	51	10	this	this	DET
dpc-6006	51	11	dataset	dataset	NOUN
dpc-6006	51	12	because	because	SCONJ
dpc-6006	51	13	the	the	DET
dpc-6006	51	14	hospital	hospital	NOUN
dpc-6006	51	15	registry	registry	NOUN
dpc-6006	51	16	records	record	VERB
dpc-6006	51	17	them	they	PRON
dpc-6006	51	18	under	under	ADP
dpc-6006	51	19	dermatopathology	dermatopathology	NOUN
dpc-6006	51	20	follow	follow	NOUN
dpc-6006	51	21	-	-	PUNCT
dpc-6006	51	22	up	up	NOUN
dpc-6006	51	23	and	and	CCONJ
dpc-6006	51	24	minor	minor	ADJ
dpc-6006	51	25	procedure	procedure	NOUN
dpc-6006	51	26	categories	category	NOUN
dpc-6006	51	27	.	.	PUNCT
dpc-6006	52	1	our	our	PRON
dpc-6006	52	2	study	study	NOUN
dpc-6006	52	3	extracted	extract	VERB
dpc-6006	52	4	only	only	ADV
dpc-6006	52	5	surgically	surgically	ADV
dpc-6006	52	6	managed	manage	VERB
dpc-6006	52	7	melanomas	melanomas	NOUN
dpc-6006	52	8	from	from	ADP
dpc-6006	52	9	the	the	DET
dpc-6006	52	10	oncology	oncology	NOUN
dpc-6006	52	11	surgery	surgery	NOUN
dpc-6006	52	12	department	department	NOUN
dpc-6006	52	13	,	,	PUNCT
dpc-6006	52	14	so	so	ADV
dpc-6006	52	15	most	most	ADJ
dpc-6006	52	16	in	in	ADP
dpc-6006	52	17	situ	situ	ADJ
dpc-6006	52	18	cases	case	NOUN
dpc-6006	52	19	were	be	AUX
dpc-6006	52	20	not	not	PART
dpc-6006	52	21	captured	capture	VERB
dpc-6006	52	22	.	.	PUNCT
dpc-6006	53	1	recurrence	recurrence	NOUN
dpc-6006	53	2	was	be	AUX
dpc-6006	53	3	defined	define	VERB
dpc-6006	53	4	as	as	ADP
dpc-6006	53	5	any	any	DET
dpc-6006	53	6	reappearance	reappearance	NOUN
dpc-6006	53	7	of	of	ADP
dpc-6006	53	8	melanoma	melanoma	NOUN
dpc-6006	53	9	after	after	ADP
dpc-6006	53	10	primary	primary	ADJ
dpc-6006	53	11	treatment	treatment	NOUN
dpc-6006	53	12	,	,	PUNCT
dpc-6006	53	13	including	include	VERB
dpc-6006	53	14	local	local	ADJ
dpc-6006	53	15	recurrence	recurrence	NOUN
dpc-6006	53	16	,	,	PUNCT
dpc-6006	53	17	regional	regional	ADJ
dpc-6006	53	18	lymph	lymph	NOUN
dpc-6006	53	19	node	node	NOUN
dpc-6006	53	20	recurrence	recurrence	NOUN
dpc-6006	53	21	,	,	PUNCT
dpc-6006	53	22	or	or	CCONJ
dpc-6006	53	23	distant	distant	ADJ
dpc-6006	53	24	recurrence	recurrence	NOUN
dpc-6006	53	25	.	.	PUNCT
dpc-6006	54	1	qualitative	qualitative	ADJ
dpc-6006	54	2	variables	variable	NOUN
dpc-6006	54	3	like	like	ADP
dpc-6006	54	4	year	year	NOUN
dpc-6006	54	5	of	of	ADP
dpc-6006	54	6	diagnosis	diagnosis	NOUN
dpc-6006	54	7	,	,	PUNCT
dpc-6006	54	8	sex	sex	NOUN
dpc-6006	54	9	,	,	PUNCT
dpc-6006	54	10	site	site	NOUN
dpc-6006	54	11	of	of	ADP
dpc-6006	54	12	primary	primary	ADJ
dpc-6006	54	13	disease	disease	NOUN
dpc-6006	54	14	,	,	PUNCT
dpc-6006	54	15	stage	stage	NOUN
dpc-6006	54	16	of	of	ADP
dpc-6006	54	17	the	the	DET
dpc-6006	54	18	disease	disease	NOUN
dpc-6006	54	19	at	at	ADP
dpc-6006	54	20	the	the	DET
dpc-6006	54	21	time	time	NOUN
dpc-6006	54	22	of	of	ADP
dpc-6006	54	23	presentation	presentation	NOUN
dpc-6006	54	24	,	,	PUNCT
dpc-6006	54	25	degree	degree	NOUN
dpc-6006	54	26	of	of	ADP
dpc-6006	54	27	breslow	breslow	ADJ
dpc-6006	54	28	thickness	thickness	NOUN
dpc-6006	54	29	,	,	PUNCT
dpc-6006	54	30	clark	clark	NOUN
dpc-6006	54	31	stage	stage	NOUN
dpc-6006	54	32	,	,	PUNCT
dpc-6006	54	33	ulceration	ulceration	NOUN
dpc-6006	54	34	,	,	PUNCT
dpc-6006	54	35	lympho	lympho	NOUN
dpc-6006	54	36	-	-	PUNCT
dpc-6006	54	37	vascular	vascular	ADJ
dpc-6006	54	38	invasion	invasion	NOUN
dpc-6006	54	39	,	,	PUNCT
dpc-6006	54	40	whether	whether	SCONJ
dpc-6006	54	41	sentinel	sentinel	ADJ
dpc-6006	54	42	lymph	lymph	NOUN
dpc-6006	54	43	node	node	ADJ
dpc-6006	54	44	biopsy	biopsy	NOUN
dpc-6006	54	45	was	be	AUX
dpc-6006	54	46	done	do	VERB
dpc-6006	54	47	and	and	CCONJ
dpc-6006	54	48	its	its	PRON
dpc-6006	54	49	results	result	NOUN
dpc-6006	54	50	,	,	PUNCT
dpc-6006	54	51	and	and	CCONJ
dpc-6006	54	52	whether	whether	SCONJ
dpc-6006	54	53	the	the	DET
dpc-6006	54	54	melanoma	melanoma	NOUN
dpc-6006	54	55	was	be	AUX
dpc-6006	54	56	excised	excise	VERB
dpc-6006	54	57	with	with	ADP
dpc-6006	54	58	adequate	adequate	ADJ
dpc-6006	54	59	margins	margin	NOUN
dpc-6006	54	60	as	as	SCONJ
dpc-6006	54	61	per	per	ADP
dpc-6006	54	62	the	the	DET
dpc-6006	54	63	british	british	PROPN
dpc-6006	54	64	association	association	PROPN
dpc-6006	54	65	of	of	ADP
dpc-6006	54	66	dermatologists	dermatologists	PROPN
dpc-6006	54	67	(	(	PUNCT
dpc-6006	54	68	bad	bad	ADJ
dpc-6006	54	69	)	)	PUNCT
dpc-6006	54	70	guidelines	guideline	NOUN
dpc-6006	54	71	were	be	AUX
dpc-6006	54	72	recorded	record	VERB
dpc-6006	54	73	in	in	ADP
dpc-6006	54	74	terms	term	NOUN
dpc-6006	54	75	of	of	ADP
dpc-6006	54	76	frequency	frequency	NOUN
dpc-6006	54	77	and	and	CCONJ
dpc-6006	54	78	percentage	percentage	NOUN
dpc-6006	54	79	.	.	PUNCT
dpc-6006	55	1	the	the	DET
dpc-6006	55	2	chi	chi	ADJ
dpc-6006	55	3	-	-	PUNCT
dpc-6006	55	4	square	square	ADJ
dpc-6006	55	5	test	test	NOUN
dpc-6006	55	6	was	be	AUX
dpc-6006	55	7	used	use	VERB
dpc-6006	55	8	for	for	ADP
dpc-6006	55	9	qualitative	qualitative	ADJ
dpc-6006	55	10	variables	variable	NOUN
dpc-6006	55	11	,	,	PUNCT
dpc-6006	55	12	while	while	SCONJ
dpc-6006	55	13	the	the	DET
dpc-6006	55	14	independent	independent	ADJ
dpc-6006	55	15	samples	sample	NOUN
dpc-6006	55	16	t	t	NOUN
dpc-6006	55	17	-	-	PUNCT
dpc-6006	55	18	test	test	NOUN
dpc-6006	55	19	was	be	AUX
dpc-6006	55	20	used	use	VERB
dpc-6006	55	21	for	for	ADP
dpc-6006	55	22	quantitative	quantitative	ADJ
dpc-6006	55	23	variables	variable	NOUN
dpc-6006	55	24	for	for	ADP
dpc-6006	55	25	comparison	comparison	NOUN
dpc-6006	55	26	between	between	ADP
dpc-6006	55	27	cases	case	NOUN
dpc-6006	55	28	where	where	SCONJ
dpc-6006	55	29	recurrence	recurrence	NOUN
dpc-6006	55	30	developed	develop	VERB
dpc-6006	55	31	or	or	CCONJ
dpc-6006	55	32	those	those	PRON
dpc-6006	55	33	where	where	SCONJ
dpc-6006	55	34	it	it	PRON
dpc-6006	55	35	did	do	VERB
dpc-6006	55	36	not	not	PART
dpc-6006	55	37	,	,	PUNCT
dpc-6006	55	38	and	and	CCONJ
dpc-6006	55	39	a	a	DET
dpc-6006	55	40	p	p	NOUN
dpc-6006	55	41	-	-	PUNCT
dpc-6006	55	42	value	value	NOUN
dpc-6006	55	43	of	of	ADP
dpc-6006	55	44	≤0.05	≤0.05	NOUN
dpc-6006	55	45	was	be	AUX
dpc-6006	55	46	considered	consider	VERB
dpc-6006	55	47	significant	significant	ADJ
dpc-6006	55	48	.	.	PUNCT
dpc-6006	56	1	multivariate	multivariate	NOUN
dpc-6006	56	2	analysis	analysis	NOUN
dpc-6006	56	3	was	be	AUX
dpc-6006	56	4	performed	perform	VERB
dpc-6006	56	5	using	use	VERB
dpc-6006	56	6	binary	binary	ADJ
dpc-6006	56	7	logistic	logistic	ADJ
dpc-6006	56	8	regression	regression	NOUN
dpc-6006	56	9	for	for	ADP
dpc-6006	56	10	variables	variable	NOUN
dpc-6006	56	11	which	which	PRON
dpc-6006	56	12	were	be	AUX
dpc-6006	56	13	found	find	VERB
dpc-6006	56	14	to	to	PART
dpc-6006	56	15	be	be	AUX
dpc-6006	56	16	significant	significant	ADJ
dpc-6006	56	17	on	on	ADP
dpc-6006	56	18	univariate	univariate	ADJ
dpc-6006	56	19	analysis	analysis	NOUN
dpc-6006	56	20	.	.	PUNCT
dpc-6006	57	1	results	result	VERB
dpc-6006	57	2	a	a	DET
dpc-6006	57	3	general	general	ADJ
dpc-6006	57	4	increase	increase	NOUN
dpc-6006	57	5	in	in	ADP
dpc-6006	57	6	the	the	DET
dpc-6006	57	7	number	number	NOUN
dpc-6006	57	8	of	of	ADP
dpc-6006	57	9	cases	case	NOUN
dpc-6006	57	10	of	of	ADP
dpc-6006	57	11	melanoma	melanoma	NOUN
dpc-6006	57	12	was	be	AUX
dpc-6006	57	13	seen	see	VERB
dpc-6006	57	14	over	over	ADP
dpc-6006	57	15	the	the	DET
dpc-6006	57	16	study	study	NOUN
dpc-6006	57	17	period	period	NOUN
dpc-6006	57	18	,	,	PUNCT
dpc-6006	57	19	with	with	ADP
dpc-6006	57	20	the	the	DET
dpc-6006	57	21	highest	high	ADJ
dpc-6006	57	22	number	number	NOUN
dpc-6006	57	23	of	of	ADP
dpc-6006	57	24	cases	case	NOUN
dpc-6006	57	25	seen	see	VERB
dpc-6006	57	26	in	in	ADP
dpc-6006	57	27	2018	2018	NUM
dpc-6006	57	28	,	,	PUNCT
dpc-6006	57	29	2021	2021	NUM
dpc-6006	57	30	,	,	PUNCT
dpc-6006	57	31	and	and	CCONJ
dpc-6006	57	32	2022	2022	NUM
dpc-6006	57	33	,	,	PUNCT
dpc-6006	57	34	accounting	account	VERB
dpc-6006	57	35	for	for	ADP
dpc-6006	57	36	99	99	NUM
dpc-6006	57	37	(	(	PUNCT
dpc-6006	57	38	17.3	17.3	NUM
dpc-6006	57	39	%	%	NOUN
dpc-6006	57	40	)	)	PUNCT
dpc-6006	57	41	,	,	PUNCT
dpc-6006	57	42	95	95	NUM
dpc-6006	57	43	(	(	PUNCT
dpc-6006	57	44	16.6	16.6	NUM
dpc-6006	57	45	%	%	NOUN
dpc-6006	57	46	)	)	PUNCT
dpc-6006	57	47	,	,	PUNCT
dpc-6006	57	48	and	and	CCONJ
dpc-6006	57	49	98	98	NUM
dpc-6006	57	50	(	(	PUNCT
dpc-6006	57	51	17.1	17.1	NUM
dpc-6006	57	52	%	%	NOUN
dpc-6006	57	53	)	)	PUNCT
dpc-6006	57	54	cases	case	NOUN
dpc-6006	57	55	,	,	PUNCT
dpc-6006	57	56	respectively	respectively	ADV
dpc-6006	57	57	.	.	PUNCT
dpc-6006	58	1	details	detail	NOUN
dpc-6006	58	2	for	for	ADP
dpc-6006	58	3	the	the	DET
dpc-6006	58	4	distribution	distribution	NOUN
dpc-6006	58	5	of	of	ADP
dpc-6006	58	6	cases	case	NOUN
dpc-6006	58	7	over	over	ADP
dpc-6006	58	8	the	the	DET
dpc-6006	58	9	years	year	NOUN
dpc-6006	58	10	is	be	AUX
dpc-6006	58	11	displayed	display	VERB
dpc-6006	58	12	in	in	ADP
dpc-6006	58	13	figure	figure	NOUN
dpc-6006	58	14	1	1	NUM
dpc-6006	58	15	.	.	PUNCT
dpc-6006	59	1	the	the	DET
dpc-6006	59	2	mean	mean	ADJ
dpc-6006	59	3	age	age	NOUN
dpc-6006	59	4	of	of	ADP
dpc-6006	59	5	our	our	PRON
dpc-6006	59	6	study	study	NOUN
dpc-6006	59	7	sample	sample	NOUN
dpc-6006	59	8	was	be	AUX
dpc-6006	59	9	60.00	60.00	NUM
dpc-6006	59	10	±	±	NUM
dpc-6006	59	11	18.03	18.03	NUM
dpc-6006	59	12	years	year	NOUN
dpc-6006	59	13	,	,	PUNCT
dpc-6006	59	14	with	with	ADP
dpc-6006	59	15	a	a	DET
dpc-6006	59	16	slight	slight	ADJ
dpc-6006	59	17	female	female	ADJ
dpc-6006	59	18	majority	majority	NOUN
dpc-6006	59	19	:	:	PUNCT
dpc-6006	59	20	292	292	NUM
dpc-6006	59	21	(	(	PUNCT
dpc-6006	59	22	51.0	51.0	NUM
dpc-6006	59	23	%	%	NOUN
dpc-6006	59	24	)	)	PUNCT
dpc-6006	59	25	.	.	PUNCT
dpc-6006	60	1	of	of	ADP
dpc-6006	60	2	the	the	DET
dpc-6006	60	3	565	565	NUM
dpc-6006	60	4	cases	case	NOUN
dpc-6006	60	5	for	for	ADP
dpc-6006	60	6	whom	whom	PRON
dpc-6006	60	7	data	datum	NOUN
dpc-6006	60	8	for	for	ADP
dpc-6006	60	9	site	site	NOUN
dpc-6006	60	10	of	of	ADP
dpc-6006	60	11	primary	primary	ADJ
dpc-6006	60	12	lesion	lesion	NOUN
dpc-6006	60	13	were	be	AUX
dpc-6006	60	14	available	available	ADJ
dpc-6006	60	15	,	,	PUNCT
dpc-6006	60	16	156	156	NUM
dpc-6006	60	17	(	(	PUNCT
dpc-6006	60	18	26.7	26.7	NUM
dpc-6006	60	19	%	%	NOUN
dpc-6006	60	20	)	)	PUNCT
dpc-6006	60	21	had	have	VERB
dpc-6006	60	22	trunk	trunk	NOUN
dpc-6006	60	23	involvement	involvement	NOUN
dpc-6006	60	24	,	,	PUNCT
dpc-6006	60	25	the	the	DET
dpc-6006	60	26	upper	upper	ADJ
dpc-6006	60	27	and	and	CCONJ
dpc-6006	60	28	lower	low	ADJ
dpc-6006	60	29	limbs	limb	NOUN
dpc-6006	60	30	were	be	AUX
dpc-6006	60	31	affected	affect	VERB
dpc-6006	60	32	in	in	ADP
dpc-6006	60	33	148	148	NUM
dpc-6006	60	34	(	(	PUNCT
dpc-6006	60	35	26.4	26.4	NUM
dpc-6006	60	36	%	%	NOUN
dpc-6006	60	37	)	)	PUNCT
dpc-6006	60	38	and	and	CCONJ
dpc-6006	61	1	147	147	NUM
dpc-6006	61	2	(	(	PUNCT
dpc-6006	61	3	26.2	26.2	NUM
dpc-6006	61	4	%	%	NOUN
dpc-6006	61	5	)	)	PUNCT
dpc-6006	61	6	cases	case	NOUN
dpc-6006	61	7	,	,	PUNCT
dpc-6006	61	8	respectively	respectively	ADV
dpc-6006	61	9	,	,	PUNCT
dpc-6006	61	10	while	while	SCONJ
dpc-6006	61	11	the	the	DET
dpc-6006	61	12	head	head	NOUN
dpc-6006	61	13	and	and	CCONJ
dpc-6006	61	14	neck	neck	NOUN
dpc-6006	61	15	were	be	AUX
dpc-6006	61	16	the	the	DET
dpc-6006	61	17	least	least	ADV
dpc-6006	61	18	frequently	frequently	ADV
dpc-6006	61	19	affected	affect	VERB
dpc-6006	61	20	:	:	PUNCT
dpc-6006	61	21	114	114	NUM
dpc-6006	61	22	cases	case	NOUN
dpc-6006	61	23	(	(	PUNCT
dpc-6006	61	24	20.7	20.7	NUM
dpc-6006	61	25	%	%	NOUN
dpc-6006	61	26	)	)	PUNCT
dpc-6006	61	27	.	.	PUNCT
dpc-6006	62	1	we	we	PRON
dpc-6006	62	2	recorded	record	VERB
dpc-6006	62	3	the	the	DET
dpc-6006	62	4	disease	disease	NOUN
dpc-6006	62	5	stage	stage	NOUN
dpc-6006	62	6	in	in	ADP
dpc-6006	62	7	the	the	DET
dpc-6006	62	8	same	same	ADJ
dpc-6006	62	9	number	number	NOUN
dpc-6006	62	10	of	of	ADP
dpc-6006	62	11	patients	patient	NOUN
dpc-6006	62	12	(	(	PUNCT
dpc-6006	62	13	565	565	NUM
dpc-6006	62	14	patients	patient	NOUN
dpc-6006	62	15	):	):	PUNCT
dpc-6006	62	16	257	257	NUM
dpc-6006	62	17	(	(	PUNCT
dpc-6006	62	18	44.7	44.7	NUM
dpc-6006	62	19	%	%	NOUN
dpc-6006	62	20	)	)	PUNCT
dpc-6006	62	21	were	be	AUX
dpc-6006	62	22	stage	stage	NOUN
dpc-6006	62	23	t1a	t1a	NOUN
dpc-6006	62	24	,	,	PUNCT
dpc-6006	62	25	and	and	CCONJ
dpc-6006	62	26	45	45	NUM
dpc-6006	62	27	(	(	PUNCT
dpc-6006	62	28	7.8	7.8	NUM
dpc-6006	62	29	%	%	NOUN
dpc-6006	62	30	)	)	PUNCT
dpc-6006	62	31	were	be	AUX
dpc-6006	62	32	stage	stage	NOUN
dpc-6006	62	33	original	original	ADJ
dpc-6006	62	34	article	article	NOUN
dpc-6006	63	1	|	|	ADV
dpc-6006	63	2	dermatol	dermatol	ADJ
dpc-6006	63	3	pract	pract	NOUN
dpc-6006	63	4	concept	concept	NOUN
dpc-6006	63	5	.	.	PUNCT
dpc-6006	64	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	64	2	3	3	NUM
dpc-6006	64	3	t1b	t1b	ADJ
dpc-6006	64	4	,	,	PUNCT
dpc-6006	64	5	while	while	SCONJ
dpc-6006	64	6	stages	stage	NOUN
dpc-6006	64	7	t2a	t2a	ADP
dpc-6006	64	8	,	,	PUNCT
dpc-6006	64	9	t2b	t2b	PROPN
dpc-6006	64	10	,	,	PUNCT
dpc-6006	64	11	t3a	t3a	PROPN
dpc-6006	64	12	,	,	PUNCT
dpc-6006	64	13	and	and	CCONJ
dpc-6006	64	14	t3b	t3b	NOUN
dpc-6006	64	15	accounted	account	VERB
dpc-6006	64	16	for	for	ADP
dpc-6006	64	17	88	88	NUM
dpc-6006	64	18	(	(	PUNCT
dpc-6006	64	19	15.5	15.5	NUM
dpc-6006	64	20	%	%	NOUN
dpc-6006	64	21	)	)	PUNCT
dpc-6006	64	22	,	,	PUNCT
dpc-6006	64	23	14	14	NUM
dpc-6006	64	24	(	(	PUNCT
dpc-6006	64	25	2.7	2.7	NUM
dpc-6006	64	26	%	%	NOUN
dpc-6006	64	27	)	)	PUNCT
dpc-6006	64	28	,	,	PUNCT
dpc-6006	64	29	42	42	NUM
dpc-6006	64	30	(	(	PUNCT
dpc-6006	64	31	7.2	7.2	NUM
dpc-6006	64	32	%	%	NOUN
dpc-6006	64	33	)	)	PUNCT
dpc-6006	64	34	,	,	PUNCT
dpc-6006	64	35	and	and	CCONJ
dpc-6006	64	36	36	36	NUM
dpc-6006	64	37	(	(	PUNCT
dpc-6006	64	38	6.4	6.4	NUM
dpc-6006	64	39	%	%	NOUN
dpc-6006	64	40	)	)	PUNCT
dpc-6006	64	41	,	,	PUNCT
dpc-6006	64	42	respectively	respectively	ADV
dpc-6006	64	43	.	.	PUNCT
dpc-6006	65	1	advanced	advanced	ADJ
dpc-6006	65	2	disease	disease	NOUN
dpc-6006	65	3	in	in	ADP
dpc-6006	65	4	the	the	DET
dpc-6006	65	5	form	form	NOUN
dpc-6006	65	6	of	of	ADP
dpc-6006	65	7	stages	stage	NOUN
dpc-6006	65	8	t4a	t4a	ADJ
dpc-6006	65	9	and	and	CCONJ
dpc-6006	65	10	t4b	t4b	NOUN
dpc-6006	65	11	were	be	AUX
dpc-6006	65	12	found	find	VERB
dpc-6006	65	13	in	in	ADP
dpc-6006	65	14	32	32	NUM
dpc-6006	65	15	(	(	PUNCT
dpc-6006	65	16	6.0	6.0	NUM
dpc-6006	65	17	%	%	NOUN
dpc-6006	65	18	)	)	PUNCT
dpc-6006	65	19	and	and	CCONJ
dpc-6006	65	20	50	50	NUM
dpc-6006	65	21	(	(	PUNCT
dpc-6006	65	22	9.5	9.5	NUM
dpc-6006	65	23	%	%	NOUN
dpc-6006	65	24	)	)	PUNCT
dpc-6006	65	25	cases	case	NOUN
dpc-6006	65	26	,	,	PUNCT
dpc-6006	65	27	respectively	respectively	ADV
dpc-6006	65	28	,	,	PUNCT
dpc-6006	65	29	while	while	SCONJ
dpc-6006	65	30	in	in	ADP
dpc-6006	65	31	situ	situ	ADJ
dpc-6006	65	32	disease	disease	NOUN
dpc-6006	65	33	was	be	AUX
dpc-6006	65	34	found	find	VERB
dpc-6006	65	35	in	in	ADP
dpc-6006	65	36	one	one	NUM
dpc-6006	65	37	(	(	PUNCT
dpc-6006	65	38	0.2	0.2	NUM
dpc-6006	65	39	%	%	NOUN
dpc-6006	65	40	)	)	PUNCT
dpc-6006	65	41	case	case	NOUN
dpc-6006	65	42	.	.	PUNCT
dpc-6006	66	1	the	the	DET
dpc-6006	66	2	distribution	distribution	NOUN
dpc-6006	66	3	of	of	ADP
dpc-6006	66	4	cases	case	NOUN
dpc-6006	66	5	on	on	ADP
dpc-6006	66	6	the	the	DET
dpc-6006	66	7	basis	basis	NOUN
dpc-6006	66	8	of	of	ADP
dpc-6006	66	9	patient	patient	ADJ
dpc-6006	66	10	and	and	CCONJ
dpc-6006	66	11	disease	disease	NOUN
dpc-6006	66	12	characteristics	characteristic	NOUN
dpc-6006	66	13	according	accord	VERB
dpc-6006	66	14	to	to	ADP
dpc-6006	66	15	recurrence	recurrence	NOUN
dpc-6006	66	16	is	be	AUX
dpc-6006	66	17	displayed	display	VERB
dpc-6006	66	18	in	in	ADP
dpc-6006	66	19	table	table	NOUN
dpc-6006	66	20	1	1	NUM
dpc-6006	66	21	.	.	PUNCT
dpc-6006	67	1	the	the	DET
dpc-6006	67	2	mean	mean	ADJ
dpc-6006	67	3	breslow	breslow	ADJ
dpc-6006	67	4	thickness	thickness	NOUN
dpc-6006	67	5	of	of	ADP
dpc-6006	67	6	the	the	DET
dpc-6006	67	7	sample	sample	NOUN
dpc-6006	67	8	was	be	AUX
dpc-6006	67	9	2.28	2.28	NUM
dpc-6006	67	10	±	±	NUM
dpc-6006	67	11	3.40	3.40	NUM
dpc-6006	67	12	mm	mm	NOUN
dpc-6006	67	13	.	.	PUNCT
dpc-6006	68	1	the	the	DET
dpc-6006	68	2	clark	clark	NOUN
dpc-6006	68	3	level	level	NOUN
dpc-6006	68	4	was	be	AUX
dpc-6006	68	5	recorded	record	VERB
dpc-6006	68	6	for	for	ADP
dpc-6006	68	7	565	565	NUM
dpc-6006	68	8	patients	patient	NOUN
dpc-6006	68	9	;	;	PUNCT
dpc-6006	68	10	only	only	ADV
dpc-6006	68	11	one	one	NUM
dpc-6006	68	12	(	(	PUNCT
dpc-6006	68	13	0.2	0.2	NUM
dpc-6006	68	14	)	)	PUNCT
dpc-6006	68	15	patient	patient	NOUN
dpc-6006	68	16	had	have	VERB
dpc-6006	68	17	stage	stage	NOUN
dpc-6006	68	18	0	0	NUM
dpc-6006	69	1	(	(	PUNCT
dpc-6006	69	2	melanoma	melanoma	NOUN
dpc-6006	69	3	in	in	ADP
dpc-6006	69	4	situ	situ	NOUN
dpc-6006	69	5	)	)	PUNCT
dpc-6006	69	6	.	.	PUNCT
dpc-6006	70	1	multiple	multiple	ADJ
dpc-6006	70	2	stage	stage	NOUN
dpc-6006	70	3	1	1	NUM
dpc-6006	70	4	cases	case	NOUN
dpc-6006	70	5	(	(	PUNCT
dpc-6006	70	6	pt1a=	pt1a=	PROPN
dpc-6006	70	7	245	245	NUM
dpc-6006	70	8	,	,	PUNCT
dpc-6006	70	9	pt1b=	pt1b=	PROPN
dpc-6006	70	10	44	44	NUM
dpc-6006	70	11	)	)	PUNCT
dpc-6006	70	12	were	be	AUX
dpc-6006	70	13	identified	identify	VERB
dpc-6006	70	14	,	,	PUNCT
dpc-6006	70	15	while	while	SCONJ
dpc-6006	70	16	the	the	DET
dpc-6006	70	17	bulk	bulk	NOUN
dpc-6006	70	18	of	of	ADP
dpc-6006	70	19	cases	case	NOUN
dpc-6006	70	20	were	be	AUX
dpc-6006	70	21	almost	almost	ADV
dpc-6006	70	22	evenly	evenly	ADV
dpc-6006	70	23	distributed	distribute	VERB
dpc-6006	70	24	across	across	ADP
dpc-6006	70	25	stages	stage	NOUN
dpc-6006	70	26	2	2	NUM
dpc-6006	70	27	,	,	PUNCT
dpc-6006	70	28	3	3	NUM
dpc-6006	70	29	,	,	PUNCT
dpc-6006	70	30	and	and	CCONJ
dpc-6006	70	31	4	4	NUM
dpc-6006	70	32	,	,	PUNCT
dpc-6006	70	33	with	with	ADP
dpc-6006	70	34	179	179	NUM
dpc-6006	70	35	(	(	PUNCT
dpc-6006	70	36	32.0	32.0	NUM
dpc-6006	70	37	%	%	NOUN
dpc-6006	70	38	)	)	PUNCT
dpc-6006	70	39	,	,	PUNCT
dpc-6006	70	40	174	174	NUM
dpc-6006	70	41	(	(	PUNCT
dpc-6006	70	42	30.9	30.9	NUM
dpc-6006	70	43	%	%	NOUN
dpc-6006	70	44	)	)	PUNCT
dpc-6006	70	45	,	,	PUNCT
dpc-6006	70	46	and	and	CCONJ
dpc-6006	70	47	184(32.4	184(32.4	NUM
dpc-6006	70	48	%	%	NOUN
dpc-6006	70	49	)	)	PUNCT
dpc-6006	70	50	cases	case	NOUN
dpc-6006	70	51	,	,	PUNCT
dpc-6006	70	52	respectively	respectively	ADV
dpc-6006	70	53	.	.	PUNCT
dpc-6006	71	1	a	a	DET
dpc-6006	71	2	total	total	NOUN
dpc-6006	71	3	of	of	ADP
dpc-6006	71	4	27	27	NUM
dpc-6006	71	5	(	(	PUNCT
dpc-6006	71	6	4.5	4.5	NUM
dpc-6006	71	7	%	%	NOUN
dpc-6006	71	8	of	of	ADP
dpc-6006	71	9	cases	case	NOUN
dpc-6006	71	10	)	)	PUNCT
dpc-6006	71	11	were	be	AUX
dpc-6006	71	12	stage	stage	NOUN
dpc-6006	71	13	5	5	NUM
dpc-6006	71	14	at	at	ADP
dpc-6006	71	15	presentation	presentation	NOUN
dpc-6006	71	16	.	.	PUNCT
dpc-6006	72	1	the	the	DET
dpc-6006	72	2	mean	mean	ADJ
dpc-6006	72	3	mitotic	mitotic	ADJ
dpc-6006	72	4	count	count	NOUN
dpc-6006	72	5	per	per	ADP
dpc-6006	72	6	high	high	ADJ
dpc-6006	72	7	-	-	PUNCT
dpc-6006	72	8	power	power	NOUN
dpc-6006	72	9	field	field	NOUN
dpc-6006	72	10	for	for	ADP
dpc-6006	72	11	the	the	DET
dpc-6006	72	12	sample	sample	NOUN
dpc-6006	72	13	was	be	AUX
dpc-6006	72	14	2.18	2.18	NUM
dpc-6006	72	15	±	±	NUM
dpc-6006	72	16	3.96	3.96	NUM
dpc-6006	72	17	per	per	ADP
dpc-6006	72	18	highpower	highpower	PROPN
dpc-6006	72	19	field	field	NOUN
dpc-6006	72	20	.	.	PUNCT
dpc-6006	73	1	a	a	DET
dpc-6006	73	2	total	total	NOUN
dpc-6006	73	3	of	of	ADP
dpc-6006	73	4	111	111	NUM
dpc-6006	73	5	(	(	PUNCT
dpc-6006	73	6	19.4	19.4	NUM
dpc-6006	73	7	%	%	NOUN
dpc-6006	73	8	)	)	PUNCT
dpc-6006	73	9	cases	case	NOUN
dpc-6006	73	10	had	have	VERB
dpc-6006	73	11	ulceration	ulceration	NOUN
dpc-6006	73	12	of	of	ADP
dpc-6006	73	13	the	the	DET
dpc-6006	73	14	primary	primary	ADJ
dpc-6006	73	15	lesion	lesion	NOUN
dpc-6006	73	16	at	at	ADP
dpc-6006	73	17	the	the	DET
dpc-6006	73	18	time	time	NOUN
dpc-6006	73	19	of	of	ADP
dpc-6006	73	20	presentation	presentation	NOUN
dpc-6006	73	21	,	,	PUNCT
dpc-6006	73	22	while	while	SCONJ
dpc-6006	73	23	28	28	NUM
dpc-6006	73	24	(	(	PUNCT
dpc-6006	73	25	4.9	4.9	NUM
dpc-6006	73	26	%	%	NOUN
dpc-6006	73	27	)	)	PUNCT
dpc-6006	73	28	had	have	VERB
dpc-6006	73	29	lymph	lymph	NOUN
dpc-6006	73	30	vascular	vascular	ADJ
dpc-6006	73	31	invasion	invasion	NOUN
dpc-6006	73	32	.	.	PUNCT
dpc-6006	74	1	a	a	DET
dpc-6006	74	2	sentinel	sentinel	ADJ
dpc-6006	74	3	lymph	lymph	NOUN
dpc-6006	74	4	node	node	ADJ
dpc-6006	74	5	biopsy	biopsy	NOUN
dpc-6006	74	6	was	be	AUX
dpc-6006	74	7	done	do	VERB
dpc-6006	74	8	in	in	ADP
dpc-6006	74	9	134	134	NUM
dpc-6006	74	10	(	(	PUNCT
dpc-6006	74	11	26.9	26.9	NUM
dpc-6006	74	12	%	%	NOUN
dpc-6006	74	13	)	)	PUNCT
dpc-6006	74	14	cases	case	NOUN
dpc-6006	74	15	,	,	PUNCT
dpc-6006	74	16	of	of	ADP
dpc-6006	74	17	which	which	PRON
dpc-6006	74	18	47	47	NUM
dpc-6006	74	19	(	(	PUNCT
dpc-6006	74	20	35.1	35.1	NUM
dpc-6006	74	21	%	%	NOUN
dpc-6006	74	22	)	)	PUNCT
dpc-6006	74	23	were	be	AUX
dpc-6006	74	24	positive	positive	ADJ
dpc-6006	74	25	for	for	ADP
dpc-6006	74	26	malignant	malignant	ADJ
dpc-6006	74	27	cells	cell	NOUN
dpc-6006	74	28	.	.	PUNCT
dpc-6006	75	1	out	out	ADP
dpc-6006	75	2	of	of	ADP
dpc-6006	75	3	the	the	DET
dpc-6006	75	4	total	total	NOUN
dpc-6006	75	5	of	of	ADP
dpc-6006	75	6	565	565	NUM
dpc-6006	75	7	patients	patient	NOUN
dpc-6006	75	8	on	on	ADP
dpc-6006	75	9	whom	whom	PRON
dpc-6006	75	10	surgery	surgery	NOUN
dpc-6006	75	11	was	be	AUX
dpc-6006	75	12	performed	perform	VERB
dpc-6006	75	13	,	,	PUNCT
dpc-6006	75	14	504	504	NUM
dpc-6006	75	15	(	(	PUNCT
dpc-6006	75	16	89.4	89.4	NUM
dpc-6006	75	17	%	%	NOUN
dpc-6006	75	18	)	)	PUNCT
dpc-6006	75	19	had	have	VERB
dpc-6006	75	20	adequate	adequate	ADJ
dpc-6006	75	21	margins	margin	NOUN
dpc-6006	75	22	according	accord	VERB
dpc-6006	75	23	to	to	ADP
dpc-6006	75	24	bad	bad	ADJ
dpc-6006	75	25	guidelines	guideline	NOUN
dpc-6006	75	26	,	,	PUNCT
dpc-6006	75	27	while	while	SCONJ
dpc-6006	75	28	61	61	NUM
dpc-6006	75	29	(	(	PUNCT
dpc-6006	75	30	10.6	10.6	NUM
dpc-6006	75	31	%	%	NOUN
dpc-6006	75	32	)	)	PUNCT
dpc-6006	75	33	did	do	VERB
dpc-6006	75	34	not	not	PART
dpc-6006	75	35	.	.	PUNCT
dpc-6006	76	1	the	the	DET
dpc-6006	76	2	distribution	distribution	NOUN
dpc-6006	76	3	of	of	ADP
dpc-6006	76	4	cases	case	NOUN
dpc-6006	76	5	on	on	ADP
dpc-6006	76	6	the	the	DET
dpc-6006	76	7	basis	basis	NOUN
dpc-6006	76	8	of	of	ADP
dpc-6006	76	9	tumor	tumor	NOUN
dpc-6006	76	10	and	and	CCONJ
dpc-6006	76	11	management	management	NOUN
dpc-6006	76	12	characteristics	characteristic	NOUN
dpc-6006	76	13	according	accord	VERB
dpc-6006	76	14	to	to	ADP
dpc-6006	76	15	recurrence	recurrence	NOUN
dpc-6006	76	16	is	be	AUX
dpc-6006	76	17	displayed	display	VERB
dpc-6006	76	18	in	in	ADP
dpc-6006	76	19	table	table	NOUN
dpc-6006	76	20	2	2	NUM
dpc-6006	76	21	.	.	PUNCT
dpc-6006	77	1	univariate	univariate	ADJ
dpc-6006	77	2	analysis	analysis	NOUN
dpc-6006	77	3	showed	show	VERB
dpc-6006	77	4	that	that	SCONJ
dpc-6006	77	5	melanomas	melanomas	NOUN
dpc-6006	77	6	on	on	ADP
dpc-6006	77	7	the	the	DET
dpc-6006	77	8	trunk	trunk	NOUN
dpc-6006	77	9	,	,	PUNCT
dpc-6006	77	10	clark	clark	NOUN
dpc-6006	77	11	stage	stage	NOUN
dpc-6006	77	12	of	of	ADP
dpc-6006	77	13	ii	ii	PROPN
dpc-6006	77	14	,	,	PUNCT
dpc-6006	77	15	breslow	breslow	VERB
dpc-6006	77	16	thin	thin	ADJ
dpc-6006	77	17	lesions	lesion	NOUN
dpc-6006	77	18	(	(	PUNCT
dpc-6006	77	19	≤1.00	≤1.00	PROPN
dpc-6006	77	20	mm	mm	PROPN
dpc-6006	77	21	)	)	PUNCT
dpc-6006	77	22	,	,	PUNCT
dpc-6006	77	23	and	and	CCONJ
dpc-6006	77	24	a	a	DET
dpc-6006	77	25	tumor	tumor	NOUN
dpc-6006	77	26	stage	stage	NOUN
dpc-6006	77	27	1b	1b	NUM
dpc-6006	77	28	were	be	AUX
dpc-6006	77	29	all	all	PRON
dpc-6006	77	30	associated	associate	VERB
dpc-6006	77	31	with	with	ADP
dpc-6006	77	32	a	a	DET
dpc-6006	77	33	decreased	decrease	VERB
dpc-6006	77	34	chance	chance	NOUN
dpc-6006	77	35	of	of	ADP
dpc-6006	77	36	recurrence	recurrence	NOUN
dpc-6006	77	37	,	,	PUNCT
dpc-6006	77	38	all	all	PRON
dpc-6006	77	39	of	of	ADP
dpc-6006	77	40	which	which	PRON
dpc-6006	77	41	remained	remain	VERB
dpc-6006	77	42	significant	significant	ADJ
dpc-6006	77	43	on	on	ADP
dpc-6006	77	44	multivariate	multivariate	NOUN
dpc-6006	77	45	analysis	analysis	NOUN
dpc-6006	77	46	.	.	PUNCT
dpc-6006	78	1	univariate	univariate	ADJ
dpc-6006	78	2	analysis	analysis	NOUN
dpc-6006	78	3	also	also	ADV
dpc-6006	78	4	showed	show	VERB
dpc-6006	78	5	that	that	SCONJ
dpc-6006	78	6	age	age	NOUN
dpc-6006	78	7	≥	≥	NOUN
dpc-6006	78	8	65	65	NUM
dpc-6006	78	9	years	year	NOUN
dpc-6006	78	10	,	,	PUNCT
dpc-6006	78	11	lesions	lesion	NOUN
dpc-6006	78	12	on	on	ADP
dpc-6006	78	13	lower	low	ADJ
dpc-6006	78	14	limb	limb	NOUN
dpc-6006	78	15	,	,	PUNCT
dpc-6006	78	16	stages	stage	NOUN
dpc-6006	78	17	4a	4a	NOUN
dpc-6006	78	18	and	and	CCONJ
dpc-6006	78	19	4b	4b	PROPN
dpc-6006	78	20	disease	disease	NOUN
dpc-6006	78	21	,	,	PUNCT
dpc-6006	78	22	breslow	breslow	ADJ
dpc-6006	78	23	thickness	thickness	NOUN
dpc-6006	78	24	of	of	ADP
dpc-6006	78	25	>	>	PUNCT
dpc-6006	78	26	4.0	4.0	NUM
dpc-6006	78	27	mm	mm	NOUN
dpc-6006	78	28	,	,	PUNCT
dpc-6006	78	29	clark	clark	NOUN
dpc-6006	78	30	stages	stage	VERB
dpc-6006	78	31	4	4	NUM
dpc-6006	78	32	and	and	CCONJ
dpc-6006	78	33	5	5	NUM
dpc-6006	78	34	,	,	PUNCT
dpc-6006	78	35	number	number	NOUN
dpc-6006	78	36	of	of	ADP
dpc-6006	78	37	mitotic	mitotic	ADJ
dpc-6006	78	38	figures	figure	NOUN
dpc-6006	78	39	≥1	≥1	X
dpc-6006	78	40	per	per	ADP
dpc-6006	78	41	high	high	ADJ
dpc-6006	78	42	-	-	PUNCT
dpc-6006	78	43	power	power	NOUN
dpc-6006	78	44	field	field	NOUN
dpc-6006	78	45	,	,	PUNCT
dpc-6006	78	46	presence	presence	NOUN
dpc-6006	78	47	of	of	ADP
dpc-6006	78	48	ulceration	ulceration	NOUN
dpc-6006	78	49	,	,	PUNCT
dpc-6006	78	50	lympho	lympho	NOUN
dpc-6006	78	51	-	-	PUNCT
dpc-6006	78	52	vascular	vascular	ADJ
dpc-6006	78	53	invasion	invasion	NOUN
dpc-6006	78	54	,	,	PUNCT
dpc-6006	78	55	positive	positive	ADJ
dpc-6006	78	56	sentinel	sentinel	NOUN
dpc-6006	78	57	lymph	lymph	NOUN
dpc-6006	78	58	node	node	NOUN
dpc-6006	78	59	biopsy	biopsy	NOUN
dpc-6006	78	60	,	,	PUNCT
dpc-6006	78	61	and	and	CCONJ
dpc-6006	78	62	inadequate	inadequate	ADJ
dpc-6006	78	63	margins	margin	NOUN
dpc-6006	78	64	on	on	ADP
dpc-6006	78	65	excision	excision	NOUN
dpc-6006	78	66	were	be	AUX
dpc-6006	78	67	all	all	PRON
dpc-6006	78	68	associated	associate	VERB
dpc-6006	78	69	with	with	ADP
dpc-6006	78	70	an	an	DET
dpc-6006	78	71	increased	increase	VERB
dpc-6006	78	72	chance	chance	NOUN
dpc-6006	78	73	of	of	ADP
dpc-6006	78	74	recurrence	recurrence	NOUN
dpc-6006	78	75	.	.	PUNCT
dpc-6006	79	1	however	however	ADV
dpc-6006	79	2	,	,	PUNCT
dpc-6006	79	3	lower	low	ADJ
dpc-6006	79	4	limb	limb	NOUN
dpc-6006	79	5	lesions	lesion	NOUN
dpc-6006	79	6	,	,	PUNCT
dpc-6006	79	7	tumor	tumor	NOUN
dpc-6006	79	8	stage	stage	NOUN
dpc-6006	79	9	4a	4a	NOUN
dpc-6006	79	10	,	,	PUNCT
dpc-6006	79	11	a	a	DET
dpc-6006	79	12	mitotic	mitotic	ADJ
dpc-6006	79	13	rate	rate	NOUN
dpc-6006	79	14	≥1	≥1	NOUN
dpc-6006	79	15	per	per	ADP
dpc-6006	79	16	high	high	ADJ
dpc-6006	79	17	-	-	PUNCT
dpc-6006	79	18	power	power	NOUN
dpc-6006	79	19	field	field	NOUN
dpc-6006	79	20	,	,	PUNCT
dpc-6006	79	21	and	and	CCONJ
dpc-6006	79	22	adequate	adequate	ADJ
dpc-6006	79	23	margins	margin	NOUN
dpc-6006	79	24	on	on	ADP
dpc-6006	79	25	excision	excision	NOUN
dpc-6006	79	26	lost	lose	VERB
dpc-6006	79	27	statistical	statistical	ADJ
dpc-6006	79	28	significance	significance	NOUN
dpc-6006	79	29	on	on	ADP
dpc-6006	79	30	multivariate	multivariate	NOUN
dpc-6006	79	31	analysis	analysis	NOUN
dpc-6006	79	32	.	.	PUNCT
dpc-6006	80	1	discussion	discussion	NOUN
dpc-6006	80	2	we	we	PRON
dpc-6006	80	3	conducted	conduct	VERB
dpc-6006	80	4	this	this	DET
dpc-6006	80	5	retrospective	retrospective	ADJ
dpc-6006	80	6	study	study	NOUN
dpc-6006	80	7	on	on	ADP
dpc-6006	80	8	patients	patient	NOUN
dpc-6006	80	9	with	with	ADP
dpc-6006	80	10	melanoma	melanoma	NOUN
dpc-6006	80	11	with	with	ADP
dpc-6006	80	12	the	the	DET
dpc-6006	80	13	aim	aim	NOUN
dpc-6006	80	14	of	of	ADP
dpc-6006	80	15	determining	determine	VERB
dpc-6006	80	16	the	the	DET
dpc-6006	80	17	association	association	NOUN
dpc-6006	80	18	between	between	ADP
dpc-6006	80	19	clinicopathological	clinicopathological	ADJ
dpc-6006	80	20	focus	focus	NOUN
dpc-6006	80	21	and	and	CCONJ
dpc-6006	80	22	the	the	DET
dpc-6006	80	23	development	development	NOUN
dpc-6006	80	24	of	of	ADP
dpc-6006	80	25	recurrent	recurrent	ADJ
dpc-6006	80	26	disease	disease	NOUN
dpc-6006	80	27	.	.	PUNCT
dpc-6006	81	1	recurrent	recurrent	ADJ
dpc-6006	81	2	disease	disease	NOUN
dpc-6006	81	3	in	in	ADP
dpc-6006	81	4	malignant	malignant	ADJ
dpc-6006	81	5	melanoma	melanoma	NOUN
dpc-6006	81	6	is	be	AUX
dpc-6006	81	7	the	the	DET
dpc-6006	81	8	reappearance	reappearance	NOUN
dpc-6006	81	9	of	of	ADP
dpc-6006	81	10	melanoma	melanoma	NOUN
dpc-6006	81	11	after	after	SCONJ
dpc-6006	81	12	it	it	PRON
dpc-6006	81	13	has	have	AUX
dpc-6006	81	14	been	be	AUX
dpc-6006	81	15	treated	treat	VERB
dpc-6006	81	16	and	and	CCONJ
dpc-6006	81	17	appeared	appear	VERB
dpc-6006	81	18	to	to	PART
dpc-6006	81	19	be	be	AUX
dpc-6006	81	20	gone	go	VERB
dpc-6006	81	21	.	.	PUNCT
dpc-6006	82	1	this	this	PRON
dpc-6006	82	2	can	can	AUX
dpc-6006	82	3	happen	happen	VERB
dpc-6006	82	4	at	at	ADP
dpc-6006	82	5	the	the	DET
dpc-6006	82	6	original	original	ADJ
dpc-6006	82	7	location	location	NOUN
dpc-6006	82	8	(	(	PUNCT
dpc-6006	82	9	local	local	ADJ
dpc-6006	82	10	recurrence	recurrence	NOUN
dpc-6006	82	11	)	)	PUNCT
dpc-6006	82	12	,	,	PUNCT
dpc-6006	82	13	in	in	ADP
dpc-6006	82	14	nearby	nearby	ADJ
dpc-6006	82	15	lymph	lymph	NOUN
dpc-6006	82	16	nodes	node	NOUN
dpc-6006	82	17	(	(	PUNCT
dpc-6006	82	18	regional	regional	ADJ
dpc-6006	82	19	recurrence	recurrence	NOUN
dpc-6006	82	20	)	)	PUNCT
dpc-6006	82	21	,	,	PUNCT
dpc-6006	82	22	or	or	CCONJ
dpc-6006	82	23	in	in	ADP
dpc-6006	82	24	other	other	ADJ
dpc-6006	82	25	parts	part	NOUN
dpc-6006	82	26	of	of	ADP
dpc-6006	82	27	the	the	DET
dpc-6006	82	28	body	body	NOUN
dpc-6006	82	29	(	(	PUNCT
dpc-6006	82	30	distant	distant	ADJ
dpc-6006	82	31	or	or	CCONJ
dpc-6006	82	32	metastatic	metastatic	ADJ
dpc-6006	82	33	recurrence	recurrence	NOUN
dpc-6006	82	34	)	)	PUNCT
dpc-6006	82	35	.	.	PUNCT
dpc-6006	83	1	the	the	DET
dpc-6006	83	2	probability	probability	NOUN
dpc-6006	83	3	and	and	CCONJ
dpc-6006	83	4	location	location	NOUN
dpc-6006	83	5	of	of	ADP
dpc-6006	83	6	recurrence	recurrence	NOUN
dpc-6006	83	7	are	be	AUX
dpc-6006	83	8	influenced	influence	VERB
dpc-6006	83	9	by	by	ADP
dpc-6006	83	10	clinicopathological	clinicopathological	ADJ
dpc-6006	83	11	factors	factor	NOUN
dpc-6006	83	12	such	such	ADJ
dpc-6006	83	13	as	as	ADP
dpc-6006	83	14	the	the	DET
dpc-6006	83	15	initial	initial	ADJ
dpc-6006	83	16	stage	stage	NOUN
dpc-6006	83	17	of	of	ADP
dpc-6006	83	18	the	the	DET
dpc-6006	83	19	melanoma	melanoma	NOUN
dpc-6006	83	20	,	,	PUNCT
dpc-6006	83	21	the	the	DET
dpc-6006	83	22	success	success	NOUN
dpc-6006	83	23	of	of	ADP
dpc-6006	83	24	the	the	DET
dpc-6006	83	25	initial	initial	ADJ
dpc-6006	83	26	treatment	treatment	NOUN
dpc-6006	83	27	,	,	PUNCT
dpc-6006	83	28	and	and	CCONJ
dpc-6006	83	29	specific	specific	ADJ
dpc-6006	83	30	patient	patient	ADJ
dpc-6006	83	31	characteristics	characteristic	NOUN
dpc-6006	83	32	[	[	X
dpc-6006	83	33	2	2	NUM
dpc-6006	83	34	]	]	PUNCT
dpc-6006	83	35	.	.	PUNCT
dpc-6006	84	1	identifying	identify	VERB
dpc-6006	84	2	patients	patient	NOUN
dpc-6006	84	3	who	who	PRON
dpc-6006	84	4	are	be	AUX
dpc-6006	84	5	at	at	ADP
dpc-6006	84	6	high	high	ADJ
dpc-6006	84	7	risk	risk	NOUN
dpc-6006	84	8	of	of	ADP
dpc-6006	84	9	recurrence	recurrence	NOUN
dpc-6006	84	10	will	will	AUX
dpc-6006	84	11	help	help	VERB
dpc-6006	84	12	the	the	DET
dpc-6006	84	13	treating	treat	VERB
dpc-6006	84	14	clinician	clinician	NOUN
dpc-6006	84	15	to	to	PART
dpc-6006	84	16	maintain	maintain	VERB
dpc-6006	84	17	a	a	DET
dpc-6006	84	18	higher	high	ADJ
dpc-6006	84	19	degree	degree	NOUN
dpc-6006	84	20	of	of	ADP
dpc-6006	84	21	vigilance	vigilance	NOUN
dpc-6006	84	22	.	.	PUNCT
dpc-6006	85	1	our	our	PRON
dpc-6006	85	2	data	data	NOUN
dpc-6006	85	3	analysis	analysis	NOUN
dpc-6006	85	4	showed	show	VERB
dpc-6006	85	5	that	that	SCONJ
dpc-6006	85	6	there	there	PRON
dpc-6006	85	7	was	be	VERB
dpc-6006	85	8	a	a	DET
dpc-6006	85	9	steadily	steadily	ADV
dpc-6006	85	10	increasing	increase	VERB
dpc-6006	85	11	trend	trend	NOUN
dpc-6006	85	12	in	in	ADP
dpc-6006	85	13	the	the	DET
dpc-6006	85	14	number	number	NOUN
dpc-6006	85	15	of	of	ADP
dpc-6006	85	16	cases	case	NOUN
dpc-6006	85	17	of	of	ADP
dpc-6006	85	18	melanoma	melanoma	NOUN
dpc-6006	85	19	reporting	report	VERB
dpc-6006	85	20	to	to	ADP
dpc-6006	85	21	our	our	PRON
dpc-6006	85	22	institute	institute	NOUN
dpc-6006	85	23	every	every	DET
dpc-6006	85	24	year	year	NOUN
dpc-6006	85	25	,	,	PUNCT
dpc-6006	85	26	in	in	ADP
dpc-6006	85	27	keeping	keep	VERB
dpc-6006	85	28	with	with	ADP
dpc-6006	85	29	existing	exist	VERB
dpc-6006	85	30	data	datum	NOUN
dpc-6006	85	31	,	,	PUNCT
dpc-6006	85	32	making	make	VERB
dpc-6006	85	33	the	the	DET
dpc-6006	85	34	conclusions	conclusion	NOUN
dpc-6006	85	35	of	of	ADP
dpc-6006	85	36	our	our	PRON
dpc-6006	85	37	study	study	NOUN
dpc-6006	85	38	even	even	ADV
dpc-6006	85	39	more	more	ADV
dpc-6006	85	40	relevant	relevant	ADJ
dpc-6006	86	1	[	[	X
dpc-6006	86	2	3,4	3,4	NUM
dpc-6006	86	3	]	]	PUNCT
dpc-6006	86	4	.	.	PUNCT
dpc-6006	87	1	we	we	PRON
dpc-6006	87	2	found	find	VERB
dpc-6006	87	3	that	that	SCONJ
dpc-6006	87	4	patients	patient	NOUN
dpc-6006	87	5	aged	age	VERB
dpc-6006	87	6	65	65	NUM
dpc-6006	87	7	years	year	NOUN
dpc-6006	87	8	or	or	CCONJ
dpc-6006	87	9	more	more	ADJ
dpc-6006	87	10	had	have	VERB
dpc-6006	87	11	a	a	DET
dpc-6006	87	12	significantly	significantly	ADV
dpc-6006	87	13	higher	high	ADJ
dpc-6006	87	14	frequency	frequency	NOUN
dpc-6006	87	15	of	of	ADP
dpc-6006	87	16	recurrent	recurrent	ADJ
dpc-6006	87	17	disease	disease	NOUN
dpc-6006	87	18	,	,	PUNCT
dpc-6006	87	19	which	which	PRON
dpc-6006	87	20	was	be	AUX
dpc-6006	87	21	in	in	ADP
dpc-6006	87	22	keeping	keeping	NOUN
dpc-6006	87	23	with	with	ADP
dpc-6006	87	24	other	other	ADJ
dpc-6006	87	25	studies	study	NOUN
dpc-6006	87	26	such	such	ADJ
dpc-6006	87	27	as	as	ADP
dpc-6006	87	28	that	that	PRON
dpc-6006	87	29	by	by	ADP
dpc-6006	87	30	fleming	fleme	VERB
dpc-6006	87	31	et	et	PROPN
dpc-6006	87	32	al	al	PROPN
dpc-6006	87	33	.	.	PROPN
dpc-6006	87	34	,	,	PUNCT
dpc-6006	87	35	where	where	SCONJ
dpc-6006	87	36	older	old	ADJ
dpc-6006	87	37	patients	patient	NOUN
dpc-6006	87	38	were	be	AUX
dpc-6006	87	39	also	also	ADV
dpc-6006	87	40	found	find	VERB
dpc-6006	87	41	to	to	PART
dpc-6006	87	42	be	be	AUX
dpc-6006	87	43	at	at	ADP
dpc-6006	87	44	an	an	DET
dpc-6006	87	45	increased	increase	VERB
dpc-6006	87	46	risk	risk	NOUN
dpc-6006	87	47	(	(	PUNCT
dpc-6006	87	48	hazard	hazard	NOUN
dpc-6006	87	49	ration	ration	NOUN
dpc-6006	87	50	hr	hr	NOUN
dpc-6006	87	51	3.34	3.34	NUM
dpc-6006	87	52	;	;	PUNCT
dpc-6006	87	53	95	95	NUM
dpc-6006	87	54	%	%	NOUN
dpc-6006	87	55	confidence	confidence	NOUN
dpc-6006	87	56	interval	interval	NOUN
dpc-6006	87	57	ci	ci	PROPN
dpc-6006	87	58	:	:	PUNCT
dpc-6006	87	59	1.53–7.25	1.53–7.25	NUM
dpc-6006	87	60	;	;	PUNCT
dpc-6006	87	61	p<0.01	p<0.01	PROPN
dpc-6006	87	62	)	)	PUNCT
dpc-6006	88	1	[	[	X
dpc-6006	88	2	11	11	NUM
dpc-6006	88	3	]	]	PUNCT
dpc-6006	88	4	.	.	PUNCT
dpc-6006	89	1	univariate	univariate	ADJ
dpc-6006	89	2	analysis	analysis	NOUN
dpc-6006	89	3	showed	show	VERB
dpc-6006	89	4	that	that	SCONJ
dpc-6006	89	5	lower	low	ADJ
dpc-6006	89	6	limb	limb	NOUN
dpc-6006	89	7	melanomas	melanoma	NOUN
dpc-6006	89	8	were	be	AUX
dpc-6006	89	9	associated	associate	VERB
dpc-6006	89	10	with	with	ADP
dpc-6006	89	11	a	a	DET
dpc-6006	89	12	higher	high	ADJ
dpc-6006	89	13	risk	risk	NOUN
dpc-6006	89	14	of	of	ADP
dpc-6006	89	15	recurrence	recurrence	NOUN
dpc-6006	89	16	;	;	PUNCT
dpc-6006	89	17	however	however	ADV
dpc-6006	89	18	,	,	PUNCT
dpc-6006	89	19	this	this	DET
dpc-6006	89	20	association	association	NOUN
dpc-6006	89	21	became	become	VERB
dpc-6006	89	22	insignificant	insignificant	ADJ
dpc-6006	89	23	on	on	ADP
dpc-6006	89	24	multivariate	multivariate	NOUN
dpc-6006	89	25	review	review	NOUN
dpc-6006	89	26	in	in	ADP
dpc-6006	89	27	this	this	DET
dpc-6006	89	28	study	study	NOUN
dpc-6006	89	29	,	,	PUNCT
dpc-6006	89	30	while	while	SCONJ
dpc-6006	89	31	head	head	NOUN
dpc-6006	89	32	and	and	CCONJ
dpc-6006	89	33	neck	neck	NOUN
dpc-6006	89	34	lesions	lesion	NOUN
dpc-6006	89	35	figure	figure	NOUN
dpc-6006	89	36	1	1	NUM
dpc-6006	89	37	.	.	PUNCT
dpc-6006	89	38	distribution	distribution	NOUN
dpc-6006	89	39	of	of	ADP
dpc-6006	89	40	cases	case	NOUN
dpc-6006	89	41	by	by	ADP
dpc-6006	89	42	year	year	NOUN
dpc-6006	89	43	.	.	PUNCT
dpc-6006	90	1	0	0	NUM
dpc-6006	91	1	20	20	NUM
dpc-6006	91	2	40	40	NUM
dpc-6006	91	3	60	60	NUM
dpc-6006	91	4	80	80	NUM
dpc-6006	91	5	100	100	NUM
dpc-6006	91	6	120	120	NUM
dpc-6006	91	7	2016	2016	NUM
dpc-6006	91	8	2017	2017	NUM
dpc-6006	91	9	2018	2018	NUM
dpc-6006	91	10	2019	2019	NUM
dpc-6006	91	11	2020	2020	NUM
dpc-6006	91	12	2021	2021	NUM
dpc-6006	91	13	2022	2022	NUM
dpc-6006	91	14	2023	2023	NUM
dpc-6006	91	15	nu	nu	PROPN
dpc-6006	91	16	m	m	AUX
dpc-6006	91	17	be	be	VERB
dpc-6006	91	18	r	r	NOUN
dpc-6006	91	19	o	o	NOUN
dpc-6006	91	20	f	f	X
dpc-6006	91	21	c	c	NOUN
dpc-6006	91	22	as	as	ADP
dpc-6006	91	23	es	es	X
dpc-6006	91	24	year	year	NOUN
dpc-6006	91	25	4	4	NUM
dpc-6006	91	26	original	original	ADJ
dpc-6006	91	27	article	article	NOUN
dpc-6006	91	28	|	|	ADV
dpc-6006	91	29	dermatol	dermatol	ADJ
dpc-6006	91	30	pract	pract	NOUN
dpc-6006	91	31	concept	concept	NOUN
dpc-6006	91	32	.	.	PUNCT
dpc-6006	92	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	92	2	table	table	NOUN
dpc-6006	92	3	2	2	NUM
dpc-6006	92	4	.	.	PUNCT
dpc-6006	92	5	distribution	distribution	NOUN
dpc-6006	92	6	of	of	ADP
dpc-6006	92	7	tumor	tumor	NOUN
dpc-6006	92	8	and	and	CCONJ
dpc-6006	92	9	management	management	NOUN
dpc-6006	92	10	characteristics	characteristic	NOUN
dpc-6006	92	11	according	accord	VERB
dpc-6006	92	12	to	to	ADP
dpc-6006	92	13	recurrence	recurrence	NOUN
dpc-6006	92	14	with	with	ADP
dpc-6006	92	15	univariate	univariate	ADJ
dpc-6006	92	16	analysis	analysis	NOUN
dpc-6006	92	17	.	.	PUNCT
dpc-6006	93	1	recurrence	recurrence	NOUN
dpc-6006	93	2	yes	yes	INTJ
dpc-6006	93	3	(	(	PUNCT
dpc-6006	93	4	n=44	n=44	NOUN
dpc-6006	93	5	)	)	PUNCT
dpc-6006	93	6	no	no	PRON
dpc-6006	93	7	(	(	PUNCT
dpc-6006	93	8	n=521	n=521	NOUN
dpc-6006	93	9	)	)	PUNCT
dpc-6006	93	10	p	p	ADJ
dpc-6006	93	11	-	-	PUNCT
dpc-6006	93	12	value	value	NOUN
dpc-6006	93	13	breslow	breslow	ADJ
dpc-6006	93	14	thickness	thickness	NOUN
dpc-6006	93	15	(	(	PUNCT
dpc-6006	93	16	mm	mm	NOUN
dpc-6006	93	17	)	)	PUNCT
dpc-6006	93	18	4.13	4.13	NUM
dpc-6006	93	19	±	±	NUM
dpc-6006	93	20	4.51	4.51	NUM
dpc-6006	93	21	2.13	2.13	NUM
dpc-6006	93	22	±	±	NUM
dpc-6006	93	23	3.27	3.27	NUM
dpc-6006	93	24	<	<	NOUN
dpc-6006	93	25	0.001	0.001	NUM
dpc-6006	93	26	thin	thin	ADJ
dpc-6006	93	27	(	(	PUNCT
dpc-6006	93	28	≤1.00	≤1.00	PROPN
dpc-6006	93	29	mm	mm	PROPN
dpc-6006	93	30	)	)	PUNCT
dpc-6006	93	31	13	13	NUM
dpc-6006	93	32	(	(	PUNCT
dpc-6006	93	33	4.4	4.4	NUM
dpc-6006	93	34	)	)	PUNCT
dpc-6006	93	35	279	279	NUM
dpc-6006	93	36	(	(	PUNCT
dpc-6006	93	37	95.6	95.6	NUM
dpc-6006	93	38	)	)	PUNCT
dpc-6006	93	39	0.002	0.002	NUM
dpc-6006	93	40	intermediate	intermediate	ADJ
dpc-6006	93	41	(	(	PUNCT
dpc-6006	93	42	1.01	1.01	NUM
dpc-6006	93	43	–	–	SYM
dpc-6006	93	44	2.00	2.00	NUM
dpc-6006	93	45	mm	mm	NOUN
dpc-6006	93	46	)	)	PUNCT
dpc-6006	93	47	7	7	NUM
dpc-6006	93	48	(	(	PUNCT
dpc-6006	93	49	7.1	7.1	NUM
dpc-6006	93	50	)	)	PUNCT
dpc-6006	93	51	92	92	NUM
dpc-6006	93	52	(	(	PUNCT
dpc-6006	93	53	92.9	92.9	NUM
dpc-6006	93	54	)	)	PUNCT
dpc-6006	93	55	0.772	0.772	NUM
dpc-6006	93	56	intermediate	intermediate	ADJ
dpc-6006	93	57	(	(	PUNCT
dpc-6006	93	58	2.01	2.01	NUM
dpc-6006	93	59	–	–	SYM
dpc-6006	93	60	4.00	4.00	NUM
dpc-6006	93	61	mm	mm	NOUN
dpc-6006	93	62	)	)	PUNCT
dpc-6006	93	63	7	7	NUM
dpc-6006	93	64	(	(	PUNCT
dpc-6006	93	65	8.8	8.8	NUM
dpc-6006	93	66	)	)	PUNCT
dpc-6006	93	67	73	73	NUM
dpc-6006	93	68	(	(	PUNCT
dpc-6006	93	69	91.2	91.2	NUM
dpc-6006	93	70	)	)	PUNCT
dpc-6006	93	71	0.725	0.725	NUM
dpc-6006	93	72	thick	thick	ADJ
dpc-6006	93	73	(	(	PUNCT
dpc-6006	93	74	>	>	X
dpc-6006	93	75	4.00	4.00	NUM
dpc-6006	93	76	mm	mm	NOUN
dpc-6006	93	77	)	)	PUNCT
dpc-6006	93	78	16	16	NUM
dpc-6006	93	79	(	(	PUNCT
dpc-6006	93	80	19.5	19.5	NUM
dpc-6006	93	81	)	)	PUNCT
dpc-6006	93	82	66	66	NUM
dpc-6006	93	83	(	(	PUNCT
dpc-6006	93	84	80.5	80.5	NUM
dpc-6006	93	85	)	)	PUNCT
dpc-6006	93	86	<	<	X
dpc-6006	93	87	0.001	0.001	NUM
dpc-6006	93	88	clark	clark	NOUN
dpc-6006	93	89	level	level	NOUN
dpc-6006	93	90	stage	stage	NOUN
dpc-6006	94	1	i	i	PRON
dpc-6006	94	2	(	(	PUNCT
dpc-6006	94	3	n	n	X
dpc-6006	94	4	[	[	X
dpc-6006	94	5	%	%	X
dpc-6006	94	6	]	]	X
dpc-6006	94	7	)	)	PUNCT
dpc-6006	94	8	1	1	NUM
dpc-6006	94	9	(	(	PUNCT
dpc-6006	94	10	100	100	NUM
dpc-6006	94	11	%	%	NOUN
dpc-6006	94	12	)	)	PUNCT
dpc-6006	94	13	0.772	0.772	NUM
dpc-6006	94	14	stage	stage	NOUN
dpc-6006	94	15	ii	ii	NOUN
dpc-6006	94	16	(	(	PUNCT
dpc-6006	94	17	n	n	X
dpc-6006	94	18	[	[	X
dpc-6006	94	19	%	%	X
dpc-6006	94	20	]	]	X
dpc-6006	94	21	)	)	PUNCT
dpc-6006	94	22	7	7	NUM
dpc-6006	94	23	(	(	PUNCT
dpc-6006	94	24	4.0	4.0	NUM
dpc-6006	94	25	%	%	NOUN
dpc-6006	94	26	)	)	PUNCT
dpc-6006	94	27	168	168	NUM
dpc-6006	94	28	(	(	PUNCT
dpc-6006	94	29	96.0	96.0	NUM
dpc-6006	94	30	%	%	NOUN
dpc-6006	94	31	)	)	PUNCT
dpc-6006	94	32	0.021	0.021	NUM
dpc-6006	94	33	stage	stage	NOUN
dpc-6006	94	34	iii	iii	X
dpc-6006	94	35	(	(	PUNCT
dpc-6006	94	36	n	n	X
dpc-6006	95	1	[	[	X
dpc-6006	95	2	%	%	X
dpc-6006	95	3	]	]	X
dpc-6006	95	4	)	)	PUNCT
dpc-6006	95	5	8	8	NUM
dpc-6006	95	6	(	(	PUNCT
dpc-6006	95	7	4.8	4.8	NUM
dpc-6006	95	8	%	%	NOUN
dpc-6006	95	9	)	)	PUNCT
dpc-6006	95	10	160	160	NUM
dpc-6006	95	11	(	(	PUNCT
dpc-6006	95	12	95.2	95.2	NUM
dpc-6006	95	13	%	%	NOUN
dpc-6006	95	14	)	)	PUNCT
dpc-6006	95	15	0.073	0.073	NUM
dpc-6006	95	16	stage	stage	NOUN
dpc-6006	95	17	iv	iv	NUM
dpc-6006	95	18	(	(	PUNCT
dpc-6006	95	19	n	n	X
dpc-6006	95	20	[	[	X
dpc-6006	95	21	%	%	X
dpc-6006	95	22	]	]	X
dpc-6006	95	23	)	)	PUNCT
dpc-6006	95	24	21	21	NUM
dpc-6006	95	25	(	(	PUNCT
dpc-6006	95	26	11.7	11.7	NUM
dpc-6006	95	27	%	%	NOUN
dpc-6006	95	28	)	)	PUNCT
dpc-6006	95	29	159	159	NUM
dpc-6006	95	30	(	(	PUNCT
dpc-6006	95	31	88.3	88.3	NUM
dpc-6006	95	32	%	%	NOUN
dpc-6006	95	33	)	)	PUNCT
dpc-6006	95	34	0.021	0.021	NUM
dpc-6006	95	35	stage	stage	NOUN
dpc-6006	95	36	v	v	NOUN
dpc-6006	95	37	(	(	PUNCT
dpc-6006	95	38	n	n	CCONJ
dpc-6006	96	1	[	[	X
dpc-6006	96	2	%	%	X
dpc-6006	96	3	]	]	X
dpc-6006	96	4	)	)	PUNCT
dpc-6006	96	5	7	7	NUM
dpc-6006	96	6	(	(	PUNCT
dpc-6006	96	7	29.2	29.2	NUM
dpc-6006	96	8	%	%	NOUN
dpc-6006	96	9	)	)	PUNCT
dpc-6006	96	10	17	17	NUM
dpc-6006	96	11	(	(	PUNCT
dpc-6006	96	12	70.8	70.8	NUM
dpc-6006	96	13	%	%	NOUN
dpc-6006	96	14	)	)	PUNCT
dpc-6006	97	1	<	<	X
dpc-6006	97	2	0.001	0.001	NUM
dpc-6006	97	3	mitotic	mitotic	ADJ
dpc-6006	97	4	rate	rate	NOUN
dpc-6006	97	5	(	(	PUNCT
dpc-6006	97	6	per	per	ADP
dpc-6006	97	7	high	high	ADJ
dpc-6006	97	8	-	-	PUNCT
dpc-6006	97	9	power	power	NOUN
dpc-6006	97	10	field	field	NOUN
dpc-6006	97	11	)	)	PUNCT
dpc-6006	97	12	4.55	4.55	NUM
dpc-6006	97	13	±	±	NUM
dpc-6006	97	14	7.07	7.07	NUM
dpc-6006	97	15	2.01	2.01	NUM
dpc-6006	97	16	±	±	NUM
dpc-6006	97	17	3.56	3.56	NUM
dpc-6006	97	18	<	<	NOUN
dpc-6006	97	19	0.001	0.001	NUM
dpc-6006	97	20	mitotic	mitotic	ADJ
dpc-6006	97	21	rate	rate	NOUN
dpc-6006	97	22	≥	≥	NOUN
dpc-6006	97	23	1	1	NUM
dpc-6006	97	24	32	32	NUM
dpc-6006	97	25	(	(	PUNCT
dpc-6006	97	26	10.9	10.9	NUM
dpc-6006	97	27	%	%	NOUN
dpc-6006	97	28	)	)	PUNCT
dpc-6006	97	29	263	263	NUM
dpc-6006	97	30	(	(	PUNCT
dpc-6006	97	31	89.1	89.1	NUM
dpc-6006	97	32	%	%	NOUN
dpc-6006	97	33	)	)	PUNCT
dpc-6006	97	34	0.004	0.004	NUM
dpc-6006	97	35	ulceration	ulceration	NOUN
dpc-6006	97	36	(	(	PUNCT
dpc-6006	97	37	n	n	CCONJ
dpc-6006	98	1	[	[	X
dpc-6006	98	2	%	%	X
dpc-6006	98	3	]	]	X
dpc-6006	98	4	)	)	PUNCT
dpc-6006	98	5	14	14	NUM
dpc-6006	98	6	(	(	PUNCT
dpc-6006	98	7	12.8	12.8	NUM
dpc-6006	98	8	%	%	NOUN
dpc-6006	98	9	)	)	PUNCT
dpc-6006	98	10	95	95	NUM
dpc-6006	98	11	(	(	PUNCT
dpc-6006	98	12	87.2	87.2	NUM
dpc-6006	98	13	%	%	NOUN
dpc-6006	98	14	)	)	PUNCT
dpc-6006	98	15	0.061	0.061	NUM
dpc-6006	98	16	lymphovascular	lymphovascular	ADJ
dpc-6006	98	17	invasion	invasion	NOUN
dpc-6006	98	18	(	(	PUNCT
dpc-6006	98	19	n	n	CCONJ
dpc-6006	99	1	[	[	X
dpc-6006	99	2	%	%	X
dpc-6006	99	3	]	]	X
dpc-6006	99	4	)	)	PUNCT
dpc-6006	99	5	7	7	NUM
dpc-6006	99	6	(	(	PUNCT
dpc-6006	99	7	25.0	25.0	NUM
dpc-6006	99	8	%	%	NOUN
dpc-6006	99	9	)	)	PUNCT
dpc-6006	99	10	21	21	NUM
dpc-6006	99	11	(	(	PUNCT
dpc-6006	99	12	75.0	75.0	NUM
dpc-6006	99	13	%	%	NOUN
dpc-6006	99	14	)	)	PUNCT
dpc-6006	99	15	0.002	0.002	NUM
dpc-6006	99	16	positive	positive	ADJ
dpc-6006	99	17	sentinel	sentinel	NOUN
dpc-6006	99	18	lymph	lymph	NOUN
dpc-6006	99	19	node	node	NOUN
dpc-6006	99	20	biopsy	biopsy	VERB
dpc-6006	99	21	8	8	NUM
dpc-6006	99	22	(	(	PUNCT
dpc-6006	99	23	17.0	17.0	NUM
dpc-6006	99	24	%	%	NOUN
dpc-6006	99	25	)	)	PUNCT
dpc-6006	99	26	39	39	NUM
dpc-6006	99	27	(	(	PUNCT
dpc-6006	99	28	83.0	83.0	NUM
dpc-6006	99	29	%	%	NOUN
dpc-6006	99	30	)	)	PUNCT
dpc-6006	99	31	0.007	0.007	NUM
dpc-6006	99	32	adequate	adequate	ADJ
dpc-6006	99	33	margins	margin	NOUN
dpc-6006	99	34	according	accord	VERB
dpc-6006	99	35	to	to	ADP
dpc-6006	99	36	british	british	PROPN
dpc-6006	99	37	association	association	PROPN
dpc-6006	99	38	of	of	ADP
dpc-6006	99	39	dermatologist	dermatologist	PROPN
dpc-6006	99	40	(	(	PUNCT
dpc-6006	99	41	bad	bad	ADJ
dpc-6006	99	42	)	)	PUNCT
dpc-6006	99	43	guidelines	guideline	NOUN
dpc-6006	99	44	yes	yes	INTJ
dpc-6006	99	45	31	31	NUM
dpc-6006	99	46	(	(	PUNCT
dpc-6006	99	47	5.8	5.8	NUM
dpc-6006	99	48	%	%	NOUN
dpc-6006	99	49	)	)	PUNCT
dpc-6006	99	50	469	469	NUM
dpc-6006	99	51	(	(	PUNCT
dpc-6006	99	52	94.2	94.2	NUM
dpc-6006	99	53	%	%	NOUN
dpc-6006	99	54	)	)	PUNCT
dpc-6006	100	1	<	<	X
dpc-6006	100	2	0.001	0.001	NUM
dpc-6006	100	3	no	no	DET
dpc-6006	100	4	17(22.8	17(22.8	ADJ
dpc-6006	100	5	%	%	NOUN
dpc-6006	100	6	)	)	PUNCT
dpc-6006	100	7	48	48	NUM
dpc-6006	100	8	(	(	PUNCT
dpc-6006	100	9	77.2	77.2	NUM
dpc-6006	100	10	%	%	NOUN
dpc-6006	100	11	)	)	PUNCT
dpc-6006	100	12	table	table	NOUN
dpc-6006	100	13	1	1	NUM
dpc-6006	100	14	.	.	PUNCT
dpc-6006	101	1	distribution	distribution	NOUN
dpc-6006	101	2	of	of	ADP
dpc-6006	101	3	patient	patient	ADJ
dpc-6006	101	4	and	and	CCONJ
dpc-6006	101	5	disease	disease	NOUN
dpc-6006	101	6	characteristics	characteristic	NOUN
dpc-6006	101	7	according	accord	VERB
dpc-6006	101	8	to	to	ADP
dpc-6006	101	9	recurrence	recurrence	NOUN
dpc-6006	101	10	with	with	ADP
dpc-6006	101	11	univariate	univariate	ADJ
dpc-6006	101	12	analysis	analysis	NOUN
dpc-6006	101	13	.	.	PUNCT
dpc-6006	102	1	recurrence	recurrence	NOUN
dpc-6006	102	2	yes	yes	INTJ
dpc-6006	102	3	(	(	PUNCT
dpc-6006	102	4	n=44	n=44	NOUN
dpc-6006	102	5	)	)	PUNCT
dpc-6006	102	6	no	no	PRON
dpc-6006	102	7	(	(	PUNCT
dpc-6006	102	8	n=521	n=521	NOUN
dpc-6006	102	9	)	)	PUNCT
dpc-6006	102	10	p	p	ADJ
dpc-6006	102	11	-	-	PUNCT
dpc-6006	102	12	value	value	NOUN
dpc-6006	102	13	age	age	NOUN
dpc-6006	102	14	(	(	PUNCT
dpc-6006	102	15	years	year	NOUN
dpc-6006	102	16	)	)	PUNCT
dpc-6006	102	17	69.77	69.77	NUM
dpc-6006	102	18	±	±	NUM
dpc-6006	102	19	15.56	15.56	NUM
dpc-6006	102	20	59.21	59.21	NUM
dpc-6006	102	21	±	±	NOUN
dpc-6006	102	22	17.99	17.99	NUM
dpc-6006	102	23	<	<	NOUN
dpc-6006	102	24	0.001	0.001	NUM
dpc-6006	102	25	age	age	NOUN
dpc-6006	102	26	≥	≥	NOUN
dpc-6006	102	27	65	65	NUM
dpc-6006	102	28	years	year	NOUN
dpc-6006	102	29	31	31	NUM
dpc-6006	102	30	(	(	PUNCT
dpc-6006	102	31	12.1	12.1	NUM
dpc-6006	102	32	%	%	NOUN
dpc-6006	102	33	)	)	PUNCT
dpc-6006	102	34	225	225	NUM
dpc-6006	102	35	(	(	PUNCT
dpc-6006	102	36	87.1	87.1	NUM
dpc-6006	102	37	%	%	NOUN
dpc-6006	102	38	)	)	PUNCT
dpc-6006	102	39	<	<	X
dpc-6006	102	40	0.001	0.001	NUM
dpc-6006	102	41	sex	sex	NOUN
dpc-6006	102	42	male	male	NOUN
dpc-6006	102	43	(	(	PUNCT
dpc-6006	102	44	n	n	CCONJ
dpc-6006	103	1	[	[	X
dpc-6006	103	2	%	%	X
dpc-6006	103	3	]	]	X
dpc-6006	103	4	)	)	PUNCT
dpc-6006	103	5	24	24	NUM
dpc-6006	103	6	(	(	PUNCT
dpc-6006	103	7	10.6	10.6	NUM
dpc-6006	103	8	)	)	PUNCT
dpc-6006	103	9	203	203	NUM
dpc-6006	103	10	(	(	PUNCT
dpc-6006	103	11	89.4	89.4	NUM
dpc-6006	103	12	)	)	PUNCT
dpc-6006	104	1	0.542	0.542	NUM
dpc-6006	104	2	female	female	ADJ
dpc-6006	104	3	(	(	PUNCT
dpc-6006	104	4	n	n	NOUN
dpc-6006	104	5	[	[	X
dpc-6006	104	6	%	%	X
dpc-6006	104	7	]	]	X
dpc-6006	104	8	)	)	PUNCT
dpc-6006	104	9	20	20	NUM
dpc-6006	104	10	(	(	PUNCT
dpc-6006	104	11	8.6	8.6	NUM
dpc-6006	104	12	)	)	PUNCT
dpc-6006	104	13	213	213	NUM
dpc-6006	104	14	(	(	PUNCT
dpc-6006	104	15	91.4	91.4	NUM
dpc-6006	104	16	)	)	PUNCT
dpc-6006	104	17	site	site	NOUN
dpc-6006	104	18	of	of	ADP
dpc-6006	104	19	primary	primary	ADJ
dpc-6006	104	20	lesion	lesion	NOUN
dpc-6006	104	21	trunk	trunk	NOUN
dpc-6006	104	22	(	(	PUNCT
dpc-6006	104	23	n	n	NOUN
dpc-6006	104	24	[	[	X
dpc-6006	104	25	%	%	X
dpc-6006	104	26	]	]	X
dpc-6006	104	27	)	)	PUNCT
dpc-6006	104	28	6	6	NUM
dpc-6006	104	29	(	(	PUNCT
dpc-6006	104	30	5.0	5.0	NUM
dpc-6006	104	31	)	)	SYM
dpc-6006	104	32	113	113	NUM
dpc-6006	104	33	(	(	PUNCT
dpc-6006	104	34	95.0	95.0	NUM
dpc-6006	104	35	)	)	PUNCT
dpc-6006	104	36	0.007	0.007	NUM
dpc-6006	104	37	upper	upper	ADJ
dpc-6006	104	38	limbs	limb	NOUN
dpc-6006	104	39	(	(	PUNCT
dpc-6006	104	40	n	n	CCONJ
dpc-6006	105	1	[	[	X
dpc-6006	105	2	%	%	X
dpc-6006	105	3	]	]	X
dpc-6006	105	4	)	)	PUNCT
dpc-6006	105	5	8	8	NUM
dpc-6006	105	6	(	(	PUNCT
dpc-6006	105	7	6.6	6.6	NUM
dpc-6006	105	8	)	)	PUNCT
dpc-6006	105	9	114	114	NUM
dpc-6006	105	10	(	(	PUNCT
dpc-6006	105	11	93.4	93.4	NUM
dpc-6006	105	12	)	)	PUNCT
dpc-6006	105	13	0.258	0.258	NUM
dpc-6006	105	14	lower	low	ADJ
dpc-6006	105	15	limbs	limb	NOUN
dpc-6006	105	16	(	(	PUNCT
dpc-6006	105	17	n	n	CCONJ
dpc-6006	105	18	[	[	X
dpc-6006	105	19	%	%	X
dpc-6006	105	20	]	]	X
dpc-6006	105	21	)	)	PUNCT
dpc-6006	105	22	19	19	NUM
dpc-6006	105	23	(	(	PUNCT
dpc-6006	105	24	15.6	15.6	NUM
dpc-6006	105	25	)	)	PUNCT
dpc-6006	105	26	103	103	NUM
dpc-6006	105	27	(	(	PUNCT
dpc-6006	105	28	84.4	84.4	NUM
dpc-6006	105	29	)	)	PUNCT
dpc-6006	105	30	0.007	0.007	NUM
dpc-6006	105	31	head	head	NOUN
dpc-6006	105	32	and	and	CCONJ
dpc-6006	105	33	neck	neck	NOUN
dpc-6006	105	34	(	(	PUNCT
dpc-6006	105	35	n	n	CCONJ
dpc-6006	105	36	[	[	X
dpc-6006	105	37	%	%	X
dpc-6006	105	38	]	]	X
dpc-6006	105	39	)	)	PUNCT
dpc-6006	105	40	11	11	NUM
dpc-6006	105	41	(	(	PUNCT
dpc-6006	105	42	11.8	11.8	NUM
dpc-6006	105	43	)	)	PUNCT
dpc-6006	105	44	82	82	NUM
dpc-6006	105	45	(	(	PUNCT
dpc-6006	105	46	88.2	88.2	NUM
dpc-6006	105	47	)	)	PUNCT
dpc-6006	105	48	0.232	0.232	NUM
dpc-6006	105	49	stage	stage	NOUN
dpc-6006	105	50	at	at	ADP
dpc-6006	105	51	presentation	presentation	NOUN
dpc-6006	105	52	in	in	ADP
dpc-6006	105	53	situ	situ	ADJ
dpc-6006	105	54	disease	disease	NOUN
dpc-6006	105	55	1	1	NUM
dpc-6006	105	56	(	(	PUNCT
dpc-6006	105	57	100	100	NUM
dpc-6006	105	58	)	)	PUNCT
dpc-6006	105	59	0.772	0.772	NUM
dpc-6006	105	60	pt1a	pt1a	PROPN
dpc-6006	105	61	(	(	PUNCT
dpc-6006	105	62	n	n	X
dpc-6006	106	1	[	[	X
dpc-6006	106	2	%	%	X
dpc-6006	106	3	]	]	X
dpc-6006	106	4	)	)	PUNCT
dpc-6006	106	5	13	13	NUM
dpc-6006	106	6	(	(	PUNCT
dpc-6006	106	7	5.0	5.0	NUM
dpc-6006	106	8	)	)	PUNCT
dpc-6006	106	9	232	232	NUM
dpc-6006	106	10	(	(	PUNCT
dpc-6006	106	11	95.0	95.0	NUM
dpc-6006	106	12	)	)	PUNCT
dpc-6006	106	13	0.054	0.054	NUM
dpc-6006	106	14	pt1b	pt1b	PROPN
dpc-6006	106	15	(	(	PUNCT
dpc-6006	106	16	n	n	X
dpc-6006	107	1	[	[	X
dpc-6006	107	2	%	%	X
dpc-6006	107	3	]	]	X
dpc-6006	107	4	)	)	PUNCT
dpc-6006	107	5	44	44	NUM
dpc-6006	107	6	(	(	PUNCT
dpc-6006	107	7	100	100	NUM
dpc-6006	107	8	)	)	PUNCT
dpc-6006	108	1	0.045	0.045	NUM
dpc-6006	108	2	pt2a	pt2a	PROPN
dpc-6006	108	3	(	(	PUNCT
dpc-6006	108	4	n	n	CCONJ
dpc-6006	108	5	[	[	X
dpc-6006	108	6	%	%	X
dpc-6006	108	7	]	]	X
dpc-6006	108	8	)	)	PUNCT
dpc-6006	108	9	7	7	NUM
dpc-6006	108	10	(	(	PUNCT
dpc-6006	108	11	8.1	8.1	NUM
dpc-6006	108	12	)	)	PUNCT
dpc-6006	108	13	79	79	NUM
dpc-6006	108	14	(	(	PUNCT
dpc-6006	108	15	91.9	91.9	NUM
dpc-6006	108	16	)	)	PUNCT
dpc-6006	108	17	0.887	0.887	NUM
dpc-6006	109	1	pt2b	pt2b	PROPN
dpc-6006	109	2	(	(	PUNCT
dpc-6006	109	3	n	n	PROPN
dpc-6006	109	4	[	[	X
dpc-6006	109	5	%	%	X
dpc-6006	109	6	]	]	X
dpc-6006	109	7	)	)	PUNCT
dpc-6006	109	8	15	15	NUM
dpc-6006	109	9	(	(	PUNCT
dpc-6006	109	10	100	100	NUM
dpc-6006	109	11	)	)	PUNCT
dpc-6006	109	12	0.255	0.255	NUM
dpc-6006	109	13	pt3a	pt3a	PROPN
dpc-6006	109	14	(	(	PUNCT
dpc-6006	109	15	n	n	NOUN
dpc-6006	110	1	[	[	X
dpc-6006	110	2	%	%	X
dpc-6006	110	3	]	]	X
dpc-6006	110	4	)	)	PUNCT
dpc-6006	110	5	3	3	NUM
dpc-6006	110	6	(	(	PUNCT
dpc-6006	110	7	7.3	7.3	NUM
dpc-6006	110	8	)	)	PUNCT
dpc-6006	110	9	38	38	NUM
dpc-6006	110	10	(	(	PUNCT
dpc-6006	110	11	92.7	92.7	NUM
dpc-6006	110	12	)	)	PUNCT
dpc-6006	110	13	0.912	0.912	NUM
dpc-6006	110	14	pt3b	pt3b	NOUN
dpc-6006	110	15	(	(	PUNCT
dpc-6006	110	16	n	n	NOUN
dpc-6006	111	1	[	[	X
dpc-6006	111	2	%	%	X
dpc-6006	111	3	]	]	X
dpc-6006	111	4	)	)	PUNCT
dpc-6006	111	5	3	3	NUM
dpc-6006	111	6	(	(	PUNCT
dpc-6006	111	7	8.3	8.3	NUM
dpc-6006	111	8	)	)	PUNCT
dpc-6006	111	9	33	33	NUM
dpc-6006	111	10	(	(	PUNCT
dpc-6006	111	11	91.7	91.7	NUM
dpc-6006	111	12	)	)	PUNCT
dpc-6006	111	13	0.895	0.895	NUM
dpc-6006	111	14	pt4a	pt4a	NOUN
dpc-6006	111	15	(	(	PUNCT
dpc-6006	111	16	n	n	X
dpc-6006	112	1	[	[	X
dpc-6006	112	2	%	%	X
dpc-6006	112	3	]	]	X
dpc-6006	112	4	)	)	PUNCT
dpc-6006	112	5	7	7	NUM
dpc-6006	112	6	(	(	PUNCT
dpc-6006	112	7	20.6	20.6	NUM
dpc-6006	112	8	)	)	PUNCT
dpc-6006	112	9	27	27	NUM
dpc-6006	112	10	(	(	PUNCT
dpc-6006	112	11	79.4	79.4	NUM
dpc-6006	112	12	)	)	PUNCT
dpc-6006	112	13	0.004	0.004	NUM
dpc-6006	112	14	pt4b	pt4b	NOUN
dpc-6006	112	15	(	(	PUNCT
dpc-6006	112	16	n	n	NUM
dpc-6006	112	17	[	[	X
dpc-6006	112	18	%	%	X
dpc-6006	112	19	]	]	X
dpc-6006	112	20	)	)	PUNCT
dpc-6006	112	21	10	10	NUM
dpc-6006	112	22	(	(	PUNCT
dpc-6006	112	23	19.2	19.2	NUM
dpc-6006	112	24	)	)	PUNCT
dpc-6006	112	25	42	42	NUM
dpc-6006	112	26	(	(	PUNCT
dpc-6006	112	27	80.8	80.8	NUM
dpc-6006	112	28	)	)	PUNCT
dpc-6006	112	29	0.001	0.001	NUM
dpc-6006	112	30	original	original	ADJ
dpc-6006	112	31	article	article	NOUN
dpc-6006	112	32	|	|	ADV
dpc-6006	112	33	dermatol	dermatol	ADJ
dpc-6006	112	34	pract	pract	NOUN
dpc-6006	112	35	concept	concept	NOUN
dpc-6006	112	36	.	.	PUNCT
dpc-6006	113	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	113	2	5	5	NUM
dpc-6006	113	3	a	a	DET
dpc-6006	113	4	breslow	breslow	ADJ
dpc-6006	113	5	thickness	thickness	NOUN
dpc-6006	113	6	,	,	PUNCT
dpc-6006	113	7	a	a	DET
dpc-6006	113	8	key	key	ADJ
dpc-6006	113	9	clinicopathological	clinicopathological	ADJ
dpc-6006	113	10	marker	marker	NOUN
dpc-6006	113	11	,	,	PUNCT
dpc-6006	113	12	of	of	ADP
dpc-6006	113	13	≤1.0	≤1.0	PROPN
dpc-6006	113	14	mm	mm	NOUN
dpc-6006	113	15	was	be	AUX
dpc-6006	113	16	associated	associate	VERB
dpc-6006	113	17	with	with	ADP
dpc-6006	113	18	a	a	DET
dpc-6006	113	19	lower	low	ADJ
dpc-6006	113	20	chance	chance	NOUN
dpc-6006	113	21	of	of	ADP
dpc-6006	113	22	recurrence	recurrence	NOUN
dpc-6006	113	23	,	,	PUNCT
dpc-6006	113	24	while	while	SCONJ
dpc-6006	113	25	for	for	ADP
dpc-6006	113	26	patients	patient	NOUN
dpc-6006	113	27	in	in	ADP
dpc-6006	113	28	our	our	PRON
dpc-6006	113	29	study	study	NOUN
dpc-6006	113	30	sample	sample	NOUN
dpc-6006	113	31	with	with	ADP
dpc-6006	113	32	a	a	DET
dpc-6006	113	33	thickness	thickness	NOUN
dpc-6006	113	34	of	of	ADP
dpc-6006	113	35	>	>	PRON
dpc-6006	113	36	4.0	4.0	NUM
dpc-6006	113	37	mm	mm	NOUN
dpc-6006	113	38	,	,	PUNCT
dpc-6006	113	39	the	the	DET
dpc-6006	113	40	converse	converse	NOUN
dpc-6006	113	41	was	be	AUX
dpc-6006	113	42	true	true	ADJ
dpc-6006	113	43	.	.	PUNCT
dpc-6006	114	1	oh	oh	INTJ
dpc-6006	114	2	et	et	NOUN
dpc-6006	114	3	al	al	PROPN
dpc-6006	114	4	.	.	PROPN
dpc-6006	114	5	reported	report	VERB
dpc-6006	114	6	that	that	SCONJ
dpc-6006	114	7	a	a	DET
dpc-6006	114	8	breslow	breslow	ADJ
dpc-6006	114	9	thickness	thickness	NOUN
dpc-6006	114	10	of	of	ADP
dpc-6006	114	11	>	>	SYM
dpc-6006	114	12	1.0	1.0	NUM
dpc-6006	114	13	mm	mm	NOUN
dpc-6006	114	14	was	be	AUX
dpc-6006	114	15	associated	associate	VERB
dpc-6006	114	16	with	with	ADP
dpc-6006	114	17	a	a	DET
dpc-6006	114	18	higher	high	ADJ
dpc-6006	114	19	risk	risk	NOUN
dpc-6006	114	20	of	of	ADP
dpc-6006	114	21	recurrence	recurrence	NOUN
dpc-6006	114	22	,	,	PUNCT
dpc-6006	114	23	(	(	PUNCT
dpc-6006	114	24	p=0.008	p=0.008	NOUN
dpc-6006	114	25	)	)	PUNCT
dpc-6006	114	26	,	,	PUNCT
dpc-6006	114	27	adding	add	VERB
dpc-6006	114	28	that	that	SCONJ
dpc-6006	114	29	there	there	PRON
dpc-6006	114	30	is	be	VERB
dpc-6006	114	31	a	a	DET
dpc-6006	114	32	variation	variation	NOUN
dpc-6006	114	33	in	in	ADP
dpc-6006	114	34	male	male	ADJ
dpc-6006	114	35	and	and	CCONJ
dpc-6006	114	36	female	female	ADJ
dpc-6006	114	37	sex	sex	NOUN
dpc-6006	114	38	:	:	PUNCT
dpc-6006	114	39	a	a	DET
dpc-6006	114	40	thickness	thickness	NOUN
dpc-6006	114	41	of	of	ADP
dpc-6006	114	42	≥2.5	≥2.5	NOUN
dpc-6006	114	43	mm	mm	NOUN
dpc-6006	114	44	in	in	ADP
dpc-6006	114	45	males	male	NOUN
dpc-6006	114	46	was	be	AUX
dpc-6006	114	47	associated	associate	VERB
dpc-6006	114	48	with	with	ADP
dpc-6006	114	49	higher	high	ADJ
dpc-6006	114	50	rates	rate	NOUN
dpc-6006	114	51	of	of	ADP
dpc-6006	114	52	recurrence	recurrence	NOUN
dpc-6006	114	53	,	,	PUNCT
dpc-6006	114	54	while	while	SCONJ
dpc-6006	114	55	the	the	DET
dpc-6006	114	56	value	value	NOUN
dpc-6006	114	57	for	for	ADP
dpc-6006	114	58	females	female	NOUN
dpc-6006	114	59	was>4.0	was>4.0	PROPN
dpc-6006	114	60	mm	mm	PROPN
dpc-6006	114	61	(	(	PUNCT
dpc-6006	114	62	p<0.05	p<0.05	PROPN
dpc-6006	114	63	)	)	PUNCT
dpc-6006	115	1	[	[	X
dpc-6006	115	2	16	16	NUM
dpc-6006	115	3	]	]	PUNCT
dpc-6006	115	4	.	.	PUNCT
dpc-6006	116	1	reschke	reschke	PROPN
dpc-6006	116	2	et	et	PROPN
dpc-6006	116	3	al	al	PROPN
dpc-6006	116	4	.	.	PROPN
dpc-6006	116	5	also	also	ADV
dpc-6006	116	6	reported	report	VERB
dpc-6006	116	7	a	a	DET
dpc-6006	116	8	similar	similar	ADJ
dpc-6006	116	9	relation	relation	NOUN
dpc-6006	116	10	between	between	ADP
dpc-6006	116	11	thickness	thickness	NOUN
dpc-6006	116	12	and	and	CCONJ
dpc-6006	116	13	recurrence	recurrence	NOUN
dpc-6006	116	14	,	,	PUNCT
dpc-6006	116	15	with	with	ADP
dpc-6006	116	16	the	the	DET
dpc-6006	116	17	addition	addition	NOUN
dpc-6006	116	18	of	of	ADP
dpc-6006	116	19	an	an	DET
dpc-6006	116	20	increased	increase	VERB
dpc-6006	116	21	risk	risk	NOUN
dpc-6006	116	22	of	of	ADP
dpc-6006	116	23	metastases	metastasis	NOUN
dpc-6006	116	24	in	in	ADP
dpc-6006	116	25	patients	patient	NOUN
dpc-6006	116	26	who	who	PRON
dpc-6006	116	27	had	have	AUX
dpc-6006	116	28	increased	increase	VERB
dpc-6006	116	29	thickness	thickness	NOUN
dpc-6006	116	30	[	[	X
dpc-6006	116	31	17	17	NUM
dpc-6006	116	32	]	]	PUNCT
dpc-6006	116	33	,	,	PUNCT
dpc-6006	116	34	as	as	SCONJ
dpc-6006	116	35	did	do	VERB
dpc-6006	116	36	von	von	PROPN
dpc-6006	116	37	lyth	lyth	PROPN
dpc-6006	116	38	et	et	PROPN
dpc-6006	116	39	al	al	PROPN
dpc-6006	116	40	.	.	PROPN
dpc-6006	116	41	,	,	PUNCT
dpc-6006	116	42	who	who	PRON
dpc-6006	116	43	noted	note	VERB
dpc-6006	116	44	that	that	SCONJ
dpc-6006	116	45	a	a	DET
dpc-6006	116	46	breslow	breslow	ADJ
dpc-6006	116	47	thickness	thickness	NOUN
dpc-6006	116	48	of	of	ADP
dpc-6006	116	49	2.01	2.01	NUM
dpc-6006	116	50	mm	mm	NOUN
dpc-6006	116	51	to	to	ADP
dpc-6006	116	52	4.0	4.0	NUM
dpc-6006	116	53	mm	mm	NOUN
dpc-6006	116	54	was	be	AUX
dpc-6006	116	55	associated	associate	VERB
dpc-6006	116	56	with	with	ADP
dpc-6006	116	57	a	a	DET
dpc-6006	116	58	greatly	greatly	ADV
dpc-6006	116	59	increased	increase	VERB
dpc-6006	116	60	risk	risk	NOUN
dpc-6006	116	61	of	of	ADP
dpc-6006	116	62	recurrence	recurrence	NOUN
dpc-6006	116	63	(	(	PUNCT
dpc-6006	116	64	hr	hr	NOUN
dpc-6006	116	65	4.0	4.0	NUM
dpc-6006	116	66	;	;	PUNCT
dpc-6006	116	67	95	95	NUM
dpc-6006	116	68	%	%	NOUN
dpc-6006	116	69	ci	ci	NOUN
dpc-6006	116	70	:	:	PUNCT
dpc-6006	116	71	2.1–7.6	2.1–7.6	NUM
dpc-6006	116	72	;	;	PUNCT
dpc-6006	116	73	p<0.05	p<0.05	NOUN
dpc-6006	116	74	)	)	PUNCT
dpc-6006	116	75	,	,	PUNCT
dpc-6006	116	76	while	while	SCONJ
dpc-6006	116	77	a	a	DET
dpc-6006	116	78	thickness	thickness	NOUN
dpc-6006	116	79	of	of	ADP
dpc-6006	116	80	>	>	SYM
dpc-6006	116	81	4.0	4.0	NUM
dpc-6006	116	82	mm	mm	NOUN
dpc-6006	116	83	carried	carry	VERB
dpc-6006	116	84	an	an	DET
dpc-6006	116	85	even	even	ADV
dpc-6006	116	86	greater	great	ADJ
dpc-6006	116	87	risk	risk	NOUN
dpc-6006	116	88	(	(	PUNCT
dpc-6006	116	89	hr	hr	NOUN
dpc-6006	116	90	6.7	6.7	NUM
dpc-6006	116	91	;	;	PUNCT
dpc-6006	116	92	95	95	NUM
dpc-6006	116	93	%	%	NOUN
dpc-6006	116	94	ci	ci	NOUN
dpc-6006	116	95	:	:	PUNCT
dpc-6006	116	96	3.4–13.0	3.4–13.0	NUM
dpc-6006	116	97	;	;	PUNCT
dpc-6006	116	98	p<0.05	p<0.05	NOUN
dpc-6006	116	99	)	)	PUNCT
dpc-6006	117	1	[	[	X
dpc-6006	117	2	13	13	NUM
dpc-6006	117	3	]	]	PUNCT
dpc-6006	117	4	.	.	PUNCT
dpc-6006	118	1	as	as	ADP
dpc-6006	118	2	with	with	ADP
dpc-6006	118	3	tumor	tumor	NOUN
dpc-6006	118	4	stage	stage	NOUN
dpc-6006	118	5	,	,	PUNCT
dpc-6006	118	6	early	early	ADJ
dpc-6006	118	7	clark	clark	NOUN
dpc-6006	118	8	stages	stage	NOUN
dpc-6006	118	9	were	be	AUX
dpc-6006	118	10	associated	associate	VERB
dpc-6006	118	11	with	with	ADP
dpc-6006	118	12	a	a	DET
dpc-6006	118	13	significantly	significantly	ADV
dpc-6006	118	14	lower	low	ADJ
dpc-6006	118	15	frequency	frequency	NOUN
dpc-6006	118	16	of	of	ADP
dpc-6006	118	17	recurrence	recurrence	NOUN
dpc-6006	118	18	versus	versus	ADP
dpc-6006	118	19	advanced	advanced	ADJ
dpc-6006	118	20	clark	clark	NOUN
dpc-6006	118	21	stages	stage	NOUN
dpc-6006	118	22	(	(	PUNCT
dpc-6006	118	23	e.g.	e.g.	ADV
dpc-6006	118	24	,	,	PUNCT
dpc-6006	118	25	for	for	ADP
dpc-6006	118	26	stages	stage	NOUN
dpc-6006	118	27	4	4	NUM
dpc-6006	118	28	and	and	CCONJ
dpc-6006	118	29	5	5	NUM
dpc-6006	118	30	)	)	PUNCT
dpc-6006	118	31	,	,	PUNCT
dpc-6006	118	32	where	where	SCONJ
dpc-6006	118	33	recurrence	recurrence	NOUN
dpc-6006	118	34	was	be	AUX
dpc-6006	118	35	much	much	ADV
dpc-6006	118	36	more	more	ADV
dpc-6006	118	37	common	common	ADJ
dpc-6006	118	38	;	;	PUNCT
dpc-6006	118	39	these	these	DET
dpc-6006	118	40	conclusions	conclusion	NOUN
dpc-6006	118	41	were	be	AUX
dpc-6006	118	42	shared	share	VERB
dpc-6006	118	43	by	by	ADP
dpc-6006	118	44	tas	tas	PROPN
dpc-6006	118	45	et	et	PROPN
dpc-6006	118	46	al	al	PROPN
dpc-6006	118	47	.	.	PUNCT
dpc-6006	119	1	[	[	X
dpc-6006	119	2	18	18	NUM
dpc-6006	119	3	]	]	PUNCT
dpc-6006	119	4	.	.	PUNCT
dpc-6006	120	1	contrariwise	contrariwise	ADV
dpc-6006	120	2	,	,	PUNCT
dpc-6006	120	3	kim	kim	PROPN
dpc-6006	120	4	et	et	PROPN
dpc-6006	120	5	al	al	PROPN
dpc-6006	120	6	.	.	PROPN
dpc-6006	120	7	reported	report	VERB
dpc-6006	120	8	that	that	SCONJ
dpc-6006	120	9	clark	clark	NOUN
dpc-6006	120	10	staging	staging	NOUN
dpc-6006	120	11	did	do	AUX
dpc-6006	120	12	not	not	PART
dpc-6006	120	13	appear	appear	VERB
dpc-6006	120	14	to	to	PART
dpc-6006	120	15	have	have	VERB
dpc-6006	120	16	a	a	DET
dpc-6006	120	17	statistically	statistically	ADV
dpc-6006	120	18	significant	significant	ADJ
dpc-6006	120	19	association	association	NOUN
dpc-6006	120	20	with	with	ADP
dpc-6006	120	21	the	the	DET
dpc-6006	120	22	development	development	NOUN
dpc-6006	120	23	of	of	ADP
dpc-6006	120	24	recurrence	recurrence	NOUN
dpc-6006	120	25	;	;	PUNCT
dpc-6006	120	26	however	however	ADV
dpc-6006	120	27	,	,	PUNCT
dpc-6006	120	28	this	this	DET
dpc-6006	120	29	study	study	NOUN
dpc-6006	120	30	was	be	AUX
dpc-6006	120	31	conducted	conduct	VERB
dpc-6006	120	32	on	on	ADP
dpc-6006	120	33	thin	thin	ADJ
dpc-6006	120	34	melanomas	melanoma	NOUN
dpc-6006	120	35	,	,	PUNCT
dpc-6006	120	36	with	with	ADP
dpc-6006	120	37	the	the	DET
dpc-6006	120	38	sample	sample	NOUN
dpc-6006	120	39	predominantly	predominantly	ADV
dpc-6006	120	40	consisting	consist	VERB
dpc-6006	120	41	of	of	ADP
dpc-6006	120	42	advanced	advanced	ADJ
dpc-6006	120	43	clark	clark	NOUN
dpc-6006	120	44	stage	stage	NOUN
dpc-6006	120	45	disease	disease	NOUN
dpc-6006	120	46	cases	case	NOUN
dpc-6006	120	47	and	and	CCONJ
dpc-6006	120	48	a	a	DET
dpc-6006	120	49	relatively	relatively	ADV
dpc-6006	120	50	small	small	ADJ
dpc-6006	120	51	number	number	NOUN
dpc-6006	120	52	of	of	ADP
dpc-6006	120	53	patients	patient	NOUN
dpc-6006	120	54	,	,	PUNCT
dpc-6006	120	55	which	which	PRON
dpc-6006	120	56	may	may	AUX
dpc-6006	120	57	have	have	AUX
dpc-6006	120	58	introduced	introduce	VERB
dpc-6006	120	59	confounding	confound	VERB
dpc-6006	120	60	[	[	X
dpc-6006	120	61	19	19	NUM
dpc-6006	120	62	]	]	PUNCT
dpc-6006	120	63	.	.	PUNCT
dpc-6006	121	1	a	a	DET
dpc-6006	121	2	mitotic	mitotic	ADJ
dpc-6006	121	3	rate	rate	NOUN
dpc-6006	121	4	of	of	ADP
dpc-6006	121	5	≥1	≥1	PROPN
dpc-6006	121	6	per	per	ADP
dpc-6006	121	7	high	high	ADJ
dpc-6006	121	8	-	-	PUNCT
dpc-6006	121	9	power	power	NOUN
dpc-6006	121	10	field	field	NOUN
dpc-6006	121	11	was	be	AUX
dpc-6006	121	12	not	not	PART
dpc-6006	121	13	associated	associate	VERB
dpc-6006	121	14	with	with	ADP
dpc-6006	121	15	an	an	DET
dpc-6006	121	16	increased	increase	VERB
dpc-6006	121	17	chance	chance	NOUN
dpc-6006	121	18	of	of	ADP
dpc-6006	121	19	recurrence	recurrence	NOUN
dpc-6006	121	20	in	in	ADP
dpc-6006	121	21	our	our	PRON
dpc-6006	121	22	study	study	NOUN
dpc-6006	121	23	;	;	PUNCT
dpc-6006	121	24	using	use	VERB
dpc-6006	121	25	a	a	DET
dpc-6006	121	26	higher	high	ADJ
dpc-6006	121	27	cutoff	cutoff	NOUN
dpc-6006	121	28	may	may	AUX
dpc-6006	121	29	have	have	AUX
dpc-6006	121	30	been	be	AUX
dpc-6006	121	31	associated	associate	VERB
dpc-6006	121	32	with	with	ADP
dpc-6006	121	33	significant	significant	ADJ
dpc-6006	121	34	results	result	NOUN
dpc-6006	121	35	on	on	ADP
dpc-6006	121	36	multivariate	multivariate	NOUN
dpc-6006	121	37	analysis	analysis	NOUN
dpc-6006	121	38	(	(	PUNCT
dpc-6006	121	39	table	table	NOUN
dpc-6006	121	40	3	3	NUM
dpc-6006	121	41	)	)	PUNCT
dpc-6006	121	42	.	.	PUNCT
dpc-6006	122	1	tas	ta	NOUN
dpc-6006	122	2	et	et	PROPN
dpc-6006	122	3	al	al	PROPN
dpc-6006	122	4	.	.	PROPN
dpc-6006	122	5	conducted	conduct	VERB
dpc-6006	122	6	a	a	DET
dpc-6006	122	7	detailed	detailed	ADJ
dpc-6006	122	8	study	study	NOUN
dpc-6006	122	9	on	on	ADP
dpc-6006	122	10	the	the	DET
dpc-6006	122	11	effect	effect	NOUN
dpc-6006	122	12	of	of	ADP
dpc-6006	122	13	a	a	DET
dpc-6006	122	14	high	high	ADJ
dpc-6006	122	15	mitotic	mitotic	ADJ
dpc-6006	122	16	index	index	NOUN
dpc-6006	122	17	in	in	ADP
dpc-6006	122	18	patients	patient	NOUN
dpc-6006	122	19	with	with	ADP
dpc-6006	122	20	melanoma	melanoma	NOUN
dpc-6006	122	21	and	and	CCONJ
dpc-6006	122	22	found	find	VERB
dpc-6006	122	23	that	that	SCONJ
dpc-6006	122	24	melanomas	melanomas	NOUN
dpc-6006	122	25	with	with	ADP
dpc-6006	122	26	a	a	DET
dpc-6006	122	27	mitotic	mitotic	ADJ
dpc-6006	122	28	count	count	NOUN
dpc-6006	122	29	of	of	ADP
dpc-6006	122	30	0	0	NUM
dpc-6006	122	31	-	-	SYM
dpc-6006	122	32	1/	1/	NUM
dpc-6006	122	33	mm2	mm2	NOUN
dpc-6006	122	34	were	be	AUX
dpc-6006	122	35	associated	associate	VERB
dpc-6006	122	36	with	with	ADP
dpc-6006	122	37	higher	high	ADJ
dpc-6006	122	38	clark	clark	NOUN
dpc-6006	122	39	stages	stage	NOUN
dpc-6006	122	40	at	at	ADP
dpc-6006	122	41	presentation	presentation	NOUN
dpc-6006	122	42	(	(	PUNCT
dpc-6006	122	43	p=0.001	p=0.001	NUM
dpc-6006	122	44	)	)	PUNCT
dpc-6006	122	45	,	,	PUNCT
dpc-6006	122	46	more	more	ADV
dpc-6006	122	47	aggressive	aggressive	ADJ
dpc-6006	122	48	tumor	tumor	NOUN
dpc-6006	122	49	stages	stage	NOUN
dpc-6006	122	50	(	(	PUNCT
dpc-6006	122	51	p=0.003	p=0.003	NOUN
dpc-6006	122	52	)	)	PUNCT
dpc-6006	122	53	,	,	PUNCT
dpc-6006	122	54	ulcerated	ulcerated	ADJ
dpc-6006	122	55	primary	primary	ADJ
dpc-6006	122	56	lesion	lesion	NOUN
dpc-6006	122	57	(	(	PUNCT
dpc-6006	122	58	p=0.006	p=0.006	NOUN
dpc-6006	122	59	)	)	PUNCT
dpc-6006	122	60	,	,	PUNCT
dpc-6006	122	61	lymphovascular	lymphovascular	ADJ
dpc-6006	122	62	disease	disease	NOUN
dpc-6006	122	63	(	(	PUNCT
dpc-6006	122	64	p=0.0001	p=0.0001	PROPN
dpc-6006	122	65	)	)	PUNCT
dpc-6006	122	66	,	,	PUNCT
dpc-6006	122	67	metastatic	metastatic	ADJ
dpc-6006	122	68	disease	disease	NOUN
dpc-6006	122	69	(	(	PUNCT
dpc-6006	122	70	p=0.005	p=0.005	NUM
dpc-6006	122	71	)	)	PUNCT
dpc-6006	122	72	,	,	PUNCT
dpc-6006	122	73	and	and	CCONJ
dpc-6006	122	74	a	a	DET
dpc-6006	122	75	higher	high	ADJ
dpc-6006	122	76	chance	chance	NOUN
dpc-6006	122	77	of	of	ADP
dpc-6006	122	78	relapse	relapse	NOUN
dpc-6006	122	79	(	(	PUNCT
dpc-6006	122	80	p=0.0001	p=0.0001	PROPN
dpc-6006	122	81	)	)	PUNCT
dpc-6006	123	1	[	[	X
dpc-6006	123	2	20	20	NUM
dpc-6006	123	3	]	]	PUNCT
dpc-6006	123	4	.	.	PUNCT
dpc-6006	124	1	ulceration	ulceration	NOUN
dpc-6006	124	2	of	of	ADP
dpc-6006	124	3	the	the	DET
dpc-6006	124	4	melanoma	melanoma	NOUN
dpc-6006	124	5	and	and	CCONJ
dpc-6006	124	6	lymphovascular	lymphovascular	ADJ
dpc-6006	124	7	invasion	invasion	NOUN
dpc-6006	124	8	at	at	ADP
dpc-6006	124	9	the	the	DET
dpc-6006	124	10	time	time	NOUN
dpc-6006	124	11	of	of	ADP
dpc-6006	124	12	presentation	presentation	NOUN
dpc-6006	124	13	were	be	AUX
dpc-6006	124	14	associated	associate	VERB
dpc-6006	124	15	with	with	ADP
dpc-6006	124	16	a	a	DET
dpc-6006	124	17	higher	high	ADJ
dpc-6006	124	18	frequency	frequency	NOUN
dpc-6006	124	19	of	of	ADP
dpc-6006	124	20	recurrence	recurrence	NOUN
dpc-6006	124	21	according	accord	VERB
dpc-6006	124	22	to	to	ADP
dpc-6006	124	23	our	our	PRON
dpc-6006	124	24	analysis	analysis	NOUN
dpc-6006	124	25	,	,	PUNCT
dpc-6006	124	26	which	which	PRON
dpc-6006	124	27	is	be	AUX
dpc-6006	124	28	in	in	ADP
dpc-6006	124	29	keeping	keep	VERB
dpc-6006	124	30	with	with	ADP
dpc-6006	124	31	existing	exist	VERB
dpc-6006	124	32	literature	literature	NOUN
dpc-6006	124	33	such	such	ADJ
dpc-6006	124	34	as	as	ADP
dpc-6006	124	35	that	that	PRON
dpc-6006	124	36	by	by	ADP
dpc-6006	124	37	von	von	PROPN
dpc-6006	124	38	schuckmann	schuckmann	PROPN
dpc-6006	124	39	et	et	PROPN
dpc-6006	124	40	al	al	PROPN
dpc-6006	124	41	.	.	PUNCT
dpc-6006	125	1	[	[	X
dpc-6006	125	2	12	12	NUM
dpc-6006	125	3	]	]	PUNCT
dpc-6006	125	4	,	,	PUNCT
dpc-6006	125	5	lyth	lyth	NOUN
dpc-6006	125	6	et	et	NOUN
dpc-6006	125	7	al	al	PROPN
dpc-6006	125	8	.	.	PUNCT
dpc-6006	126	1	[	[	X
dpc-6006	126	2	13	13	NUM
dpc-6006	126	3	]	]	PUNCT
dpc-6006	126	4	,	,	PUNCT
dpc-6006	126	5	and	and	CCONJ
dpc-6006	126	6	kim	kim	PROPN
dpc-6006	126	7	et	et	PROPN
dpc-6006	126	8	al	al	PROPN
dpc-6006	126	9	.	.	PUNCT
dpc-6006	127	1	[	[	X
dpc-6006	127	2	19]–a	19]–a	NUM
dpc-6006	127	3	clear	clear	ADJ
dpc-6006	127	4	indication	indication	NOUN
dpc-6006	127	5	that	that	SCONJ
dpc-6006	127	6	such	such	ADJ
dpc-6006	127	7	cases	case	NOUN
dpc-6006	127	8	need	need	VERB
dpc-6006	127	9	more	more	ADV
dpc-6006	127	10	aggressive	aggressive	ADJ
dpc-6006	127	11	management	management	NOUN
dpc-6006	127	12	and	and	CCONJ
dpc-6006	127	13	surveillance	surveillance	NOUN
dpc-6006	127	14	.	.	PUNCT
dpc-6006	128	1	a	a	DET
dpc-6006	128	2	limitation	limitation	NOUN
dpc-6006	128	3	of	of	ADP
dpc-6006	128	4	our	our	PRON
dpc-6006	128	5	study	study	NOUN
dpc-6006	128	6	is	be	AUX
dpc-6006	128	7	that	that	SCONJ
dpc-6006	128	8	local	local	ADJ
dpc-6006	128	9	,	,	PUNCT
dpc-6006	128	10	regional	regional	ADJ
dpc-6006	128	11	and	and	CCONJ
dpc-6006	128	12	distant	distant	ADJ
dpc-6006	128	13	recurrences	recurrence	NOUN
dpc-6006	128	14	were	be	AUX
dpc-6006	128	15	analyzed	analyze	VERB
dpc-6006	128	16	together	together	ADV
dpc-6006	128	17	.	.	PUNCT
dpc-6006	129	1	while	while	SCONJ
dpc-6006	129	2	these	these	PRON
dpc-6006	129	3	represent	represent	VERB
dpc-6006	129	4	biologically	biologically	ADV
dpc-6006	129	5	distinct	distinct	ADJ
dpc-6006	129	6	events	event	NOUN
dpc-6006	129	7	,	,	PUNCT
dpc-6006	129	8	our	our	PRON
dpc-6006	129	9	retrospective	retrospective	ADJ
dpc-6006	129	10	database	database	NOUN
dpc-6006	129	11	did	do	AUX
dpc-6006	129	12	not	not	PART
dpc-6006	129	13	consistently	consistently	ADV
dpc-6006	129	14	differentiate	differentiate	VERB
dpc-6006	129	15	between	between	ADP
dpc-6006	129	16	them	they	PRON
dpc-6006	129	17	.	.	PUNCT
dpc-6006	130	1	future	future	ADJ
dpc-6006	130	2	perspective	perspective	NOUN
dpc-6006	130	3	studies	study	NOUN
dpc-6006	130	4	should	should	AUX
dpc-6006	130	5	stratify	stratify	VERB
dpc-6006	130	6	recurrence	recurrence	NOUN
dpc-6006	130	7	by	by	ADP
dpc-6006	130	8	type	type	NOUN
dpc-6006	130	9	to	to	PART
dpc-6006	130	10	examine	examine	VERB
dpc-6006	130	11	independent	independent	ADJ
dpc-6006	130	12	predictive	predictive	ADJ
dpc-6006	130	13	factors	factor	NOUN
dpc-6006	130	14	for	for	ADP
dpc-6006	130	15	local	local	ADJ
dpc-6006	130	16	versus	versus	ADP
dpc-6006	130	17	metastatic	metastatic	ADJ
dpc-6006	130	18	disease	disease	NOUN
dpc-6006	130	19	.	.	PUNCT
dpc-6006	131	1	did	do	AUX
dpc-6006	131	2	not	not	PART
dpc-6006	131	3	appear	appear	VERB
dpc-6006	131	4	to	to	PART
dpc-6006	131	5	have	have	VERB
dpc-6006	131	6	any	any	DET
dpc-6006	131	7	association	association	NOUN
dpc-6006	131	8	with	with	ADP
dpc-6006	131	9	an	an	DET
dpc-6006	131	10	increased	increase	VERB
dpc-6006	131	11	risk	risk	NOUN
dpc-6006	131	12	of	of	ADP
dpc-6006	131	13	recurrence	recurrence	NOUN
dpc-6006	131	14	.	.	PUNCT
dpc-6006	132	1	previous	previous	ADJ
dpc-6006	132	2	studies	study	NOUN
dpc-6006	132	3	on	on	ADP
dpc-6006	132	4	the	the	DET
dpc-6006	132	5	subject	subject	NOUN
dpc-6006	132	6	such	such	ADJ
dpc-6006	132	7	as	as	ADP
dpc-6006	132	8	that	that	PRON
dpc-6006	132	9	by	by	ADP
dpc-6006	132	10	von	von	PROPN
dpc-6006	132	11	schuckmann	schuckmann	PROPN
dpc-6006	132	12	et	et	PROPN
dpc-6006	132	13	al	al	PROPN
dpc-6006	132	14	.	.	PROPN
dpc-6006	132	15	have	have	AUX
dpc-6006	132	16	demonstrated	demonstrate	VERB
dpc-6006	132	17	that	that	PRON
dpc-6006	132	18	head	head	NOUN
dpc-6006	132	19	and	and	CCONJ
dpc-6006	132	20	neck	neck	NOUN
dpc-6006	132	21	lesions	lesion	NOUN
dpc-6006	132	22	are	be	AUX
dpc-6006	132	23	associated	associate	VERB
dpc-6006	132	24	with	with	ADP
dpc-6006	132	25	an	an	DET
dpc-6006	132	26	increased	increase	VERB
dpc-6006	132	27	risk	risk	NOUN
dpc-6006	132	28	of	of	ADP
dpc-6006	132	29	recurrence	recurrence	NOUN
dpc-6006	132	30	(	(	PUNCT
dpc-6006	132	31	hr	hr	NOUN
dpc-6006	132	32	1.67	1.67	NUM
dpc-6006	132	33	;	;	PUNCT
dpc-6006	132	34	95	95	NUM
dpc-6006	132	35	%	%	NOUN
dpc-6006	132	36	cl	cl	NOUN
dpc-6006	132	37	1.01–2.76	1.01–2.76	NUM
dpc-6006	132	38	;	;	PUNCT
dpc-6006	132	39	p<0.05	p<0.05	PROPN
dpc-6006	132	40	)	)	PUNCT
dpc-6006	133	1	[	[	X
dpc-6006	133	2	12	12	NUM
dpc-6006	133	3	]	]	PUNCT
dpc-6006	133	4	.	.	PUNCT
dpc-6006	134	1	however	however	ADV
dpc-6006	134	2	,	,	PUNCT
dpc-6006	134	3	it	it	PRON
dpc-6006	134	4	is	be	AUX
dpc-6006	134	5	important	important	ADJ
dpc-6006	134	6	to	to	PART
dpc-6006	134	7	note	note	VERB
dpc-6006	134	8	here	here	ADV
dpc-6006	134	9	that	that	SCONJ
dpc-6006	134	10	not	not	PART
dpc-6006	134	11	all	all	DET
dpc-6006	134	12	studies	study	NOUN
dpc-6006	134	13	agree	agree	VERB
dpc-6006	134	14	with	with	ADP
dpc-6006	134	15	this	this	DET
dpc-6006	134	16	result	result	NOUN
dpc-6006	134	17	:	:	PUNCT
dpc-6006	134	18	lyth	lyth	NOUN
dpc-6006	134	19	et	et	NOUN
dpc-6006	134	20	al	al	PROPN
dpc-6006	134	21	.	.	PROPN
dpc-6006	134	22	demonstrated	demonstrate	VERB
dpc-6006	134	23	that	that	SCONJ
dpc-6006	134	24	the	the	DET
dpc-6006	134	25	site	site	NOUN
dpc-6006	134	26	of	of	ADP
dpc-6006	134	27	lesion	lesion	NOUN
dpc-6006	134	28	,	,	PUNCT
dpc-6006	134	29	whether	whether	SCONJ
dpc-6006	134	30	head	head	NOUN
dpc-6006	134	31	and	and	CCONJ
dpc-6006	134	32	neck	neck	NOUN
dpc-6006	134	33	,	,	PUNCT
dpc-6006	134	34	lower	low	ADJ
dpc-6006	134	35	limbs	limb	NOUN
dpc-6006	134	36	,	,	PUNCT
dpc-6006	134	37	or	or	CCONJ
dpc-6006	134	38	any	any	DET
dpc-6006	134	39	other	other	ADJ
dpc-6006	134	40	,	,	PUNCT
dpc-6006	134	41	was	be	AUX
dpc-6006	134	42	not	not	PART
dpc-6006	134	43	associated	associate	VERB
dpc-6006	134	44	with	with	ADP
dpc-6006	134	45	an	an	DET
dpc-6006	134	46	increased	increase	VERB
dpc-6006	134	47	risk	risk	NOUN
dpc-6006	134	48	of	of	ADP
dpc-6006	134	49	recurrence	recurrence	NOUN
dpc-6006	134	50	[	[	X
dpc-6006	134	51	13	13	NUM
dpc-6006	134	52	]	]	PUNCT
dpc-6006	134	53	.	.	PUNCT
dpc-6006	135	1	we	we	PRON
dpc-6006	135	2	believe	believe	VERB
dpc-6006	135	3	this	this	DET
dpc-6006	135	4	subject	subject	NOUN
dpc-6006	135	5	requires	require	VERB
dpc-6006	135	6	further	further	ADJ
dpc-6006	135	7	study	study	NOUN
dpc-6006	135	8	prior	prior	ADV
dpc-6006	135	9	to	to	ADP
dpc-6006	135	10	forming	form	VERB
dpc-6006	135	11	concrete	concrete	ADJ
dpc-6006	135	12	conclusions	conclusion	NOUN
dpc-6006	135	13	.	.	PUNCT
dpc-6006	136	1	unsurprisingly	unsurprisingly	ADV
dpc-6006	136	2	,	,	PUNCT
dpc-6006	136	3	advanced	advanced	ADJ
dpc-6006	136	4	stages	stage	NOUN
dpc-6006	136	5	of	of	ADP
dpc-6006	136	6	melanoma	melanoma	NOUN
dpc-6006	136	7	were	be	AUX
dpc-6006	136	8	associated	associate	VERB
dpc-6006	136	9	with	with	ADP
dpc-6006	136	10	a	a	DET
dpc-6006	136	11	higher	high	ADJ
dpc-6006	136	12	rate	rate	NOUN
dpc-6006	136	13	of	of	ADP
dpc-6006	136	14	recurrence	recurrence	NOUN
dpc-6006	136	15	,	,	PUNCT
dpc-6006	136	16	while	while	SCONJ
dpc-6006	136	17	the	the	DET
dpc-6006	136	18	converse	converse	NOUN
dpc-6006	136	19	was	be	AUX
dpc-6006	136	20	true	true	ADJ
dpc-6006	136	21	for	for	ADP
dpc-6006	136	22	earlier	early	ADJ
dpc-6006	136	23	stages	stage	NOUN
dpc-6006	136	24	,	,	PUNCT
dpc-6006	136	25	in	in	ADP
dpc-6006	136	26	our	our	PRON
dpc-6006	136	27	study	study	NOUN
dpc-6006	136	28	.	.	PUNCT
dpc-6006	137	1	we	we	PRON
dpc-6006	137	2	found	find	VERB
dpc-6006	137	3	that	that	SCONJ
dpc-6006	137	4	stage	stage	NOUN
dpc-6006	137	5	4b	4b	PROPN
dpc-6006	137	6	was	be	AUX
dpc-6006	137	7	associated	associate	VERB
dpc-6006	137	8	with	with	ADP
dpc-6006	137	9	a	a	DET
dpc-6006	137	10	statistically	statistically	ADV
dpc-6006	137	11	significant	significant	ADJ
dpc-6006	137	12	increase	increase	NOUN
dpc-6006	137	13	in	in	ADP
dpc-6006	137	14	this	this	DET
dpc-6006	137	15	risk	risk	NOUN
dpc-6006	137	16	.	.	PUNCT
dpc-6006	138	1	additionally	additionally	ADV
dpc-6006	138	2	,	,	PUNCT
dpc-6006	138	3	stage	stage	NOUN
dpc-6006	138	4	1b	1b	NUM
dpc-6006	138	5	was	be	AUX
dpc-6006	138	6	associated	associate	VERB
dpc-6006	138	7	with	with	ADP
dpc-6006	138	8	good	good	ADJ
dpc-6006	138	9	outcomes	outcome	NOUN
dpc-6006	138	10	,	,	PUNCT
dpc-6006	138	11	while	while	SCONJ
dpc-6006	138	12	the	the	DET
dpc-6006	138	13	stages	stage	NOUN
dpc-6006	138	14	between	between	ADP
dpc-6006	138	15	these	these	DET
dpc-6006	138	16	two	two	NUM
dpc-6006	138	17	did	do	AUX
dpc-6006	138	18	not	not	PART
dpc-6006	138	19	appear	appear	VERB
dpc-6006	138	20	to	to	PART
dpc-6006	138	21	have	have	VERB
dpc-6006	138	22	a	a	DET
dpc-6006	138	23	statistically	statistically	ADV
dpc-6006	138	24	significant	significant	ADJ
dpc-6006	138	25	association	association	NOUN
dpc-6006	138	26	with	with	ADP
dpc-6006	138	27	recurrence	recurrence	NOUN
dpc-6006	138	28	in	in	ADP
dpc-6006	138	29	our	our	PRON
dpc-6006	138	30	sample	sample	NOUN
dpc-6006	138	31	.	.	PUNCT
dpc-6006	139	1	feigelson	feigelson	NOUN
dpc-6006	139	2	et	et	PROPN
dpc-6006	139	3	al	al	PROPN
dpc-6006	139	4	.	.	PROPN
dpc-6006	139	5	reported	report	VERB
dpc-6006	139	6	similar	similar	ADJ
dpc-6006	139	7	results	result	NOUN
dpc-6006	139	8	:	:	PUNCT
dpc-6006	139	9	the	the	DET
dpc-6006	139	10	more	more	ADV
dpc-6006	139	11	advanced	advanced	ADJ
dpc-6006	139	12	the	the	DET
dpc-6006	139	13	stage	stage	NOUN
dpc-6006	139	14	,	,	PUNCT
dpc-6006	139	15	the	the	PRON
dpc-6006	139	16	higher	high	ADJ
dpc-6006	139	17	the	the	DET
dpc-6006	139	18	risk	risk	NOUN
dpc-6006	139	19	of	of	ADP
dpc-6006	139	20	recurrence	recurrence	NOUN
dpc-6006	139	21	[	[	X
dpc-6006	139	22	14	14	NUM
dpc-6006	139	23	]	]	PUNCT
dpc-6006	139	24	.	.	PUNCT
dpc-6006	140	1	von	von	PROPN
dpc-6006	140	2	schumann	schumann	PROPN
dpc-6006	140	3	et	et	PROPN
dpc-6006	140	4	al	al	PROPN
dpc-6006	140	5	.	.	PROPN
dpc-6006	140	6	reported	report	VERB
dpc-6006	140	7	a	a	DET
dpc-6006	140	8	significant	significant	ADJ
dpc-6006	140	9	increase	increase	NOUN
dpc-6006	140	10	in	in	ADP
dpc-6006	140	11	risk	risk	NOUN
dpc-6006	140	12	of	of	ADP
dpc-6006	140	13	recurrence	recurrence	NOUN
dpc-6006	140	14	in	in	ADP
dpc-6006	140	15	stage	stage	NOUN
dpc-6006	140	16	4a	4a	NOUN
dpc-6006	140	17	(	(	PUNCT
dpc-6006	140	18	hr	hr	NOUN
dpc-6006	140	19	1.48	1.48	NUM
dpc-6006	140	20	;	;	PUNCT
dpc-6006	140	21	95	95	NUM
dpc-6006	140	22	%	%	NOUN
dpc-6006	140	23	ci	ci	NOUN
dpc-6006	140	24	:	:	PUNCT
dpc-6006	140	25	0.48–4.59	0.48–4.59	NUM
dpc-6006	140	26	;	;	PUNCT
dpc-6006	140	27	p<0.05	p<0.05	PROPN
dpc-6006	140	28	)	)	PUNCT
dpc-6006	140	29	and	and	CCONJ
dpc-6006	140	30	4b	4b	X
dpc-6006	140	31	(	(	PUNCT
dpc-6006	140	32	hr	hr	NOUN
dpc-6006	140	33	3.86	3.86	NUM
dpc-6006	140	34	;	;	PUNCT
dpc-6006	140	35	95	95	NUM
dpc-6006	140	36	%	%	NOUN
dpc-6006	140	37	cl	cl	NOUN
dpc-6006	140	38	:	:	PUNCT
dpc-6006	140	39	1.40–10.64	1.40–10.64	NUM
dpc-6006	140	40	;	;	PUNCT
dpc-6006	140	41	p<0.05	p<0.05	NOUN
dpc-6006	140	42	)	)	PUNCT
dpc-6006	141	1	[	[	X
dpc-6006	141	2	12	12	NUM
dpc-6006	141	3	]	]	PUNCT
dpc-6006	141	4	.	.	PUNCT
dpc-6006	142	1	moreover	moreover	ADV
dpc-6006	142	2	,	,	PUNCT
dpc-6006	142	3	liang	liang	PROPN
dpc-6006	142	4	et	et	PROPN
dpc-6006	142	5	al	al	PROPN
dpc-6006	142	6	.	.	PROPN
dpc-6006	142	7	noted	note	VERB
dpc-6006	142	8	that	that	SCONJ
dpc-6006	142	9	cases	case	NOUN
dpc-6006	142	10	with	with	ADP
dpc-6006	142	11	a	a	DET
dpc-6006	142	12	more	more	ADV
dpc-6006	142	13	advanced	advanced	ADJ
dpc-6006	142	14	stage	stage	NOUN
dpc-6006	142	15	at	at	ADP
dpc-6006	142	16	the	the	DET
dpc-6006	142	17	time	time	NOUN
dpc-6006	142	18	of	of	ADP
dpc-6006	142	19	presentation	presentation	NOUN
dpc-6006	142	20	not	not	PART
dpc-6006	142	21	only	only	ADV
dpc-6006	142	22	had	have	VERB
dpc-6006	142	23	a	a	DET
dpc-6006	142	24	higher	high	ADJ
dpc-6006	142	25	risk	risk	NOUN
dpc-6006	142	26	of	of	ADP
dpc-6006	142	27	recurrence	recurrence	NOUN
dpc-6006	142	28	but	but	CCONJ
dpc-6006	142	29	were	be	AUX
dpc-6006	142	30	also	also	ADV
dpc-6006	142	31	at	at	ADP
dpc-6006	142	32	an	an	DET
dpc-6006	142	33	increased	increase	VERB
dpc-6006	142	34	risk	risk	NOUN
dpc-6006	142	35	of	of	ADP
dpc-6006	142	36	developing	develop	VERB
dpc-6006	142	37	recurrence	recurrence	NOUN
dpc-6006	142	38	earlier	early	ADV
dpc-6006	142	39	than	than	ADP
dpc-6006	142	40	those	those	DET
dpc-6006	142	41	patients	patient	NOUN
dpc-6006	142	42	with	with	ADP
dpc-6006	142	43	earlier	early	ADJ
dpc-6006	142	44	stage	stage	NOUN
dpc-6006	142	45	disease	disease	NOUN
dpc-6006	142	46	at	at	ADP
dpc-6006	142	47	presentation	presentation	NOUN
dpc-6006	142	48	[	[	X
dpc-6006	142	49	15	15	NUM
dpc-6006	142	50	]	]	PUNCT
dpc-6006	142	51	.	.	PUNCT
dpc-6006	143	1	table	table	NOUN
dpc-6006	143	2	3	3	NUM
dpc-6006	143	3	.	.	PUNCT
dpc-6006	143	4	multivariate	multivariate	NOUN
dpc-6006	143	5	analysis	analysis	NOUN
dpc-6006	143	6	of	of	ADP
dpc-6006	143	7	significant	significant	ADJ
dpc-6006	143	8	factors	factor	NOUN
dpc-6006	143	9	.	.	PUNCT
dpc-6006	144	1	variable	variable	ADJ
dpc-6006	144	2	p	p	NOUN
dpc-6006	144	3	-	-	PUNCT
dpc-6006	144	4	value	value	NOUN
dpc-6006	144	5	variables	variable	NOUN
dpc-6006	144	6	with	with	ADP
dpc-6006	144	7	decreased	decrease	VERB
dpc-6006	144	8	risk	risk	NOUN
dpc-6006	144	9	of	of	ADP
dpc-6006	144	10	recurrence	recurrence	NOUN
dpc-6006	144	11	lesions	lesion	NOUN
dpc-6006	144	12	of	of	ADP
dpc-6006	144	13	trunk	trunk	NOUN
dpc-6006	144	14	0.008	0.008	NUM
dpc-6006	144	15	clark	clark	NOUN
dpc-6006	144	16	stage	stage	PROPN
dpc-6006	144	17	ii	ii	PROPN
dpc-6006	144	18	0.022	0.022	NUM
dpc-6006	144	19	tumor	tumor	NOUN
dpc-6006	144	20	stage	stage	NOUN
dpc-6006	144	21	1b	1b	NUM
dpc-6006	144	22	0.042	0.042	NUM
dpc-6006	144	23	breslow	breslow	ADJ
dpc-6006	144	24	thin	thin	ADJ
dpc-6006	144	25	lesions	lesion	NOUN
dpc-6006	144	26	(	(	PUNCT
dpc-6006	144	27	≤1.00	≤1.00	NOUN
dpc-6006	144	28	mm	mm	PROPN
dpc-6006	144	29	)	)	PUNCT
dpc-6006	144	30	0.002	0.002	NUM
dpc-6006	144	31	variables	variable	NOUN
dpc-6006	144	32	with	with	ADP
dpc-6006	144	33	increased	increase	VERB
dpc-6006	144	34	risk	risk	NOUN
dpc-6006	144	35	of	of	ADP
dpc-6006	144	36	recurrence	recurrence	NOUN
dpc-6006	144	37	age	age	NOUN
dpc-6006	144	38	≥	≥	NUM
dpc-6006	144	39	65	65	NUM
dpc-6006	144	40	years	year	NOUN
dpc-6006	144	41	0.001	0.001	NUM
dpc-6006	144	42	lower	low	ADJ
dpc-6006	144	43	limb	limb	NOUN
dpc-6006	144	44	lesions	lesion	NOUN
dpc-6006	144	45	0.609	0.609	NUM
dpc-6006	144	46	tumor	tumor	NOUN
dpc-6006	144	47	stage	stage	NOUN
dpc-6006	144	48	4a	4a	NOUN
dpc-6006	144	49	0.684	0.684	NUM
dpc-6006	144	50	tumor	tumor	NOUN
dpc-6006	144	51	stage	stage	NOUN
dpc-6006	145	1	4b	4b	PROPN
dpc-6006	145	2	<	<	X
dpc-6006	145	3	0.001	0.001	NUM
dpc-6006	145	4	breslow	breslow	ADJ
dpc-6006	145	5	thick	thick	ADJ
dpc-6006	145	6	lesions	lesion	NOUN
dpc-6006	145	7	(	(	PUNCT
dpc-6006	145	8	>	>	X
dpc-6006	145	9	4.00	4.00	NUM
dpc-6006	145	10	mm	mm	NOUN
dpc-6006	145	11	)	)	PUNCT
dpc-6006	145	12	<	<	X
dpc-6006	145	13	0.001	0.001	NUM
dpc-6006	145	14	clark	clark	NOUN
dpc-6006	145	15	stage	stage	NOUN
dpc-6006	145	16	iv	iv	NUM
dpc-6006	145	17	0.029	0.029	NUM
dpc-6006	145	18	clark	clark	NOUN
dpc-6006	145	19	stage	stage	NOUN
dpc-6006	145	20	v	v	ADP
dpc-6006	145	21	0.035	0.035	NUM
dpc-6006	145	22	mitotic	mitotic	ADJ
dpc-6006	145	23	rate	rate	NOUN
dpc-6006	145	24	≥	≥	NOUN
dpc-6006	145	25	1	1	NUM
dpc-6006	145	26	0.224	0.224	NUM
dpc-6006	145	27	ulceration	ulceration	NOUN
dpc-6006	145	28	<	<	NOUN
dpc-6006	145	29	0.001	0.001	NUM
dpc-6006	145	30	lymph	lymph	NOUN
dpc-6006	145	31	vascular	vascular	NOUN
dpc-6006	145	32	invasion	invasion	NOUN
dpc-6006	145	33	<	<	X
dpc-6006	145	34	0.001	0.001	NUM
dpc-6006	145	35	positive	positive	ADJ
dpc-6006	145	36	sentinel	sentinel	NOUN
dpc-6006	145	37	lymph	lymph	NOUN
dpc-6006	145	38	node	node	NOUN
dpc-6006	145	39	biopsy	biopsy	VERB
dpc-6006	145	40	0.004	0.004	NUM
dpc-6006	145	41	6	6	NUM
dpc-6006	145	42	original	original	ADJ
dpc-6006	145	43	article	article	NOUN
dpc-6006	145	44	|	|	ADV
dpc-6006	145	45	dermatol	dermatol	ADJ
dpc-6006	145	46	pract	pract	NOUN
dpc-6006	145	47	concept	concept	NOUN
dpc-6006	145	48	.	.	PUNCT
dpc-6006	146	1	2025;15(4):6006	2025;15(4):6006	NUM
dpc-6006	146	2	7	7	NUM
dpc-6006	146	3	.	.	PUNCT
dpc-6006	146	4	bobos	bobos	PROPN
dpc-6006	146	5	m.	m.	PROPN
dpc-6006	146	6	histopathologic	histopathologic	PROPN
dpc-6006	146	7	classification	classification	NOUN
dpc-6006	146	8	and	and	CCONJ
dpc-6006	146	9	prognostic	prognostic	ADJ
dpc-6006	146	10	factors	factor	NOUN
dpc-6006	146	11	of	of	ADP
dpc-6006	146	12	melanoma	melanoma	NOUN
dpc-6006	146	13	:	:	PUNCT
dpc-6006	146	14	a	a	DET
dpc-6006	146	15	2021	2021	NUM
dpc-6006	146	16	update	update	NOUN
dpc-6006	146	17	.	.	PUNCT
dpc-6006	147	1	ital	ital	PROPN
dpc-6006	147	2	j	j	PROPN
dpc-6006	147	3	dermatol	dermatol	PROPN
dpc-6006	147	4	venerol	venerol	PROPN
dpc-6006	147	5	.	.	PUNCT
dpc-6006	148	1	2021	2021	NUM
dpc-6006	148	2	jun;156(3):300	jun;156(3):300	NUM
dpc-6006	148	3	-	-	PUNCT
dpc-6006	148	4	321	321	NUM
dpc-6006	148	5	.	.	PUNCT
dpc-6006	149	1	doi	doi	NOUN
dpc-6006	149	2	:	:	PUNCT
dpc-6006	149	3	10.23736	10.23736	NUM
dpc-6006	149	4	/	/	SYM
dpc-6006	149	5	s2784	s2784	PROPN
dpc-6006	149	6	-	-	PUNCT
dpc-6006	149	7	8671.21.06958	8671.21.06958	NUM
dpc-6006	149	8	-	-	SYM
dpc-6006	149	9	3	3	NUM
dpc-6006	149	10	.	.	PUNCT
dpc-6006	150	1	pmid	pmid	NOUN
dpc-6006	150	2	:	:	PUNCT
dpc-6006	150	3	33982546	33982546	NUM
dpc-6006	150	4	8	8	NUM
dpc-6006	150	5	.	.	PUNCT
dpc-6006	151	1	heistein	heistein	PROPN
dpc-6006	151	2	jb	jb	PROPN
dpc-6006	151	3	,	,	PUNCT
dpc-6006	151	4	acharya	acharya	PROPN
dpc-6006	151	5	u.	u.	PROPN
dpc-6006	151	6	malignant	malignant	ADJ
dpc-6006	151	7	melanoma	melanoma	NOUN
dpc-6006	151	8	.	.	PUNCT
dpc-6006	152	1	in	in	ADP
dpc-6006	152	2	:	:	PUNCT
dpc-6006	152	3	statpearls	statpearl	NOUN
dpc-6006	153	1	[	[	X
dpc-6006	153	2	internet	internet	NOUN
dpc-6006	153	3	]	]	PUNCT
dpc-6006	153	4	.	.	PUNCT
dpc-6006	154	1	treasure	treasure	NOUN
dpc-6006	154	2	island	island	NOUN
dpc-6006	154	3	(	(	PUNCT
dpc-6006	154	4	fl	fl	PROPN
dpc-6006	154	5	):	):	PUNCT
dpc-6006	154	6	statpearls	statpearls	PROPN
dpc-6006	154	7	publishing	publishing	NOUN
dpc-6006	154	8	;	;	PUNCT
dpc-6006	154	9	2022	2022	NUM
dpc-6006	154	10	jan-	jan-	NOUN
dpc-6006	154	11	.	.	PUNCT
dpc-6006	155	1	pmid	pmid	NOUN
dpc-6006	155	2	:	:	PUNCT
dpc-6006	155	3	29262210	29262210	NUM
dpc-6006	155	4	9	9	NUM
dpc-6006	155	5	.	.	PUNCT
dpc-6006	156	1	pathak	pathak	PROPN
dpc-6006	156	2	s	s	PROPN
dpc-6006	156	3	,	,	PUNCT
dpc-6006	156	4	zito	zito	PROPN
dpc-6006	156	5	pm	pm	PROPN
dpc-6006	156	6	.	.	PUNCT
dpc-6006	157	1	clinical	clinical	ADJ
dpc-6006	157	2	guidelines	guideline	NOUN
dpc-6006	157	3	for	for	ADP
dpc-6006	157	4	the	the	DET
dpc-6006	157	5	staging	staging	NOUN
dpc-6006	157	6	,	,	PUNCT
dpc-6006	157	7	diagnosis	diagnosis	NOUN
dpc-6006	157	8	,	,	PUNCT
dpc-6006	157	9	and	and	CCONJ
dpc-6006	157	10	management	management	NOUN
dpc-6006	157	11	of	of	ADP
dpc-6006	157	12	cutaneous	cutaneous	ADJ
dpc-6006	157	13	malignant	malignant	ADJ
dpc-6006	157	14	melanoma	melanoma	NOUN
dpc-6006	157	15	.	.	PUNCT
dpc-6006	158	1	in	in	ADP
dpc-6006	158	2	:	:	PUNCT
dpc-6006	158	3	statpearls	statpearl	NOUN
dpc-6006	159	1	[	[	X
dpc-6006	159	2	internet	internet	NOUN
dpc-6006	159	3	]	]	PUNCT
dpc-6006	159	4	.	.	PUNCT
dpc-6006	160	1	treasure	treasure	NOUN
dpc-6006	160	2	island	island	NOUN
dpc-6006	160	3	(	(	PUNCT
dpc-6006	160	4	fl	fl	PROPN
dpc-6006	160	5	):	):	PUNCT
dpc-6006	160	6	statpearls	statpearl	NOUN
dpc-6006	160	7	publishing	publishing	NOUN
dpc-6006	160	8	;	;	PUNCT
dpc-6006	160	9	2022	2022	NUM
dpc-6006	160	10	jan–.	jan–.	PUNCT
dpc-6006	161	1	pmid	pmid	NOUN
dpc-6006	161	2	:	:	PUNCT
dpc-6006	161	3	29262210	29262210	NUM
dpc-6006	161	4	10	10	NUM
dpc-6006	161	5	.	.	PUNCT
dpc-6006	162	1	jenkins	jenkins	PROPN
dpc-6006	162	2	rw	rw	PROPN
dpc-6006	162	3	,	,	PUNCT
dpc-6006	162	4	fisher	fisher	PROPN
dpc-6006	162	5	de	de	PROPN
dpc-6006	162	6	.	.	PROPN
dpc-6006	162	7	treatment	treatment	NOUN
dpc-6006	162	8	of	of	ADP
dpc-6006	162	9	advanced	advanced	ADJ
dpc-6006	162	10	melanoma	melanoma	NOUN
dpc-6006	162	11	in	in	ADP
dpc-6006	162	12	2020	2020	NUM
dpc-6006	162	13	and	and	CCONJ
dpc-6006	162	14	beyond	beyond	ADP
dpc-6006	162	15	.	.	PUNCT
dpc-6006	163	1	j	j	PROPN
dpc-6006	163	2	invest	invest	VERB
dpc-6006	163	3	dermatol	dermatol	NOUN
dpc-6006	163	4	.	.	PUNCT
dpc-6006	164	1	2021	2021	NUM
dpc-6006	164	2	jan;141(1):23	jan;141(1):23	ADV
dpc-6006	164	3	-	-	PUNCT
dpc-6006	164	4	31	31	NUM
dpc-6006	164	5	.	.	PUNCT
dpc-6006	165	1	doi	doi	NOUN
dpc-6006	165	2	:	:	PUNCT
dpc-6006	165	3	10.1016	10.1016	NUM
dpc-6006	165	4	/	/	SYM
dpc-6006	165	5	j.jid.2020.03.943	j.jid.2020.03.943	PROPN
dpc-6006	165	6	.	.	PUNCT
dpc-6006	166	1	pmid	pmid	NOUN
dpc-6006	166	2	:	:	PUNCT
dpc-6006	166	3	32386834	32386834	NUM
dpc-6006	166	4	11	11	NUM
dpc-6006	166	5	.	.	PUNCT
dpc-6006	167	1	fleming	fleming	PROPN
dpc-6006	167	2	nh	nh	PROPN
dpc-6006	167	3	,	,	PUNCT
dpc-6006	167	4	tian	tian	PROPN
dpc-6006	167	5	j	j	PROPN
dpc-6006	167	6	,	,	PUNCT
dpc-6006	167	7	vega	vega	PROPN
dpc-6006	167	8	-	-	PUNCT
dpc-6006	167	9	saenz	saenz	PROPN
dpc-6006	167	10	de	de	PROPN
dpc-6006	167	11	miera	miera	PROPN
dpc-6006	167	12	e	e	PROPN
dpc-6006	167	13	,	,	PUNCT
dpc-6006	167	14	et	et	PROPN
dpc-6006	167	15	al	al	PROPN
dpc-6006	167	16	.	.	PROPN
dpc-6006	167	17	impact	impact	NOUN
dpc-6006	167	18	of	of	ADP
dpc-6006	167	19	age	age	NOUN
dpc-6006	167	20	on	on	ADP
dpc-6006	167	21	the	the	DET
dpc-6006	167	22	management	management	NOUN
dpc-6006	167	23	of	of	ADP
dpc-6006	167	24	primary	primary	ADJ
dpc-6006	167	25	melanoma	melanoma	NOUN
dpc-6006	167	26	patients	patient	NOUN
dpc-6006	167	27	.	.	PUNCT
dpc-6006	168	1	oncology	oncology	NOUN
dpc-6006	168	2	.	.	PUNCT
dpc-6006	169	1	2013;85(3):173	2013;85(3):173	NUM
dpc-6006	169	2	-	-	SYM
dpc-6006	169	3	81	81	NUM
dpc-6006	169	4	.	.	PUNCT
dpc-6006	170	1	doi	doi	NOUN
dpc-6006	170	2	:	:	PUNCT
dpc-6006	170	3	10.1159/000351499	10.1159/000351499	NUM
dpc-6006	170	4	.	.	PUNCT
dpc-6006	171	1	pmid	pmid	NOUN
dpc-6006	171	2	:	:	PUNCT
dpc-6006	171	3	24052077	24052077	NUM
dpc-6006	171	4	12	12	NUM
dpc-6006	171	5	.	.	PUNCT
dpc-6006	172	1	von	von	PROPN
dpc-6006	172	2	schuckmann	schuckmann	PROPN
dpc-6006	172	3	la	la	PROPN
dpc-6006	172	4	,	,	PUNCT
dpc-6006	172	5	hughes	hughes	PROPN
dpc-6006	172	6	mcb	mcb	PROPN
dpc-6006	172	7	,	,	PUNCT
dpc-6006	172	8	ghiasvand	ghiasvand	NOUN
dpc-6006	172	9	r	r	NOUN
dpc-6006	172	10	,	,	PUNCT
dpc-6006	172	11	et	et	PROPN
dpc-6006	172	12	al	al	PROPN
dpc-6006	172	13	.	.	PROPN
dpc-6006	172	14	risk	risk	NOUN
dpc-6006	172	15	of	of	ADP
dpc-6006	172	16	melanoma	melanoma	NOUN
dpc-6006	172	17	recurrence	recurrence	NOUN
dpc-6006	172	18	after	after	ADP
dpc-6006	172	19	diagnosis	diagnosis	NOUN
dpc-6006	172	20	of	of	ADP
dpc-6006	172	21	a	a	DET
dpc-6006	172	22	high	high	ADJ
dpc-6006	172	23	-	-	PUNCT
dpc-6006	172	24	risk	risk	NOUN
dpc-6006	172	25	primary	primary	ADJ
dpc-6006	172	26	tumor	tumor	NOUN
dpc-6006	172	27	.	.	PUNCT
dpc-6006	173	1	jama	jama	PROPN
dpc-6006	173	2	dermatol	dermatol	NOUN
dpc-6006	173	3	.	.	PUNCT
dpc-6006	174	1	2019	2019	NUM
dpc-6006	174	2	jun	jun	PROPN
dpc-6006	174	3	1;155(6):688	1;155(6):688	NUM
dpc-6006	174	4	-	-	PUNCT
dpc-6006	174	5	693	693	NUM
dpc-6006	174	6	.	.	PUNCT
dpc-6006	175	1	doi	doi	NOUN
dpc-6006	175	2	:	:	PUNCT
dpc-6006	175	3	10.1001	10.1001	NUM
dpc-6006	175	4	/	/	SYM
dpc-6006	175	5	jamadermatol.2019.0440	jamadermatol.2019.0440	PROPN
dpc-6006	175	6	.	.	PUNCT
dpc-6006	176	1	pmid	pmid	NOUN
dpc-6006	176	2	:	:	PUNCT
dpc-6006	176	3	31021094	31021094	NUM
dpc-6006	176	4	13	13	NUM
dpc-6006	176	5	.	.	PUNCT
dpc-6006	177	1	lyth	lyth	PROPN
dpc-6006	177	2	j	j	PROPN
dpc-6006	177	3	,	,	PUNCT
dpc-6006	177	4	falk	falk	NOUN
dpc-6006	177	5	m	m	PROPN
dpc-6006	177	6	,	,	PUNCT
dpc-6006	177	7	maroti	maroti	PROPN
dpc-6006	177	8	m	m	PROPN
dpc-6006	177	9	,	,	PUNCT
dpc-6006	177	10	eriksson	eriksson	PROPN
dpc-6006	177	11	h	h	PROPN
dpc-6006	177	12	,	,	PUNCT
dpc-6006	177	13	ingvar	ingvar	PROPN
dpc-6006	177	14	c.	c.	PROPN
dpc-6006	177	15	prognostic	prognostic	ADJ
dpc-6006	177	16	risk	risk	NOUN
dpc-6006	177	17	factors	factor	NOUN
dpc-6006	177	18	of	of	ADP
dpc-6006	177	19	first	first	ADJ
dpc-6006	177	20	recurrence	recurrence	NOUN
dpc-6006	177	21	in	in	ADP
dpc-6006	177	22	patients	patient	NOUN
dpc-6006	177	23	with	with	ADP
dpc-6006	177	24	primary	primary	ADJ
dpc-6006	177	25	stages	stage	NOUN
dpc-6006	177	26	i	i	PROPN
dpc-6006	177	27	-	-	PUNCT
dpc-6006	177	28	ii	ii	NOUN
dpc-6006	177	29	cutaneous	cutaneous	ADJ
dpc-6006	177	30	malignant	malignant	ADJ
dpc-6006	177	31	melanoma	melanoma	NOUN
dpc-6006	177	32	from	from	ADP
dpc-6006	177	33	the	the	DET
dpc-6006	177	34	population	population	NOUN
dpc-6006	177	35	-	-	PUNCT
dpc-6006	177	36	based	base	VERB
dpc-6006	177	37	swedish	swedish	ADJ
dpc-6006	177	38	melanoma	melanoma	PROPN
dpc-6006	177	39	register	register	VERB
dpc-6006	177	40	.	.	PUNCT
dpc-6006	178	1	j	j	PROPN
dpc-6006	178	2	eur	eur	PROPN
dpc-6006	178	3	acad	acad	PROPN
dpc-6006	178	4	dermatol	dermatol	NOUN
dpc-6006	178	5	venereol	venereol	NOUN
dpc-6006	178	6	.	.	PUNCT
dpc-6006	179	1	2017	2017	NUM
dpc-6006	179	2	sep;31(9):1468	sep;31(9):1468	NOUN
dpc-6006	179	3	-	-	PUNCT
dpc-6006	179	4	1474	1474	NUM
dpc-6006	179	5	.	.	PUNCT
dpc-6006	180	1	doi	doi	NOUN
dpc-6006	180	2	:	:	PUNCT
dpc-6006	180	3	10.1111	10.1111	NUM
dpc-6006	180	4	/	/	SYM
dpc-6006	180	5	jdv.14280	jdv.14280	NOUN
dpc-6006	180	6	.	.	PUNCT
dpc-6006	181	1	pmid	pmid	NOUN
dpc-6006	181	2	:	:	PUNCT
dpc-6006	181	3	28515668	28515668	NUM
dpc-6006	181	4	14	14	NUM
dpc-6006	181	5	.	.	PUNCT
dpc-6006	182	1	feigelson	feigelson	PROPN
dpc-6006	182	2	hs	hs	PROPN
dpc-6006	182	3	,	,	PUNCT
dpc-6006	182	4	powers	powers	PROPN
dpc-6006	182	5	jd	jd	PROPN
dpc-6006	182	6	,	,	PUNCT
dpc-6006	182	7	kumar	kumar	PROPN
dpc-6006	182	8	m	m	PROPN
dpc-6006	182	9	,	,	PUNCT
dpc-6006	182	10	carroll	carroll	PROPN
dpc-6006	182	11	nm	nm	PROPN
dpc-6006	182	12	,	,	PUNCT
dpc-6006	182	13	pathy	pathy	ADJ
dpc-6006	182	14	a	a	PRON
dpc-6006	182	15	,	,	PUNCT
dpc-6006	182	16	ritzwoller	ritzwoller	NOUN
dpc-6006	182	17	dp	dp	PROPN
dpc-6006	182	18	.	.	PUNCT
dpc-6006	182	19	melanoma	melanoma	PROPN
dpc-6006	182	20	incidence	incidence	NOUN
dpc-6006	182	21	,	,	PUNCT
dpc-6006	182	22	recurrence	recurrence	NOUN
dpc-6006	182	23	,	,	PUNCT
dpc-6006	182	24	and	and	CCONJ
dpc-6006	182	25	mortality	mortality	NOUN
dpc-6006	182	26	in	in	ADP
dpc-6006	182	27	an	an	DET
dpc-6006	182	28	integrated	integrate	VERB
dpc-6006	182	29	healthcare	healthcare	NOUN
dpc-6006	182	30	system	system	NOUN
dpc-6006	182	31	:	:	PUNCT
dpc-6006	182	32	a	a	DET
dpc-6006	182	33	retrospective	retrospective	ADJ
dpc-6006	182	34	cohort	cohort	NOUN
dpc-6006	182	35	study	study	NOUN
dpc-6006	182	36	.	.	PUNCT
dpc-6006	183	1	cancer	cancer	NOUN
dpc-6006	183	2	med	med	PROPN
dpc-6006	183	3	.	.	PUNCT
dpc-6006	184	1	2019	2019	NUM
dpc-6006	184	2	aug;8(9):4508	aug;8(9):4508	PROPN
dpc-6006	184	3	-	-	PUNCT
dpc-6006	184	4	4516	4516	NUM
dpc-6006	184	5	.	.	PUNCT
dpc-6006	185	1	doi	doi	NOUN
dpc-6006	185	2	:	:	PUNCT
dpc-6006	185	3	10.1002	10.1002	NUM
dpc-6006	185	4	/cam4.2252	/cam4.2252	NOUN
dpc-6006	185	5	.	.	PUNCT
dpc-6006	186	1	pmid	pmid	NOUN
dpc-6006	186	2	:	:	PUNCT
dpc-6006	186	3	31366147	31366147	NUM
dpc-6006	186	4	15	15	NUM
dpc-6006	186	5	.	.	PUNCT
dpc-6006	187	1	liang	liang	PROPN
dpc-6006	187	2	c	c	PROPN
dpc-6006	187	3	,	,	PUNCT
dpc-6006	187	4	hu	hu	PROPN
dpc-6006	187	5	w	w	PROPN
dpc-6006	187	6	,	,	PUNCT
dpc-6006	187	7	li	li	PROPN
dpc-6006	187	8	j	j	PROPN
dpc-6006	187	9	,	,	PUNCT
dpc-6006	187	10	zhang	zhang	PROPN
dpc-6006	187	11	x	x	PROPN
dpc-6006	187	12	,	,	PUNCT
dpc-6006	187	13	zhou	zhou	PROPN
dpc-6006	187	14	z	z	PROPN
dpc-6006	187	15	,	,	PUNCT
dpc-6006	187	16	liang	liang	PROPN
dpc-6006	187	17	y.	y.	PROPN
dpc-6006	187	18	early	early	ADJ
dpc-6006	187	19	time	time	NOUN
dpc-6006	187	20	to	to	PART
dpc-6006	187	21	recurrence	recurrence	NOUN
dpc-6006	187	22	predicts	predict	NOUN
dpc-6006	187	23	worse	bad	ADJ
dpc-6006	187	24	survival	survival	NOUN
dpc-6006	187	25	in	in	ADP
dpc-6006	187	26	patients	patient	NOUN
dpc-6006	187	27	with	with	ADP
dpc-6006	187	28	localized	localized	ADJ
dpc-6006	187	29	or	or	CCONJ
dpc-6006	187	30	regionally	regionally	ADV
dpc-6006	187	31	advanced	advanced	ADJ
dpc-6006	187	32	cutaneous	cutaneous	ADJ
dpc-6006	187	33	melanoma	melanoma	NOUN
dpc-6006	187	34	.	.	PUNCT
dpc-6006	188	1	dermatol	dermatol	NOUN
dpc-6006	188	2	ther	ther	ADV
dpc-6006	188	3	.	.	PUNCT
dpc-6006	189	1	2021	2021	NUM
dpc-6006	189	2	jul;34(4):e14981	jul;34(4):e14981	NOUN
dpc-6006	189	3	.	.	PUNCT
dpc-6006	190	1	doi	doi	NOUN
dpc-6006	190	2	:	:	PUNCT
dpc-6006	190	3	10.1111	10.1111	NUM
dpc-6006	190	4	/	/	SYM
dpc-6006	190	5	dth.14981	dth.14981	PROPN
dpc-6006	190	6	.	.	PUNCT
dpc-6006	191	1	pmid	pmid	NOUN
dpc-6006	191	2	:	:	PUNCT
dpc-6006	191	3	34052802	34052802	NUM
dpc-6006	191	4	16	16	NUM
dpc-6006	191	5	.	.	PUNCT
dpc-6006	192	1	oh	oh	INTJ
dpc-6006	192	2	y	y	NOUN
dpc-6006	192	3	,	,	PUNCT
dpc-6006	192	4	choi	choi	NOUN
dpc-6006	192	5	s	s	PART
dpc-6006	192	6	,	,	PUNCT
dpc-6006	192	7	cho	cho	VERB
dpc-6006	192	8	my	my	PRON
dpc-6006	192	9	,	,	PUNCT
dpc-6006	192	10	et	et	PROPN
dpc-6006	192	11	al	al	PROPN
dpc-6006	192	12	.	.	PUNCT
dpc-6006	192	13	male	male	ADJ
dpc-6006	192	14	sex	sex	NOUN
dpc-6006	192	15	and	and	CCONJ
dpc-6006	192	16	breslow	breslow	ADJ
dpc-6006	192	17	thickness	thickness	NOUN
dpc-6006	192	18	are	be	AUX
dpc-6006	192	19	important	important	ADJ
dpc-6006	192	20	risk	risk	NOUN
dpc-6006	192	21	factors	factor	NOUN
dpc-6006	192	22	for	for	ADP
dpc-6006	192	23	recurrence	recurrence	NOUN
dpc-6006	192	24	of	of	ADP
dpc-6006	192	25	localized	localized	ADJ
dpc-6006	192	26	melanoma	melanoma	NOUN
dpc-6006	192	27	in	in	ADP
dpc-6006	192	28	korean	korean	ADJ
dpc-6006	192	29	populations	population	NOUN
dpc-6006	192	30	.	.	PUNCT
dpc-6006	193	1	j	j	PROPN
dpc-6006	193	2	am	be	AUX
dpc-6006	193	3	acad	acad	ADJ
dpc-6006	193	4	dermatol	dermatol	NOUN
dpc-6006	193	5	.	.	PUNCT
dpc-6006	194	1	2020	2020	NUM
dpc-6006	194	2	oct;83(4	oct;83(4	NUM
dpc-6006	194	3	):	):	PUNCT
dpc-6006	194	4	1071	1071	NUM
dpc-6006	194	5	-	-	SYM
dpc-6006	194	6	1079	1079	NUM
dpc-6006	194	7	.	.	PUNCT
dpc-6006	195	1	doi	doi	NOUN
dpc-6006	195	2	:	:	PUNCT
dpc-6006	195	3	10.1016	10.1016	NUM
dpc-6006	195	4	/	/	SYM
dpc-6006	195	5	j.jaad.2019.09.029	j.jaad.2019.09.029	PROPN
dpc-6006	195	6	.	.	PUNCT
dpc-6006	196	1	pmid	pmid	NOUN
dpc-6006	196	2	:	:	PUNCT
dpc-6006	196	3	31521913	31521913	NUM
dpc-6006	196	4	17	17	NUM
dpc-6006	196	5	.	.	PUNCT
dpc-6006	197	1	reschke	reschke	PROPN
dpc-6006	197	2	r	r	NOUN
dpc-6006	197	3	,	,	PUNCT
dpc-6006	197	4	dumann	dumann	NOUN
dpc-6006	197	5	k	k	NOUN
dpc-6006	197	6	,	,	PUNCT
dpc-6006	197	7	ziemer	ziemer	PROPN
dpc-6006	197	8	m.	m.	NOUN
dpc-6006	197	9	risk	risk	NOUN
dpc-6006	197	10	stratification	stratification	NOUN
dpc-6006	197	11	and	and	CCONJ
dpc-6006	197	12	clinical	clinical	ADJ
dpc-6006	197	13	characteristics	characteristic	NOUN
dpc-6006	197	14	of	of	ADP
dpc-6006	197	15	patients	patient	NOUN
dpc-6006	197	16	with	with	ADP
dpc-6006	197	17	late	late	ADJ
dpc-6006	197	18	recurrence	recurrence	NOUN
dpc-6006	197	19	of	of	ADP
dpc-6006	197	20	melanoma	melanoma	NOUN
dpc-6006	197	21	(	(	PUNCT
dpc-6006	197	22	>	>	SYM
dpc-6006	197	23	10	10	NUM
dpc-6006	197	24	years	year	NOUN
dpc-6006	197	25	)	)	PUNCT
dpc-6006	197	26	.	.	PUNCT
dpc-6006	198	1	j	j	PROPN
dpc-6006	198	2	clin	clin	PROPN
dpc-6006	198	3	med	med	PROPN
dpc-6006	198	4	.	.	PUNCT
dpc-6006	199	1	2022	2022	NUM
dpc-6006	199	2	apr	apr	NOUN
dpc-6006	199	3	5;11(7):2026	5;11(7):2026	NUM
dpc-6006	199	4	.	.	PUNCT
dpc-6006	200	1	doi	doi	NOUN
dpc-6006	200	2	:	:	PUNCT
dpc-6006	200	3	10.3390	10.3390	NUM
dpc-6006	200	4	/	/	SYM
dpc-6006	200	5	jcm11072026	jcm11072026	NOUN
dpc-6006	200	6	.	.	PUNCT
dpc-6006	201	1	pmid	pmid	NOUN
dpc-6006	201	2	:	:	PUNCT
dpc-6006	201	3	35408499	35408499	NUM
dpc-6006	201	4	18	18	NUM
dpc-6006	201	5	.	.	PUNCT
dpc-6006	202	1	tas	tas	PROPN
dpc-6006	202	2	f	f	PROPN
dpc-6006	202	3	,	,	PUNCT
dpc-6006	202	4	erturk	erturk	PROPN
dpc-6006	202	5	k.	k.	PROPN
dpc-6006	202	6	recurrence	recurrence	PROPN
dpc-6006	202	7	behavior	behavior	NOUN
dpc-6006	202	8	in	in	ADP
dpc-6006	202	9	early	early	ADJ
dpc-6006	202	10	-	-	PUNCT
dpc-6006	202	11	stage	stage	NOUN
dpc-6006	202	12	cutaneous	cutaneous	ADJ
dpc-6006	202	13	melanoma	melanoma	NOUN
dpc-6006	202	14	:	:	PUNCT
dpc-6006	202	15	pattern	pattern	NOUN
dpc-6006	202	16	,	,	PUNCT
dpc-6006	202	17	timing	timing	NOUN
dpc-6006	202	18	,	,	PUNCT
dpc-6006	202	19	survival	survival	NOUN
dpc-6006	202	20	,	,	PUNCT
dpc-6006	202	21	and	and	CCONJ
dpc-6006	202	22	influencing	influence	VERB
dpc-6006	202	23	factors	factor	NOUN
dpc-6006	202	24	.	.	PUNCT
dpc-6006	203	1	melanoma	melanoma	NOUN
dpc-6006	203	2	res	re	NOUN
dpc-6006	203	3	.	.	PUNCT
dpc-6006	204	1	2017	2017	NUM
dpc-6006	204	2	apr;27(2):134	apr;27(2):134	NOUN
dpc-6006	204	3	-	-	PUNCT
dpc-6006	204	4	139	139	NUM
dpc-6006	204	5	.	.	PUNCT
dpc-6006	205	1	doi	doi	NOUN
dpc-6006	205	2	:	:	PUNCT
dpc-6006	205	3	10.1097	10.1097	NUM
dpc-6006	205	4	/cmr.0000000000000332	/cmr.0000000000000332	NOUN
dpc-6006	205	5	.	.	PUNCT
dpc-6006	206	1	pmid	pmid	NOUN
dpc-6006	206	2	:	:	PUNCT
dpc-6006	206	3	28114588	28114588	NUM
dpc-6006	206	4	19	19	NUM
dpc-6006	206	5	.	.	PUNCT
dpc-6006	207	1	kim	kim	PROPN
dpc-6006	207	2	d	d	PROPN
dpc-6006	207	3	,	,	PUNCT
dpc-6006	207	4	chu	chu	PROPN
dpc-6006	207	5	s	s	PROPN
dpc-6006	207	6	,	,	PUNCT
dpc-6006	207	7	khan	khan	PROPN
dpc-6006	207	8	au	au	PROPN
dpc-6006	207	9	,	,	PUNCT
dpc-6006	207	10	et	et	PROPN
dpc-6006	207	11	al	al	PROPN
dpc-6006	207	12	.	.	PUNCT
dpc-6006	208	1	risk	risk	NOUN
dpc-6006	208	2	factors	factor	NOUN
dpc-6006	208	3	and	and	CCONJ
dpc-6006	208	4	patterns	pattern	NOUN
dpc-6006	208	5	of	of	ADP
dpc-6006	208	6	recurrence	recurrence	NOUN
dpc-6006	208	7	after	after	ADP
dpc-6006	208	8	sentinel	sentinel	ADJ
dpc-6006	208	9	lymph	lymph	NOUN
dpc-6006	208	10	node	node	NOUN
dpc-6006	208	11	biopsy	biopsy	NOUN
dpc-6006	208	12	for	for	ADP
dpc-6006	208	13	thin	thin	ADJ
dpc-6006	208	14	melanoma	melanoma	NOUN
dpc-6006	208	15	.	.	PUNCT
dpc-6006	209	1	arch	arch	ADJ
dpc-6006	209	2	dermatol	dermatol	NOUN
dpc-6006	209	3	res	re	NOUN
dpc-6006	209	4	.	.	PUNCT
dpc-6006	210	1	2022	2022	NUM
dpc-6006	210	2	apr;314(3):285	apr;314(3):285	NOUN
dpc-6006	210	3	-	-	PUNCT
dpc-6006	210	4	292	292	NUM
dpc-6006	210	5	.	.	PUNCT
dpc-6006	211	1	doi	doi	NOUN
dpc-6006	211	2	:	:	PUNCT
dpc-6006	211	3	10.1007	10.1007	NUM
dpc-6006	211	4	/s00403	/s00403	NOUN
dpc-6006	211	5	-	-	PUNCT
dpc-6006	211	6	021	021	NUM
dpc-6006	211	7	-	-	PUNCT
dpc-6006	211	8	02229	02229	NUM
dpc-6006	211	9	-	-	SYM
dpc-6006	211	10	8	8	NUM
dpc-6006	211	11	.	.	PUNCT
dpc-6006	212	1	pmid	pmid	NOUN
dpc-6006	212	2	:	:	PUNCT
dpc-6006	212	3	34905293	34905293	NUM
dpc-6006	212	4	20	20	NUM
dpc-6006	212	5	.	.	PUNCT
dpc-6006	213	1	tas	tas	PROPN
dpc-6006	213	2	f	f	PROPN
dpc-6006	213	3	,	,	PUNCT
dpc-6006	213	4	erturk	erturk	PROPN
dpc-6006	213	5	k.	k.	PROPN
dpc-6006	214	1	different	different	ADJ
dpc-6006	214	2	mitotic	mitotic	ADJ
dpc-6006	214	3	rates	rate	NOUN
dpc-6006	214	4	are	be	AUX
dpc-6006	214	5	associated	associate	VERB
dpc-6006	214	6	with	with	ADP
dpc-6006	214	7	different	different	ADJ
dpc-6006	214	8	prognostic	prognostic	ADJ
dpc-6006	214	9	factors	factor	NOUN
dpc-6006	214	10	,	,	PUNCT
dpc-6006	214	11	relapses	relapse	NOUN
dpc-6006	214	12	,	,	PUNCT
dpc-6006	214	13	and	and	CCONJ
dpc-6006	214	14	survival	survival	NOUN
dpc-6006	214	15	rates	rate	NOUN
dpc-6006	214	16	in	in	ADP
dpc-6006	214	17	melanoma	melanoma	NOUN
dpc-6006	214	18	.	.	PUNCT
dpc-6006	215	1	int	int	NOUN
dpc-6006	215	2	j	j	PROPN
dpc-6006	215	3	dermatol	dermatol	NOUN
dpc-6006	215	4	.	.	PUNCT
dpc-6006	216	1	2022	2022	NUM
dpc-6006	216	2	apr;61(4):472	apr;61(4):472	NOUN
dpc-6006	216	3	-	-	PUNCT
dpc-6006	216	4	479	479	NUM
dpc-6006	216	5	.	.	PUNCT
dpc-6006	217	1	doi	doi	NOUN
dpc-6006	217	2	:	:	PUNCT
dpc-6006	217	3	10.1111	10.1111	NUM
dpc-6006	217	4	/ijd.15939	/ijd.15939	NOUN
dpc-6006	217	5	.	.	PUNCT
dpc-6006	218	1	pmid	pmid	NOUN
dpc-6006	218	2	:	:	PUNCT
dpc-6006	218	3	34905293	34905293	NUM
dpc-6006	218	4	this	this	DET
dpc-6006	218	5	study	study	NOUN
dpc-6006	218	6	’s	’s	PART
dpc-6006	218	7	strength	strength	NOUN
dpc-6006	218	8	lies	lie	VERB
dpc-6006	218	9	in	in	ADP
dpc-6006	218	10	its	its	PRON
dpc-6006	218	11	comparatively	comparatively	ADV
dpc-6006	218	12	large	large	ADJ
dpc-6006	218	13	sample	sample	NOUN
dpc-6006	218	14	size	size	NOUN
dpc-6006	218	15	as	as	ADV
dpc-6006	218	16	well	well	ADV
dpc-6006	218	17	as	as	ADP
dpc-6006	218	18	in	in	ADP
dpc-6006	218	19	the	the	DET
dpc-6006	218	20	confirmation	confirmation	NOUN
dpc-6006	218	21	of	of	ADP
dpc-6006	218	22	recurrence	recurrence	NOUN
dpc-6006	218	23	on	on	ADP
dpc-6006	218	24	tissue	tissue	NOUN
dpc-6006	218	25	biopsy	biopsy	NOUN
dpc-6006	218	26	.	.	PUNCT
dpc-6006	219	1	moreover	moreover	ADV
dpc-6006	219	2	,	,	PUNCT
dpc-6006	219	3	the	the	DET
dpc-6006	219	4	data	datum	NOUN
dpc-6006	219	5	collected	collect	VERB
dpc-6006	219	6	were	be	AUX
dpc-6006	219	7	diverse	diverse	ADJ
dpc-6006	219	8	,	,	PUNCT
dpc-6006	219	9	broadbased	broadbased	ADJ
dpc-6006	219	10	,	,	PUNCT
dpc-6006	219	11	and	and	CCONJ
dpc-6006	219	12	covered	cover	VERB
dpc-6006	219	13	a	a	DET
dpc-6006	219	14	wide	wide	ADJ
dpc-6006	219	15	range	range	NOUN
dpc-6006	219	16	of	of	ADP
dpc-6006	219	17	variables	variable	NOUN
dpc-6006	219	18	based	base	VERB
dpc-6006	219	19	on	on	ADP
dpc-6006	219	20	our	our	PRON
dpc-6006	219	21	institute	institute	NOUN
dpc-6006	219	22	’s	’s	PART
dpc-6006	219	23	robust	robust	ADJ
dpc-6006	219	24	medical	medical	ADJ
dpc-6006	219	25	record	record	NOUN
dpc-6006	219	26	keeping	keeping	NOUN
dpc-6006	219	27	.	.	PUNCT
dpc-6006	220	1	our	our	PRON
dpc-6006	220	2	study	study	NOUN
dpc-6006	220	3	was	be	AUX
dpc-6006	220	4	limited	limit	VERB
dpc-6006	220	5	by	by	ADP
dpc-6006	220	6	its	its	PRON
dpc-6006	220	7	retrospective	retrospective	ADJ
dpc-6006	220	8	nature	nature	NOUN
dpc-6006	220	9	and	and	CCONJ
dpc-6006	220	10	carries	carry	VERB
dpc-6006	220	11	the	the	DET
dpc-6006	220	12	restrictions	restriction	NOUN
dpc-6006	220	13	inherent	inherent	ADJ
dpc-6006	220	14	in	in	ADP
dpc-6006	220	15	this	this	DET
dpc-6006	220	16	study	study	NOUN
dpc-6006	220	17	design	design	NOUN
dpc-6006	220	18	.	.	PUNCT
dpc-6006	221	1	in	in	ADP
dpc-6006	221	2	addition	addition	NOUN
dpc-6006	221	3	,	,	PUNCT
dpc-6006	221	4	as	as	SCONJ
dpc-6006	221	5	the	the	DET
dpc-6006	221	6	patient	patient	ADJ
dpc-6006	221	7	data	datum	NOUN
dpc-6006	221	8	were	be	AUX
dpc-6006	221	9	collected	collect	VERB
dpc-6006	221	10	from	from	ADP
dpc-6006	221	11	a	a	DET
dpc-6006	221	12	single	single	ADJ
dpc-6006	221	13	center	center	NOUN
dpc-6006	221	14	which	which	PRON
dpc-6006	221	15	draws	draw	VERB
dpc-6006	221	16	its	its	PRON
dpc-6006	221	17	patients	patient	NOUN
dpc-6006	221	18	from	from	ADP
dpc-6006	221	19	a	a	DET
dpc-6006	221	20	specific	specific	ADJ
dpc-6006	221	21	part	part	NOUN
dpc-6006	221	22	of	of	ADP
dpc-6006	221	23	the	the	DET
dpc-6006	221	24	country	country	NOUN
dpc-6006	221	25	,	,	PUNCT
dpc-6006	221	26	the	the	DET
dpc-6006	221	27	results	result	NOUN
dpc-6006	221	28	may	may	AUX
dpc-6006	221	29	not	not	PART
dpc-6006	221	30	be	be	AUX
dpc-6006	221	31	generalizable	generalizable	ADJ
dpc-6006	221	32	to	to	ADP
dpc-6006	221	33	the	the	DET
dpc-6006	221	34	whole	whole	ADJ
dpc-6006	221	35	population	population	NOUN
dpc-6006	221	36	.	.	PUNCT
dpc-6006	222	1	our	our	PRON
dpc-6006	222	2	findings	finding	NOUN
dpc-6006	222	3	help	help	AUX
dpc-6006	222	4	identify	identify	VERB
dpc-6006	222	5	clinicopathological	clinicopathological	ADJ
dpc-6006	222	6	predictors	predictor	NOUN
dpc-6006	222	7	of	of	ADP
dpc-6006	222	8	recurrence	recurrence	NOUN
dpc-6006	222	9	which	which	PRON
dpc-6006	222	10	can	can	AUX
dpc-6006	222	11	guide	guide	VERB
dpc-6006	222	12	clinicians	clinician	NOUN
dpc-6006	222	13	in	in	ADP
dpc-6006	222	14	tailoring	tailor	VERB
dpc-6006	222	15	follow	follow	NOUN
dpc-6006	222	16	-	-	PUNCT
dpc-6006	222	17	up	up	ADP
dpc-6006	222	18	intensity	intensity	NOUN
dpc-6006	222	19	and	and	CCONJ
dpc-6006	222	20	surveillance	surveillance	NOUN
dpc-6006	222	21	.	.	PUNCT
dpc-6006	223	1	however	however	ADV
dpc-6006	223	2	,	,	PUNCT
dpc-6006	223	3	our	our	PRON
dpc-6006	223	4	study	study	NOUN
dpc-6006	223	5	did	do	AUX
dpc-6006	223	6	not	not	PART
dpc-6006	223	7	consider	consider	VERB
dpc-6006	223	8	the	the	DET
dpc-6006	223	9	variation	variation	NOUN
dpc-6006	223	10	in	in	ADP
dpc-6006	223	11	treatment	treatment	NOUN
dpc-6006	223	12	modalities	modality	NOUN
dpc-6006	223	13	offered	offer	VERB
dpc-6006	223	14	to	to	ADP
dpc-6006	223	15	each	each	DET
dpc-6006	223	16	patient	patient	NOUN
dpc-6006	223	17	,	,	PUNCT
dpc-6006	223	18	which	which	PRON
dpc-6006	223	19	may	may	AUX
dpc-6006	223	20	have	have	AUX
dpc-6006	223	21	resulted	result	VERB
dpc-6006	223	22	in	in	ADP
dpc-6006	223	23	a	a	DET
dpc-6006	223	24	degree	degree	NOUN
dpc-6006	223	25	of	of	ADP
dpc-6006	223	26	confounding	confound	VERB
dpc-6006	223	27	within	within	ADP
dpc-6006	223	28	our	our	PRON
dpc-6006	223	29	results	result	NOUN
dpc-6006	223	30	.	.	PUNCT
dpc-6006	224	1	conclusion	conclusion	NOUN
dpc-6006	224	2	advancing	advance	VERB
dpc-6006	224	3	age	age	NOUN
dpc-6006	224	4	,	,	PUNCT
dpc-6006	224	5	tumor	tumor	NOUN
dpc-6006	224	6	stage	stage	NOUN
dpc-6006	224	7	,	,	PUNCT
dpc-6006	224	8	breslow	breslow	ADJ
dpc-6006	224	9	thickness	thickness	NOUN
dpc-6006	224	10	,	,	PUNCT
dpc-6006	224	11	clark	clark	NOUN
dpc-6006	224	12	stage	stage	NOUN
dpc-6006	224	13	,	,	PUNCT
dpc-6006	224	14	ulceration	ulceration	NOUN
dpc-6006	224	15	,	,	PUNCT
dpc-6006	224	16	and	and	CCONJ
dpc-6006	224	17	lympho	lympho	NOUN
dpc-6006	224	18	-	-	PUNCT
dpc-6006	224	19	vascular	vascular	ADJ
dpc-6006	224	20	invasion	invasion	NOUN
dpc-6006	224	21	were	be	AUX
dpc-6006	224	22	all	all	PRON
dpc-6006	224	23	identified	identify	VERB
dpc-6006	224	24	as	as	ADP
dpc-6006	224	25	significant	significant	ADJ
dpc-6006	224	26	clinicopathological	clinicopathological	ADJ
dpc-6006	224	27	factors	factor	NOUN
dpc-6006	224	28	associated	associate	VERB
dpc-6006	224	29	with	with	ADP
dpc-6006	224	30	the	the	DET
dpc-6006	224	31	increased	increase	VERB
dpc-6006	224	32	frequency	frequency	NOUN
dpc-6006	224	33	of	of	ADP
dpc-6006	224	34	melanoma	melanoma	NOUN
dpc-6006	224	35	recurrence	recurrence	NOUN
dpc-6006	224	36	.	.	PUNCT
dpc-6006	225	1	future	future	ADJ
dpc-6006	225	2	studies	study	NOUN
dpc-6006	225	3	should	should	AUX
dpc-6006	225	4	aim	aim	VERB
dpc-6006	225	5	to	to	PART
dpc-6006	225	6	focus	focus	VERB
dpc-6006	225	7	to	to	ADP
dpc-6006	225	8	incorporating	incorporate	VERB
dpc-6006	225	9	these	these	DET
dpc-6006	225	10	variables	variable	NOUN
dpc-6006	225	11	into	into	ADP
dpc-6006	225	12	a	a	DET
dpc-6006	225	13	validated	validate	VERB
dpc-6006	225	14	scoring	scoring	NOUN
dpc-6006	225	15	system	system	NOUN
dpc-6006	225	16	to	to	PART
dpc-6006	225	17	predict	predict	VERB
dpc-6006	225	18	recurrence	recurrence	NOUN
dpc-6006	225	19	and	and	CCONJ
dpc-6006	225	20	overall	overall	ADJ
dpc-6006	225	21	prognosis	prognosis	NOUN
dpc-6006	225	22	at	at	ADP
dpc-6006	225	23	the	the	DET
dpc-6006	225	24	time	time	NOUN
dpc-6006	225	25	of	of	ADP
dpc-6006	225	26	diagnosis	diagnosis	NOUN
dpc-6006	225	27	.	.	PUNCT
dpc-6006	226	1	such	such	DET
dpc-6006	226	2	a	a	DET
dpc-6006	226	3	tool	tool	NOUN
dpc-6006	226	4	should	should	AUX
dpc-6006	226	5	assist	assist	VERB
dpc-6006	226	6	clinicians	clinician	NOUN
dpc-6006	226	7	in	in	ADP
dpc-6006	226	8	tailoring	tailor	VERB
dpc-6006	226	9	surveillance	surveillance	NOUN
dpc-6006	226	10	and	and	CCONJ
dpc-6006	226	11	management	management	NOUN
dpc-6006	226	12	strategies	strategy	NOUN
dpc-6006	226	13	to	to	ADP
dpc-6006	226	14	the	the	DET
dpc-6006	226	15	individual	individual	ADJ
dpc-6006	226	16	risk	risk	NOUN
dpc-6006	226	17	profile	profile	NOUN
dpc-6006	226	18	of	of	ADP
dpc-6006	226	19	each	each	DET
dpc-6006	226	20	patient	patient	NOUN
dpc-6006	226	21	.	.	PUNCT
dpc-6006	227	1	references	reference	NOUN
dpc-6006	227	2	1	1	NUM
dpc-6006	227	3	.	.	PUNCT
dpc-6006	227	4	ahme	ahme	PROPN
dpc-6006	227	5	b	b	PROPN
dpc-6006	227	6	,	,	PUNCT
dpc-6006	227	7	qadir	qadir	PROPN
dpc-6006	227	8	mi	mi	PROPN
dpc-6006	227	9	,	,	PUNCT
dpc-6006	227	10	ghafoor	ghafoor	PROPN
dpc-6006	227	11	s.	s.	PROPN
dpc-6006	227	12	malignant	malignant	ADJ
dpc-6006	227	13	melanoma	melanoma	NOUN
dpc-6006	227	14	:	:	PUNCT
dpc-6006	227	15	skin	skin	NOUN
dpc-6006	227	16	cancer	cancer	NOUN
dpc-6006	227	17	-	-	PUNCT
dpc-6006	227	18	diagnosis	diagnosis	NOUN
dpc-6006	227	19	,	,	PUNCT
dpc-6006	227	20	prevention	prevention	NOUN
dpc-6006	227	21	,	,	PUNCT
dpc-6006	227	22	and	and	CCONJ
dpc-6006	227	23	treatment	treatment	NOUN
dpc-6006	227	24	.	.	PUNCT
dpc-6006	228	1	crit	crit	PROPN
dpc-6006	228	2	rev	rev	PROPN
dpc-6006	228	3	eukaryot	eukaryot	PROPN
dpc-6006	228	4	gene	gene	NOUN
dpc-6006	228	5	expr	expr	NOUN
dpc-6006	228	6	.	.	PUNCT
dpc-6006	229	1	2020;30(4):291	2020;30(4):291	NUM
dpc-6006	229	2	-	-	SYM
dpc-6006	229	3	297	297	NUM
dpc-6006	229	4	.	.	PUNCT
dpc-6006	230	1	doi	doi	NOUN
dpc-6006	230	2	:	:	PUNCT
dpc-6006	231	1	10.1615	10.1615	NUM
dpc-6006	231	2	/	/	SYM
dpc-6006	231	3	critreveukaryotgeneexpr.2020028454	critreveukaryotgeneexpr.2020028454	NOUN
dpc-6006	231	4	.	.	PUNCT
dpc-6006	232	1	pmid	pmid	NOUN
dpc-6006	232	2	:	:	PUNCT
dpc-6006	232	3	32894659	32894659	NUM
dpc-6006	232	4	2	2	NUM
dpc-6006	232	5	.	.	PUNCT
dpc-6006	233	1	arnold	arnold	PROPN
dpc-6006	233	2	m	m	PROPN
dpc-6006	233	3	,	,	PUNCT
dpc-6006	233	4	singh	singh	PROPN
dpc-6006	233	5	d	d	PROPN
dpc-6006	233	6	,	,	PUNCT
dpc-6006	233	7	laversanne	laversanne	NOUN
dpc-6006	233	8	m	m	PROPN
dpc-6006	233	9	,	,	PUNCT
dpc-6006	233	10	et	et	PROPN
dpc-6006	233	11	al	al	PROPN
dpc-6006	233	12	.	.	PUNCT
dpc-6006	233	13	global	global	ADJ
dpc-6006	233	14	burden	burden	NOUN
dpc-6006	233	15	of	of	ADP
dpc-6006	233	16	cutaneous	cutaneous	ADJ
dpc-6006	233	17	melanoma	melanoma	NOUN
dpc-6006	233	18	in	in	ADP
dpc-6006	233	19	2020	2020	NUM
dpc-6006	233	20	and	and	CCONJ
dpc-6006	233	21	projections	projection	NOUN
dpc-6006	233	22	to	to	ADP
dpc-6006	233	23	2040	2040	NUM
dpc-6006	233	24	.	.	PUNCT
dpc-6006	234	1	jama	jama	PROPN
dpc-6006	234	2	dermatol	dermatol	NOUN
dpc-6006	234	3	.	.	PUNCT
dpc-6006	235	1	2022	2022	NUM
dpc-6006	235	2	may	may	AUX
dpc-6006	235	3	1;158(5):495	1;158(5):495	ADV
dpc-6006	235	4	-	-	PUNCT
dpc-6006	235	5	503	503	NUM
dpc-6006	235	6	.	.	PUNCT
dpc-6006	236	1	doi	doi	NOUN
dpc-6006	236	2	:	:	PUNCT
dpc-6006	236	3	10.1001	10.1001	NUM
dpc-6006	236	4	/	/	SYM
dpc-6006	236	5	jamadermatol.2022.0160	jamadermatol.2022.0160	PROPN
dpc-6006	236	6	.	.	PUNCT
dpc-6006	237	1	pmid	pmid	NOUN
dpc-6006	237	2	:	:	PUNCT
dpc-6006	237	3	35546288	35546288	NUM
dpc-6006	237	4	3	3	NUM
dpc-6006	237	5	.	.	PUNCT
dpc-6006	238	1	porter	porter	PROPN
dpc-6006	238	2	e	e	PROPN
dpc-6006	238	3	,	,	PUNCT
dpc-6006	238	4	timoney	timoney	PROPN
dpc-6006	238	5	i	i	PROPN
dpc-6006	238	6	,	,	PUNCT
dpc-6006	238	7	byrne	byrne	PROPN
dpc-6006	238	8	b	b	PROPN
dpc-6006	238	9	,	,	PUNCT
dpc-6006	238	10	et	et	PROPN
dpc-6006	238	11	al	al	PROPN
dpc-6006	238	12	.	.	PUNCT
dpc-6006	239	1	metastatic	metastatic	ADJ
dpc-6006	239	2	melanoma	melanoma	NOUN
dpc-6006	239	3	in	in	ADP
dpc-6006	239	4	the	the	DET
dpc-6006	239	5	mid	mid	PROPN
dpc-6006	239	6	-	-	PROPN
dpc-6006	239	7	west	west	NOUN
dpc-6006	239	8	of	of	ADP
dpc-6006	239	9	ireland	ireland	PROPN
dpc-6006	239	10	:	:	PUNCT
dpc-6006	239	11	a	a	DET
dpc-6006	239	12	retrospective	retrospective	ADJ
dpc-6006	239	13	review	review	NOUN
dpc-6006	239	14	.	.	PUNCT
dpc-6006	240	1	ir	ir	PROPN
dpc-6006	240	2	j	j	PROPN
dpc-6006	240	3	med	med	PROPN
dpc-6006	240	4	sci	sci	PROPN
dpc-6006	240	5	.	.	PROPN
dpc-6006	240	6	2022	2022	NUM
dpc-6006	240	7	jan	jan	PROPN
dpc-6006	240	8	8:1–5	8:1–5	NUM
dpc-6006	240	9	.	.	PUNCT
dpc-6006	241	1	doi	doi	NOUN
dpc-6006	241	2	:	:	PUNCT
dpc-6006	241	3	10.1007	10.1007	NUM
dpc-6006	241	4	/	/	SYM
dpc-6006	241	5	s11845	s11845	NOUN
dpc-6006	241	6	-	-	PUNCT
dpc-6006	241	7	021	021	NUM
dpc-6006	241	8	-	-	PUNCT
dpc-6006	241	9	02912	02912	NUM
dpc-6006	241	10	-	-	PUNCT
dpc-6006	241	11	9	9	NUM
dpc-6006	241	12	.	.	PUNCT
dpc-6006	242	1	pmid	pmid	NOUN
dpc-6006	242	2	:	:	PUNCT
dpc-6006	242	3	35546288	35546288	NUM
dpc-6006	242	4	4	4	NUM
dpc-6006	242	5	.	.	PUNCT
dpc-6006	243	1	leiter	leiter	PROPN
dpc-6006	243	2	u	u	PROPN
dpc-6006	243	3	,	,	PUNCT
dpc-6006	243	4	keim	keim	PROPN
dpc-6006	243	5	u	u	PROPN
dpc-6006	243	6	,	,	PUNCT
dpc-6006	243	7	garbe	garbe	PROPN
dpc-6006	243	8	c.	c.	PROPN
dpc-6006	243	9	epidemiology	epidemiology	PROPN
dpc-6006	243	10	of	of	ADP
dpc-6006	243	11	skin	skin	NOUN
dpc-6006	243	12	cancer	cancer	NOUN
dpc-6006	243	13	:	:	PUNCT
dpc-6006	243	14	update	update	NOUN
dpc-6006	243	15	2019	2019	NUM
dpc-6006	243	16	.	.	PUNCT
dpc-6006	244	1	adv	adv	PROPN
dpc-6006	244	2	exp	exp	NOUN
dpc-6006	244	3	med	med	ADJ
dpc-6006	244	4	biol	biol	NOUN
dpc-6006	244	5	.	.	PUNCT
dpc-6006	245	1	2020;1268:123	2020;1268:123	ADP
dpc-6006	245	2	-	-	SYM
dpc-6006	245	3	139	139	NUM
dpc-6006	245	4	.	.	PUNCT
dpc-6006	246	1	doi	doi	NOUN
dpc-6006	246	2	:	:	PUNCT
dpc-6006	246	3	10.1007/978	10.1007/978	NUM
dpc-6006	246	4	-	-	SYM
dpc-6006	246	5	3	3	NUM
dpc-6006	246	6	-	-	PUNCT
dpc-6006	246	7	030	030	NUM
dpc-6006	246	8	-	-	PUNCT
dpc-6006	246	9	46227	46227	NUM
dpc-6006	246	10	-	-	PUNCT
dpc-6006	246	11	7_6	7_6	NOUN
dpc-6006	246	12	.	.	PUNCT
dpc-6006	247	1	pmid	pmid	NOUN
dpc-6006	247	2	:	:	PUNCT
dpc-6006	247	3	32918216	32918216	NUM
dpc-6006	247	4	5	5	NUM
dpc-6006	247	5	.	.	PUNCT
dpc-6006	247	6	choquet	choquet	PROPN
dpc-6006	247	7	h	h	PROPN
dpc-6006	247	8	,	,	PUNCT
dpc-6006	247	9	ashrafzadeh	ashrafzadeh	ADP
dpc-6006	247	10	s	s	PROPN
dpc-6006	247	11	,	,	PUNCT
dpc-6006	247	12	kim	kim	PROPN
dpc-6006	247	13	y	y	PROPN
dpc-6006	247	14	,	,	PUNCT
dpc-6006	247	15	asgari	asgari	PROPN
dpc-6006	247	16	mm	mm	PROPN
dpc-6006	247	17	,	,	PUNCT
dpc-6006	247	18	jorgenson	jorgenson	PROPN
dpc-6006	247	19	e.	e.	PROPN
dpc-6006	247	20	genetic	genetic	PROPN
dpc-6006	247	21	and	and	CCONJ
dpc-6006	247	22	environmental	environmental	ADJ
dpc-6006	247	23	factors	factor	NOUN
dpc-6006	247	24	underlying	underlie	VERB
dpc-6006	247	25	keratinocyte	keratinocyte	NOUN
dpc-6006	247	26	carcinoma	carcinoma	NOUN
dpc-6006	247	27	risk	risk	NOUN
dpc-6006	247	28	.	.	PUNCT
dpc-6006	248	1	jci	jci	PROPN
dpc-6006	248	2	insight	insight	PROPN
dpc-6006	248	3	.	.	PUNCT
dpc-6006	249	1	2020	2020	NUM
dpc-6006	249	2	may	may	AUX
dpc-6006	249	3	21;5(10):e134783	21;5(10):e134783	VERB
dpc-6006	249	4	.	.	PUNCT
dpc-6006	250	1	doi	doi	NOUN
dpc-6006	250	2	:	:	PUNCT
dpc-6006	250	3	10.1172	10.1172	NUM
dpc-6006	250	4	/	/	SYM
dpc-6006	250	5	jci.insight.134783	jci.insight.134783	PROPN
dpc-6006	250	6	.	.	PUNCT
dpc-6006	251	1	pmid	pmid	NOUN
dpc-6006	251	2	:	:	PUNCT
dpc-6006	251	3	32434987	32434987	NUM
dpc-6006	251	4	6	6	NUM
dpc-6006	251	5	.	.	PUNCT
dpc-6006	252	1	mar	mar	PROPN
dpc-6006	252	2	vj	vj	PROPN
dpc-6006	252	3	,	,	PUNCT
dpc-6006	252	4	soyer	soyer	PROPN
dpc-6006	252	5	hp	hp	PROPN
dpc-6006	252	6	,	,	PUNCT
dpc-6006	252	7	button	button	NOUN
dpc-6006	252	8	-	-	PUNCT
dpc-6006	252	9	sloan	sloan	NOUN
dpc-6006	252	10	a	a	NOUN
dpc-6006	252	11	,	,	PUNCT
dpc-6006	252	12	et	et	PROPN
dpc-6006	252	13	al	al	PROPN
dpc-6006	252	14	.	.	PUNCT
dpc-6006	252	15	diagnosis	diagnosis	NOUN
dpc-6006	252	16	and	and	CCONJ
dpc-6006	252	17	management	management	NOUN
dpc-6006	252	18	of	of	ADP
dpc-6006	252	19	cutaneous	cutaneous	ADJ
dpc-6006	252	20	melanoma	melanoma	NOUN
dpc-6006	252	21	.	.	PUNCT
dpc-6006	253	1	aust	aust	PROPN
dpc-6006	253	2	j	j	PROPN
dpc-6006	253	3	gen	gen	PROPN
dpc-6006	253	4	pract	pract	PROPN
dpc-6006	253	5	.	.	PUNCT
dpc-6006	254	1	2020	2020	NUM
dpc-6006	254	2	nov;49(11):733	nov;49(11):733	PROPN
dpc-6006	254	3	-	-	PUNCT
dpc-6006	255	1	739	739	NUM
dpc-6006	255	2	.	.	PUNCT
dpc-6006	255	3	doi	doi	NOUN
dpc-6006	255	4	:	:	PUNCT
dpc-6006	255	5	10.31128	10.31128	NUM
dpc-6006	255	6	/	/	SYM
dpc-6006	255	7	ajgp-02	ajgp-02	PROPN
dpc-6006	255	8	-	-	PUNCT
dpc-6006	255	9	20	20	NUM
dpc-6006	255	10	-	-	PUNCT
dpc-6006	255	11	5238	5238	NUM
dpc-6006	255	12	.	.	PUNCT
dpc-6006	256	1	pmid	pmid	NOUN
dpc-6006	256	2	:	:	PUNCT
dpc-6006	256	3	33123704	33123704	NUM